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Abstract 
Complications from cardiovascular disease, such as a heart attack or a stroke, 
represent the leading cause of death in the United States and many developed and 
developing countries.   Atherosclerosis is the primary pathology underlying 
cardiovascular disease.  It is caused by an increase in endothelial cell (EC) permeability, 
leading to the buildup of cholesterol and lipids which form the atherosclerotic plaque.  
Accelerated aging in regions of atherosclerosis contribute to the development and 
progression of the disease. The global hypothesis that motivated this research was that 
activation of deacetylase antioxidant regulator, Sirtuin1 (SIRT1), improved function in 
senescent ECs by increasing the integrity of cell-cell junctions.  In turn, this led to 
elevated EC permeability, a decline in the response to shear stress, and elevated traction 
forces. 
Aging of hCB-ECs significantly increased permeability due to changes in tight 
junction protein localization and phosphorylation.  Activation of SIRT1 significantly 
reduced permeability in aged hCB-ECs and restored junction integrity.  ECs under flow 
also exhibited changes in cell junctions with increasing age.  Aged hCB-ECs were less 
responsive to shear stress, exhibiting lower levels of atheroprotective genes, KLF2 and 
eNOS.  Activation of SIRT1 in aged hCB-ECs restored the response to shear stress by 
altering localization and phosphorylation of adherens junction protein, VE-cadherin.  
  
v
The endothelial glycocalyx is a layer of proteoglycans and glycoproteins on the surface 
of ECs that is important in maintaining EC barrier function.  In aging ECs, the 
glycocalyx was thinner and less dense.  However, activation of SIRT1 restored the 
structure of the glycocalyx, suggesting that the positive effect of SIRT1 on elevated 
permeability in aged hCB-ECs may also be due to restoration of the glycocalyx.  Aged 
hCB-ECs also exhibited elevated traction forces for measurements done with single cells, 
cell clusters (2 to 3 cells), and cell monolayers (20 to 30 cells).  The elevated traction 
forces correlated with altered actin localization and increased actin filament thickness.  
Activation of SIRT1 reduced traction forces and decreased actin stress fiber thickness in 
aged hCB-ECs, suggesting that the effects of SIRT1 on cell-cell junctions alters binding of 
junction proteins to the actin cytoskeleton and generation of cell traction forces.  
Together, these results implicate an important role for SIRT1 in regulating permeability 
and mechanotransduction in aging endothelium. 
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Chapter 1. Introduction. 
1.1 Research Overview 
Complications from cardiovascular disease, such as heart attack and stroke, 
represent the leading cause of death in the United States and many developed and 
developing countries.  In 2008, approximately 672,000 people died of heart disease or 
stroke, which accounts for about 27% of all deaths.[148]  While mortality and morbidity 
is decreasing in the United States,[148] the incidence of the disease is increasing in 
developed countries such as China and India.  Atherosclerosis is the primary pathology 
underlying heart disease and stroke.  The disease is localized to large and medium sized 
arteries and involves a complex sequence of events in which the accumulation of lipids 
and cholesterol in the arterial intima initiates an inflammatory response.  The result is a 
thickened intima consisting of lipids, macrophages and smooth muscle cells.  The 
thickened intima can compromise blood flow or rupture, causing a thrombus to form, 
blocking blood flow and precipitating a heart attack or stroke.  The earliest events in the 
disease process involve changes to the function of endothelium leading to increased 
adhesion of leukocytes, altered permeability and decreased release of the vasodilator 
nitric oxide (NO). There are several risk factors for atherosclerosis including age, high 
cholesterol levels, diabetes, genetics, hypertension, and smoking.[35] 
There is evidence of accelerated aging of endothelial cells (ECs) in regions of 
atherosclerosis.   Senescent ECs in these lesion-prone areas exhibit elevated levels of 
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senescence-associated β-galactosidase [109] and telomere shortening.[123]   In 
atherosclerotic regions in both animals and humans, ECs undergo high cell turnover and 
are exposed to high levels of oxidative stress, which can lead to replicative senescence 
[13, 123] or stress-induced senescence.[54]  However, senescent ECs are not found in 
arteries that are free of atherosclerosis, suggesting that development of cell senescence is 
due to local, rather than systemic, changes.[109]  The development of atherosclerosis is 
also related to changes in EC function including decreased expression of endothelial 
nitric oxide synthase (eNOS) [32, 102] and elevated EC permeability [26, 27], both of 
which could be altered by cell senescence. 
The major goal of this research was to understand the effect of cell aging on 
permeability and mechanotransduction.  Further, we sought to identify the role of 
deacetylase antoxidant regulator SIRT1 in reversing age-associated phenotypes.  SIRT1 
levels have been shown to be low at vessel branches, which are regions of low and 
oscillating shear stress.[24]  These are also regions where the endothelial glycocalyx, 
which plays an important role in EC barrier function and nitric oxide (NO) generation, is 
degraded.[57, 192]  This suggests a possible link between EC mechanosensing and 
SIRT1.  While the relationship between SIRT1 and cell aging has been well-studied, its 
impact on age-associated changes in endothelial cell function is not well understood.   A 
better understanding of endothelial cell aging and SIRT1 could lead to improved 
treatments for atherosclerosis. 
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The specific aims for this project are to (1) evaluate the effect of cell senescence 
on albumin permeability of blood-derived endothelial cells, (2) determine a role for 
SIRT1 in regulating cell mechanotransduction in the aging endothelial cell response to 
shear stress, and (3) examine the effect of endothelial cell aging on cell traction forces for 
isolated cells and clusters.  
In Chapter 2, we addressed Specific Aim 1 by measuring albumin permeability 
in aging endothelial cells.   We used the Transwell permeability assay to measure 
permeability of young and old hCB-ECs and to compare these with values from human 
aortic ECs (HAECs).  We then examined the role of cell proliferation and changes in cell 
junction protein expression and localization, as possible reasons for elevated 
permeability in aged cells.  Lastly, we examined how activation of SIRT1 with several 
agents could alter permeability and cell junctions. 
In Chapter 3, we addressed Specific Aim 2 by using qRT-PCR to measure change 
in gene expression as aging ECs were subjected to steady shear stress.  Decreased 
responsiveness in aged ECs was attributed to changes in cell mechanotransduction.  We 
assessed changes in both the structure and function of the glycocalyx and VE-cadherin 
using immunofluorescence and Western blots.  We further established a role for SIRT1 
in regulating cell mechanotransduction by using activators and inhibitors, as well as by 
using transient siRNA transfection to knockdown SIRT1.  Upon altering SIRT1, we 
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subsequently examined changes in the response to shear stress as well as changes to the 
glycocalyx and VE-cadherin. 
In Chapter 4, we addressed Specific Aim 3 by examining changes in isolated EC 
traction forces with increasing age.  We then examined how increased traction forces in 
aged ECs correlated with changes in the actin cytoskeleton and elevated permeability.   
Furthermore, we examined the role of SIRT1 in reversal of age-associated increase in 
traction forces by treating ECs with activators and inhibitors of SIRT1 and then 
monitoring changes in traction forces and actin. 
In Chapter 5, we further addressed Specific Aim 3 by examining changes in EC 
traction forces for clusters of cells and confluent monolayers.  We compared these values 
with those obtained for isolated cells.  The effect of different SIRT1 treatments was then 
evaluated for cell clusters.  We further examined the role of actin and RhoA, a protein 
important in cell contractility, in age-associated changes in traction forces. 
In Chapter 6, we summarize the main results and conclusions from this work. 
We also discuss future directions and implications of this work. 
1.2 Role of Endothelium in Maintaining Tissue Homeostasis 
1.2.1 Function of Endothelial Cells in Blood Vessel 
Endothelial cells comprise the inner lining of blood vessels.  They are 
surrounded by a layer of smooth muscle cells, which aid in vessel dilation and 
constriction.  ECs form a barrier between the blood and other layers of the blood vessel, 
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thereby regulating transport of molecules across the endothelium.  ECs are also 
important in blood clotting and inflammation responses.  Specific cell surface markers 
including CD34, von Willebrand factor, and VE-cadherin can be used to characterize 
and identify ECs.   The presence of these markers can be verified with either flow 
cytometry or immunofluorescence. 
1.2.2 Influence of Vascular Geometry on Endothelial Cell Function 
and Atherogenesis 
Vascular geometry influences the local flow properties and the initiation of 
atherosclerosis.[117]  Atherogenesis tends to occur at specific locations, such as vessel 
branches and regions of curvature, in the blood vessel.  In these areas, there is significant 
variation in flow fields and shear stress [91, 117] and lesion formation and intimal 
thickening are correlated with low and oscillating shear stresses that change 
direction.[92]..  ECs in these regions are polygonal in shape and are prone to express 
adhesion molecules for leukocytes and release cytokines, which promotes the 
development of atherosclerosis.[33]  In contrast, regions away from branches or regions 
of curvature are exposed to a unidirectional pulsatile shear stress.[117]  The ECs are 
quiescent and express proteins that limit platelet and leukocyte adhesion and are anti-
inflammatory.[38]  A number of factors influence the development of atherosclerosis 
including biomechanical changes to the cell after exposure to uniform and laminar 
shear, fluid flow types, and the interaction of local hemodynamics and risk factors. 
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1.2.3 Transport in the Endothelium 
 The endothelium plays an important role in regulating water and 
macromolecular transport, leukocyte adhesion and transmigration, vessel remodeling, 
apoptosis, generation and metabolism of biochemical substances, and modulation of 
smooth muscle cell (SMC) function and proliferation [36].  Endothelial cells (ECs) 
respond to mechanical forces such as shear stress by modulating signaling pathways 
and overall cell function.[31]  As a result, the local hemodynamics impact EC vascular 
homeostasis and influence the development of atherosclerosis.  Transport of monocytes 
by arterial fluid dynamics and subsequent adhesion to activated endothelium may also 
influence the location of atherosclerotic lesions.[164] 
An increase in the permeability of the endothelial layer to proteins influences the 
development and progression of atherosclerosis.[118, 157]  Localized sites of elevated 
endothelial permeability occur at lesion-prone regions of arteries prior to the onset of 
atherosclerosis.[79]  Such sites of increased permeability likely represent increased 
transport through endothelial cell junctions.[20, 79, 157] 
1.2.4 EC Dysfunction Near Atherosclerotic Lesions 
 There are a number of changes that occur to blood vessel ECs during 
atherosclerosis including increased adhesion of leukocytes, altered permeability, 
disintegration of the glycocalyx,[57, 192] and decreased release of the vasodilator nitric 
oxide (NO).  The glycocalyx plays an important role in maintaining the endothelial 
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barrier and regulating levels of NO, which are important in maintaining EC function.[57, 
192]  Additionally, ECs in regions prone to develop atherosclerosis experience high cell 
turnover and high oxidative stress, which leads to replicative senescence and stress-
induced senescence.  When ECs in the arterial endothelium undergo senescence, they 
become larger, are unable to divide, resist apoptosis, and contribute to a loss of tissue 
homeostasis,[17] which can ultimately lead to cardiovascular disease development.   In 
these regions, the glycocalyx is less abundant.  While higher oxidative stress alters the 
glycocalyx in young ECs, changes to the glycocalyx during cell senescence are not 
understood. 
1.2.5 Role of SIRT1 in Regulating EC Permeability 
Both gene and protein expression levels of deacetylase SIRTUIN1 (SIRT1) have 
been shown to be reduced in senescent ECs [199].  In contrast, the protein levels of LKB1, 
a serine/threonine kinase and tumor suppressor, and the phosphorylation of its 
downstream target AMPK(Thr172) were are high in senescent cells.  Overexpression of 
LKB1 or hyperphosphorylation of AMPK (Thr172) promoted cellular senescence and 
decreased endothelial proliferation.[199] 
In primary porcine aortic endothelial cells [199], human embryonic kidney 293T 
cells [95], and mouse liver cells,[95] the deacetylase SIRTUIN1 (SIRT1) promoted 
proliferation and prevents senescence by downregulation and deacetylation of liver 
kinase B1 (LKB1), a serine/threonine kinase and tumor suppressor.   Senescence could be 
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reversed by knocking down LKB1 with siRNA or by downregulating LKB1 via 
activation of SIRT1 with Resveratrol.[199]  Reversal of senescence via these pathways 
also increased EC proliferation.[199]  Knocking down of SIRT1 induced senescence and 
elevated the protein levels of LKB1 and phosphorylated AMPK(Thr172). 
 
Figure 1: Resveratrol inhibits PDE4 to activate the Epac1-Rap1 pathway.  This 
increases junctional VE-cadherin and a subsequent decrease in permeability. 
Resveratrol indirectly activates SIRT1 via competitive inhibition of cAMP-
degrading phosphodiesterases.[128] Elevated levels of membrane-associated cAMP 
activate the cyclic AMP-regulated guanosine nucleotide exchange factor Epac1 which, in 
turn, leads to guanosine triphosphate (GTP) binding to the small G protein Rap1 [128].  
GTP bound Rap1 activates SIRT1 but also causes changes to the cortical cytoskeleton 
and organization of VE-cadherin in the endothelial junctions [42], leading to reduced 
endothelial permeability.[59]    Thus, changes that occur during cell aging which affect 
the pathway leading to SIRT1 activity may also elevate permeability through endothelial 
junctions. 
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1.3 Blood-Derived Endothelial Cells 
Late-outgrowth endothelial progenitor cells (EPCs) derived from umbilical cord 
blood (hCB-ECs) are a suitable model to study cell aging because these cells undergo a 
significant number of population doublings in vitro and their permeability is close to 
values for large artery permeability in vivo.[1, 11]  Additionally, these cells express EC 
molecular markers and no markers for monocytes or macrophages, and respond to flow 
in the same manner as large vessel endothelium.[1, 11]  ECs that possess the high 
proliferative potential of late-outgrowth EPCs can be isolated from arterial 
endothelium.[11, 80, 89]  Progenitor cells from young animals injected into older animals 
preferentially localize to sites of endothelial dysfunction and reverse atherosclerosis in 
older animals.[138]  This result suggests that a decline in progenitor cell adhesion, 
incorporation into the endothelium and function with age may influence the onset and 
progression of atherosclerosis.  Further, endogenous bone marrow-derived circulating 
EPCs adhere to sites of acute endothelial injury, such as vein grafts.[190, 197]  
 
1.4 Response of Endothelium to Steady Unidirectional Flow 
1.4.1 Unidirectional Shear Stress Causes Rearrangement of Cell 
Cytoskeleton 
In vitro, exposure of confluent endothelial cells to steady or unidirectional shear 
stress induces a change in shape and orientation such that the cells are elongated and 
aligned in the direction of flow.[44]  Such EC organization is observed in vivo away from 
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vessel branches whereas around vessel branches, ECs exhibit a rounder shape without 
any preferred orientation.[44]  The endothelial cell actin cytoskeleton reorganizes in 
response to shear stress, aligning in the direction of flow.  Prominent actin stress fibers 
appear [58] and cell proliferation is inhibited.   
The dynamic response to shear stress reflects the different signaling pathways 
activated by fluid shear stress.  Within 15 seconds of application of shear stress, a 
complex is formed in endothelial cell junctions involving VE-cadherin, platelet-
endothelial cell adhesion molecule (PECAM) and vascular endothelial growth factor 
receptor 2 (VEGFR2).[166] After binding VEGF, VEGFR2, as part of the 
mechanotransduction complex, binds to phosphatidylinositol-3-OH kinase (PI(3)K) 
which activates integrins initiating responses such as Jun NH2-terminal kinase (JNK) 
activation, nuclear factor κB (NFκB) activation and nuclear translocation [68]  which 
then leads to expression of adhesion molecules for leukocytes and secretion of MCP-1. 
PI(3)K also activates the protein kinase B or Akt which leads to activation of NOS III and 
other early anti-inflammatory responses.  In addition to transient pro-inflammatory 
activity, JNK is phosphorylated and localizes to focal adhesions.  There, the JNK focal 
adhesion complex promotes EC alignment under unidirectional shear stress.[70] 
The longer-term response to shear stress takes several hours or days and 
involves activation of the mitogen activated protein kinase 5 (MEK5) by transient 
increases in reactive oxygen species.  In turn, MEK5 phosphorylates extracellular signal-
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regulated kinase 5 (ERK5) which then activates the transcription factor myocyte 
enhancement factor 2(MEF2).[130]    In turn, MEF2 promotes KLF2 expression. Further, 
KLF2 expression and Nuclear Factor-like 2 (Nrf2) produce antioxidants that control the 
intracellular levels of ROS, limiting activation of NFκB.[119] The PECAM/VE-
Cadherin/PI(3)K and MEK/ERK5/MEF2 pathways activated by shear stress intersect in 
several ways to modulate the response to flow.  Shear mediated activation of PI(3)K and 
Akt leads to the activation of Nrf2[43]  which influences KLF2 activation.[84]   KLF2 
regulates actin cytoskeleton organization which regulate the level of JNK and its 
downstream mediators, thereby limiting the pro-inflammatory response of steady and 
pulsatile shear stress.[8]   
1.4.2 Unidirectional Flow and Shear Stress Promote an Anti-
Thrombotic and Anti-Inflammatory Phenotype   
A key physiological response to flow in vivo is the release of NO, which causes 
vessel dilation. NO is produced in ECs by endothelial nitric oxide synthase (eNOS or 
NOS III) [15].  NO diffuses to smooth muscle where it acts upon soluble guanylate 
cyclase to alter production of cyclic GMP that decreases the activity of myosin light 
chain kinase, causing relaxation of the muscle.  When ECs are exposed to steady or 
pulsatile unidirectional shear stress, NO production increases due to a change in the 
activity of NOS III followed by a sustained increase in NOS III levels.[75]  Changes in 
brachial artery dilation are used to assess endothelial dysfunction in early 
atherosclerosis.[71]  In addition to serving as a potent vasodilator, NO inhibits 
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expression of monocyte chemoattractant protein-1 (MCP-1) and vascular cell adhesion 
molecule-1 (VCAM-1), prevents SMC proliferation, and decreases platelet 
aggregation.[127] 
The zinc-finger transcription factor Kruppel-like factor 2 (KLF-2) is a key 
regulator of oxidative and inflammatory responses to shear stress.[46, 130] This 
transcription factor is expressed by endothelial cells but not expressed by SMC in 
mature blood vessels.[46] KLF-2 exhibits continued high levels of expression after 7 days 
exposure to a pulsatile shear stress of 1.2 Pa in vitro [46] due to stabilization of mRNA 
levels by shear stress [171] and down-regulation of microRNA-92 which inhibits KLF-2 
protein levels.[187] KLF-2 induces NOS III and the anti-thrombotic molecule 
thrombomodulin, and inhibits cytokine-induced expression of VCAM-1 and E-selectin, 
but does not affect cyclooxygenase 2, which is involved in PGI2 production.[152] KLF-2 
overexpression blocks VCAM-1 and E-selectin expression by blocking activation of 
NFκB. 
1.4.3 Shear Stress Regulates Metabolic Activity 
A key regulator of metabolic activity sensitive to shear stress is SIRTUIN1 
(SIRT1) that deacetylates proteins that regulate antioxidant activity and energy balance, 
promotes proliferation, and prevents senescence.  Steady and pulsatile shear stress of 1.2 
Pa increase SIRT1 levels and mitochondrial biosynthesis.[23]  Shear stress also elevates 
adenosine monophosphate (AMP)-activated protein kinase (AMPK), which regulates 
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energy metabolism and facilitates the ability of SIRT1 to activate NOS III [23].  
Interestingly, SIRT1 elevates KLF2 levels providing an important regulatory loop that 
promotes an anti-oxidative environment and limit cell aging when ECs are exposed to 
unidirectional shear stress.[65] 
The application of shear stress causes a number of very rapid changes including 
ion channel opening, production of reactive oxygen species (ROS), activation of G 
proteins and focal adhesion movement.[44]   Potential mechanisms initiating these 
processes likely involve the glycocalyx, a soft layer of proteoglycan on the cell surface; 
primary cilia which extend from the endothelial cell surface; cytoskeleton deformation 
and focal adhesions.[45]  However, the manner by which the applied stress is translated 
into a chemical signal has yet to be established. 
1.5 Response of Aged ECs to Fluid Shear Stress 
Aging at the cellular level is associated with replicative senescence or stress-
induced senescence.  For replicative senescence, the cell doubling time increases and 
ultimately ceases with increasing cell age due to telomere shortening which protects 
against genetic mutation.[53]  Stress-induced senescence is primarily caused by 
environmental stresses such as intracellular oxidative stress, DNA damage by radiation, 
or chromatin decondensation.  Endothelium at lesion-prone sites and on advanced 
lesions show signs of advanced aging, including elevated levels of β-galactosidase, a 
histochemical marker for senescence,[108] and telomere shortening.[122] ECs near 
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atherosclerotic lesions often experience high cell turnover and high levels of oxidative 
stress, induced by a combination of the reversing oscillatory flow and presence of risk 
factors for cardiovascular disease. 
Cell energy metabolism is altered during senescence. In particular, levels of 
SIRT1 are reduced which also reduces a number of anti-thrombotic and anti-
inflammatory genes.[53]  NO release is impaired as ECs age and NOS III production 
induced by shear stress is reduced in senescent human ECs [102]. Following exposure to 
TNFα or short periods of shear stress, senescent ECs exhibit greater monocyte adhesion 
than do younger ECs.[102]  When levels of human telomerase, a reverse transcriptase, 
are elevated in late passage human ECs, NOS III levels are increased and monocyte 
adhesion is reduced.  Previous studies have shown that drugs that activate the Sirtuins 
activate eNOS through a cAMP/PKA- and PI3K/Akt-dependent pathway by inducing 
the phosphorylation of eNOS at Ser1177.[125, 134]  NO has also been shown to activate 
the SIRT1 promoter in white adipose tissue.[120] Additionally, SIRT1 deacetylates and 
activates the eNOS enzyme [103], indicating that a positive feedback mechanism exists 
between these two key signaling molecules. 
Elevating SIRT1 levels reverses EC senescence.  Resveratrol has been used to 
reduce age-associated metabolic phenotypes [129] and it may mitigate symptoms 
associated with atherogenesis.  Resveratrol acts upon SIRT1 via competitive inhibition of 
phosphodiesterase 4 which causes elevated cAMP levels.[129]  The resulting elevation of 
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cAMP activates effector protein Epac1, and sequentially increases Rap1, intracellular 
Ca2+ and activates the CamKKβ-AMPK pathway to activate SIRT1.[129]  Elevated cAMP 
levels cause a decrease in endothelial permeability by activation of protein kinase A 
which then inactivates myosin light chain kinase [105] or activates Epac-mediated 
Rap1.[59]  Further, membrane associated cAMP bound to Epac1 interacts with 
phosphodiesterase 4, to bind to VE-cadherin [137] and regulates endothelial 
permeability by redistributing tight junction molecules to cell junctions.[42] Given the 
shear stress sensitivity of SIRT1 and VE-cadherin, shear stress should influence EC 
senescence. 
Studies suggest that there are similarities between exposure to shear stress and 
aging.    Cyclin-dependent kinase inhibitor 2A and 2B, which reduce cell proliferation, 
are elevated by both aging and exposure to 1.2 Pa shear stress for 24 hours.[114]  
Expression of NADPH oxidase 4 is reduced by unidirectional shear stress and aging.   
NADPH oxidase 4 promotes production of oxygen radicals, and a reduction in the level 
of this enzyme protects the aging ECs from oxidative damage.  This is offset by a 
reduction in aging cells of NOS III and argininosuccinate synthetase 1; the levels of these 
enzymes are elevated by shear stress in older ECs, although to a less extent than 
younger cells.[114]  Argininosuccinate synthetase 1 catalyzes the rate-limiting step of 
arginine biosynthesis and can regulate NO release and monocyte adhesion independent 
of NOS III levels.[113]  Increased monocyte adhesion in older ECs exposed to TNFα is 
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due to a reduction in NO release and an increase in the expression of CD44, which can 
bind to leukocytes, but not to changes in the levels of leukocyte adhesion molecules 
VCAM-1, ICAM-1and E-selectin.[112]  Interestingly, CD44 levels are not affected by 
exposure of older ECs to shear stress.[112] 
There is evidence that EPCs from elderly patients can become more responsive to 
shear stress through activation of specific pathways, such as the CXCR4/Janus kinase 
pathway.[189]  Peripheral blood late-outgrowth EPCs that are isolated from elderly 
patients have decreased migration and adhesion in vitro and reduced reendothelization 
in vivo in nude mice with carotid artery denudation injury.[189]  However, when the 
EPCs are pretreated with 15 dynes/cm2 shear stress for 12 hours, there is enhanced 
migration, adhesion, and reendothelization.  The authors show that upregulation of the 
CXCR4/Janus kinase pathway under shear stress may play a role in the improved 
function of the EPCs from elderly individuals.[189]  Additionally, loss of function of 
transient receptor potential cation channel subfamily V member 4 (TRPV4) gene in ECs 
has also been shown to decrease response to shear stress by decreasing vasodilation.  
TRPV4 is involved in the synthesis of nitric oxide and in endothelium-derived 
hyperpolarizing factor (EDHF) signaling.[76] 
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1.6 Endothelial Glycocalyx  
1.6.1 Composition 
The glycocalyx is composed of membrane-bound glycoproteins on the surface of 
endothelial cells and is important in regulating the endothelial barrier [78, 183] and the 
response to shear stress.[57, 111, 192]  The glycocalyx consists of glycoproteins bearing 
acidic oligosaccharides with terminal sialic acids (SA), and proteoglycans with 
associated glycosaminoglycans of heparan sulfate, chondroitin sulfate, and hyaluronic 
acid.   
1.6.2 Endothelial Glycocalyx in Disease Development 
Changes in the glycocalyx in both microvasculature and microvasculature have 
been shown to lead affect disease development.  Disruption of the glycocalyx in 
capillaries will increase the permeability of capillary beds.[150]  If this occurs in the 
glomerulus of the kidneys, it can lead to albuminuria.[150]  Increased systemic 
microvascular permeability, which can lead to ischemia and diabetes, is also a possible 
consequence of endothelial glycocalyx disruption.[150]  Disintegration of the glycocalyx 
also leads to cardiovascular pathologies, including atherosclerosis.[168] 
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1.6.3 Role of Glycocalyx in Mechanosensing 
 
Figure 2: Cell under A) static and B) flow conditions.  Glycocalyx experiences 
drag under flow conditions, which also affect ATP generation.  Tension is transmitted 
to the lateral borders and basal membrane, where adhesion receptors, such as VE-
cadherin or integrins, experience changes in tension. Adapted from Hahn et al (2009). 
Heparan sulfate has been previously shown to co-localize with VE-cadherin at 
the periphery of the cell for ECs exposed to shear stress.[192]  Degradation of heparan 
sulfate blocked shear-induced VE-cadherin junctional localization and led to an increase 
in cell migration and proliferation.[192]  Enzymatic degradation of sialic acid, heparan 
sulfate, and hyaluronic acid from the surface of bovine aortic endothelial cells blocked 
shear-induced NO production.[126]  Heparan sulfate is a primary component of the 
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glycocalyx and acts as a mechanosensor by mediating NO production in response to 
shear stress.[57]  Furthermore, heparan sulfate-matrix interactions are involved in 
regulating cell migration when cells are exposed to shear stress.[111]  Other components 
of the glycocalyx, including syndecan-1 and glypican-1, have been shown to be 
important in mechanotransduction.  Syndecan-1 is a transmembrane protein linked to 
the cytoskeleton.  Knockdown of syndecan-1 induces a pro-inflammatory state [172] and 
prevents activation of RhoA.[172]. Glypican-1 is a protein present on the surface of the 
ECs that regulates the activation of eNOS by fluid shear stress.[50] For ECs under flow, 
the cell experiences drag from the glycocalyx.  This tension at the surface of the cell is 
transmitted to the lateral borders and the basal membrane, where adhesion receptors, 
such as PECAM, VE-cadherin, or integrins, experience changes in tension.[69]  ECs 
exposed to laminar, uniform, unidirectional shear stress for at least 24 hours are known 
to realign and elongate along the direction of fluid flow.[48, 144]  When ECs are treated 
with heparinase, an enzyme that degrades heparan sulfate, there is no realignment of 
ECs in the direction of flow.[192]  Knockdown of syndecan-1 also prevents cytoskeleton-
dependent alignment of ECs after exposure to shear stress.[50]  Furthermore, VE-
cadherin does not redistribute to cell-cell junctions after treatment with heparinase 
suggesting that heparan sulfate and VE-cadherin interact for cytoskeletal rearrangement 
after EC exposure to flow.[192]  It is likely that the role of the endothelial glycocalyx in 
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aging endothelial cells is important because of its function as a mechanosensor and its 
role in regulating permeability. 
1.6.4 Visualization of Glycocalyx 
Visualization of the glycocalyx is important to establish its presence and exact 
role in disease development.  There are several methods that have been used to detect 
the glycocalyx including immunofluorescence staining and transmission electron 
microscopy (TEM).[143]  Components of the glycocalyx, such as heparan sulfate, can be 
labeled with antibodies and visualized on the confocal microscope.  One drawback to 
this technique is the dehydration of the tissue during aldehyde fixation, limited 
resolution of the confocal microscope to tenths of micrometers, and glare from 
fluorescent labels.[51]  Another drawback of immunofluorescence staining is that 
antibodies label specific components of the glycocalyx and the antibodies used varies in 
the literature.[51]  Heparan sulfate antibodies (US Biological) are commonly used to 
measure the glycocalyx thickness and density.  However, antibodies for heparan sulfate 
core proteins, such as perlecan, have also been used as a measure of glycocalyx thickness 
and density.[77]  While perlecan is a basement membrane protein, it has been shown to 
be secreted to the luminal endothelial cell surface.[72]  Methods for immunofluorescence 
of the glycocalyx typically use low percentages (~2%) of formaldehyde for fixation to 
minimize damage to the glycocalyx.[50, 192, 195] 
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In conventional TEM, live cells or tissue are prepared for microscopy by 
aldehyde fixation followed by alcohol dehydration.  Because the glycocalyx is very 
delicate and easily disturbed, this type of sample preparation can compromise the 
integrity of the layer leading to discrepancies in results.[51] Ebong et al have described 
measurement of the endothelial glycocalyx using rapid freezing/freeze substitution 
(RF/FS) TEM to preserve the structure.[51]  This technique involves aldehyde fixation 
and then rapid freezing using a liquid nitrogen slam freezer.  The frozen vitrified liquid 
is then replaced with acetone.  Thin 80nm sections are then cut in the sample and 
imaged with TEM.  The group measured a glycocalyx thickness of 11µm in the 
macrovascular bovine aortic endothelial cells.[51]  This value is much closer to values 
reported for large arteries in vivo.  Results from the work indicate that the elimination of 
the alcohol dehydration steps traditionally used in TEM leads to a better preserved 
glycocalyx.  A drawback of RF/FS TEM is that individual components of the glycocalyx 
cannot yet be labeled.  However, it is possible that a technique could be developed to 
use a metal, like gold, to label components for imaging on the TEM that would allow 
researchers to better study individual glycocalyx components. 
Another promising technique to visualize the glycocalyx, especially for ex vivo 
and in vivo samples, is two-photon microscopy.  The use of two photons of longer 
wavelengths, will allow for better penetration depth of the tissue, better resolution, 
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optical sectioning, and low phototoxicity.  Additionally, the technique can be used in 
vivo to visualize dynamic changes in the glycocalyx in large vessels.[104] 
1.7 Endothelial Cell Traction Forces 
The spatial distribution of forces a cell exerts on its substrate can be measured 
using Traction Force Microscopy.  To measure these forces, cells are seeded onto either 
gels containing fluorescent beads [141] or PDMS microposts.[154]  Confocal images are 
taken of the cells before and after cell removal by trypsin.  The displacement of either the 
beads or microposts is used to calculate the spatial distribution of tractions across the 
cell. 
Traction forces in endothelial cells play a role in cell migration and adhesion with 
forces being highest at the ends of the pseudopodia.[141]  Age-related intimal stiffening 
of bovine aortic endothelial cells has been shown to increase cell traction forces.  This 
result also correlated with increased actomyosin cell contractility.  Traction forces were 
also higher for stiffer substrates, which correlated with an elevated permeability of stiff 
substrates.  This suggests that cell stiffening can alter traction forces and 
permeability.[87]   
Endothelial cells exert stress on the substrate and on neighboring cells through 
the linkages formed by the cytoskeleton connections to integrins bound to their 
extracellular matrix protein ligands.  Stresses between individual cells and substrate 
depend upon the type and amount of extracellular matrix ligand and the elasticity of the 
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substrate.  In spite of the nonuniform distribution of traction stresses, confluent layers of 
ECs exhibit a uniform distribution of intracellular tension.[86]  After exposure to flow 
for 16 hours, the EC traction force was slightly greater for cells exposed to steady shear 
stress than for cells under static conditions or exposed to a recirculating flow.[161]  
Steady flow also caused the surface traction force vectors to align in the direction of 
flow, whereas the surface traction force vectors exhibited no preferred direction for cells 
under static conditions or exposed to the recirculating flow.  These differences in the 
traction forces in response to unidirectional shear stress led to greater intercellular forces 
that were associated with increased levels of endothelial junction proteins. After 24 
hours exposure to unidirectional flow, significant anisotropy in intracellular tension 
arose, with higher values normal to the direction of flow, possibly reflecting the 
reorganization of the cytoskeleton.[86]  Interestingly, the tension induced by shear stress 
is much less than the intracellular tension, suggesting that while changes to the 
intracellular tension are initiated by shear stress, the magnitude of the intracellular 
tension reflects biochemical changes within the cell [86] as well as cell-cell and cell-
substrate interactions. 
1.8 Motivation and Significance 
There are several important risk factors for the development of atherosclerosis 
and cardiovascular disease, including age, genetics, and lifestyle.  While regions of 
atherosclerosis contain cells that have undergone accelerated aging, the relationship 
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between the two remains unclear.  The motivation of this work is to better understand 
how cell senescence affects both the structure and function of different components of 
the cell.  Furthermore, we seek to find feasible targets that can reverse age-associated 
phenotypes in aging ECs.  Current models for studying vascular endothelium include 
aortic ECs from either human or bovine sources.  However, these cell sources are limited 
by the number of population doublings they can undergo.  Human cord blood-derived 
endothelial cells (hCB-ECs) represent a promising source for studying cell aging because 
of their high proliferative potential in subconfluent cultures and their low, physiological 
permeability.  Development of this aging model will allow others to studying EC aging 
and treatments for age-associated diseases.  In this work, we also elucidate the role of 
SIRT1 in regulating permeability, cell mechanotransduction, and cell contractility.  
SIRT1 may be a potential target for therapies that aim to reduce or reverse age-
associated pathologies. 
1.9 Specific Aims 
This research aims to better understand the effect of cell aging on EC 
permeability and mechanotransduction. We hypothesize that 1) aged ECs will exhibit 
increased permeability due to changes in tight junction protein expression and 
localization, and increased senescence, 2) aged ECs have a decreased expression of 
atheroprotective genes KLF2 and eNOS due to altered mechanotransduction, and 3) 
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aged ECs exhibit increased cell traction forces caused by alterations to actin.  Specific 
Aims to address this hypothesis are:  
Specific Aim 1: Evaluate effect of cellular senescence on albumin permeability of 
blood-derived endothelial cells 
The goal of this aim is was to measure permeability in aging cord blood-derived 
endothelial cells and to compare these values with those from human aortic endothelial 
cells.  We hypothesized that increased cell age would lead to increased permeability due 
to changes in cell junctions.  Albumin permeability across low passage hCB-EC and 
human aortic endothelial cells (HAECs) monolayers were be measured using Transwell 
membranes. The expression and localization of tight junction protein occludin, ZO-1, 
and ZO-2, and tyrosine phosphorylation of occludin in hCB-ECs and HAECs were 
investigated as the basis for the difference in permeability.  Rates of proliferation and 
mitosis were also be determined in both cell types.  To age the cells in culture, hCB-ECs 
will be passaged (1:10 split).  hCB-ECs of >44 population doublings will be compared to 
hCB-ECs of < 31 population doublings in terms of permeability measurements and 
junction protein expression.    Cell age was confirmed using a telomerase assay.  High 
passage hCB-ECs were treated with activators SIRT1 to determine whether the elevated 
permeability levels can be reduced by reducing cellular senescence. 
Specific Aim 2: Evaluate effect of glycocalyx on aged cell response to flow. 
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The goal of this aim is to determine how EC aging affects cell 
mechanotransducers and the response to shear stress.  We hypothesized that EC aging 
and senescence alters both the structure and function of the glycocalyx and VE-cadherin 
to alter the response of ECs to shear stress.  Young and old ECs derived from late 
outgrowth hCB-ECs in umbilical cord blood were subjected to unidirectional, 
physiological shear stress.  Using immunofluorescence, we determined whether changes 
in glycocalyx composition affect VE-cadherin localization and VE-cadherin organization.  
We also assessed whether changes to the glycocalyx are associated with the altered 
response to shear stress in aged ECs.  qRT-PCR for KLF2 and eNOS gene expression 
levels were used to show whether treatment with how treatments that affect SIRT1 alter 
the response to flow.  We used immunofluorescence and Western blots to further 
investigate whether improvements in the response to flow are due to changes in the 
glycocalyx or VE-cadherin organization. 
Specific Aim 3: Examine the effect of aging on cell traction forces. 
The goal of this aim is to determine how cell aging alters EC traction forces for 
isolated ECs and clusters of ECs.  We hypothesize that aging will have increased traction 
forces due to changes in actin.  Traction force microscopy was used to measure cell 
traction forces and immunofluorescence will be used to measure changes in actin.   
Western blots will be used to detect changes in RhoA with increased cell age.  We will 
also use different activators and inhibitors, as well as knockdown, of SIRT1 to determine 
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its role on cell traction forces and actin.  We will further determine the role of the 
endothelial glycocalyx on regulating cell traction forces, because both are important in 
maintaining low permeability levels in endothelial monolayers. 
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Chapter 2. Effect of Cellular Senescence on Albumin 
Permeability of Blood-Derived Endothelial Cells. 
2.1 Introduction 
The vascular endothelium plays a key role in the regulation of transport of 
macromolecules and water into tissues and blood vessels.  An increase in the 
permeability of the endothelial layer to proteins influences the development and 
progression of atherosclerosis [118, 157].  Localized sites of elevated endothelial 
permeability occur at lesion-prone regions of arteries prior to the onset of atherosclerosis 
[79].  Such sites of increased permeability likely represent increased transport through 
endothelial cell junctions [20, 79, 157].  
As cells age, morphological and physiological changes occur that may alter 
macromolecular transport and subsequent disease development.  Aging at the cellular 
level is associated with replicative senescence or stress-induced senescence [54].  
Senescent cells become more frequent in aging individuals, exhibit an altered 
phenotype, contribute to a loss of tissue homeostasis, and play a role in the development 
of age-associated pathologies [17].  Elevated levels of β-galactosidase, a histochemical 
marker for senescence, have been found in atherosclerotic lesions [109].  Because 
endothelial cells at sites that develop atherosclerosis often experience high cell turnover, 
endothelial cells in these regions exhibit greater replicative senescence [13, 123] that may 
be linked to altered permeability.  Additionally, environmental stresses in atheroprone 
regions of blood vessels may induce premature senescence [54]. 
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The deacetylase SIRTUIN1 (SIRT1) promotes proliferation and prevents 
senescence by targeting liver kinase B1 (LKB1), a serine/threonine kinase and tumor 
suppressor, in primary porcine aortic endothelial cells [199].  Senescence can be reversed 
by knocking down LKB1 with siRNA or by downregulating LKB1 via activation of 
SIRT1 with Resveratrol [199].  Resveratrol indirectly activates SIRT1 via competitive 
inhibition of cAMP-degrading phosphodiesterases [128]. Elevated levels of membrane-
associated cAMP activate the cyclic AMP-regulated guanosine nucleotide exchange 
factor Epac1 which, in turn, leads to guanosine triphosphate (GTP) binding to the small 
G protein Rap1 [128].  GTP bound Rap1 activates SIRT1 but also causes changes to the 
cortical cytoskeleton and organization of VE-cadherin in the endothelial junctions [42], 
leading to reduced endothelial permeability [59].    Thus, changes that occur during cell 
aging which affect the pathway leading to SIRT1 activity may also elevate permeability 
through endothelial junctions.    
Endothelial cells (ECs) derived from late outgrowth endothelial progenitor cells 
(EPCs) in human umbilical cord or adult blood represent a promising source of 
endothelium for applications in regenerative medicine [1, 11, 12].  These cells express 
many of the molecular markers found on large vessel endothelium [11, 80, 89], and 
respond to flow in the same manner as large vessel endothelium [1, 11]. ECs that possess 
the high proliferative potential of late-outgrowth EPCs can be isolated from arterial 
endothelium [88].  Circulating EPCs do not appear to contribute significantly to the 
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endothelium overlying atherosclerotic lesions [67].  Progenitor cells from young animals 
injected into older animals preferentially localize to sites of endothelial dysfunction and 
can reverse atherosclerosis in older animals [138]. This result suggests that a decline in 
progenitor cell adhesion, incorporation into the endothelium and function with age may 
influence the onset and progression of atherosclerosis. Further, endogenous bone 
marrow-derived circulating EPCs adhere to sites of acute endothelial injury, such as vein 
grafts [190, 197].  
In this study, we tested the hypotheses that (1) human endothelial cells derived 
from endothelial progenitor cells isolated from umbilical cord blood (hCB-ECs)  (hCB-
ECs) exhibited low permeability which increased as the hCB-ECs age and undergo 
senescence and that (2) the change in permeability of hCB-ECs is due to changes in tight 
junction protein localization and the activity of Epac1 [59].  To address these hypotheses, 
we determined the permeability to the serum protein albumin of hCB-ECs, and assessed 
the extent to which cell replication, occludin expression and phosphorylation, and cell 
age influence permeability differences of hCB-ECs and human aortic ECs (HAECs).  We 
also examined the effect of agents that specifically activate Epac1 and SIRT1 upon the 
permeability in late passage hCB-ECs. 
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2.2 Methods and Materials  
2.2.1 Cell Culture 
Human umbilical cord blood derived endothelial cells (hCB-ECs) and human 
adult peripheral blood derived endothelial cells (hPB-ECs) were isolated from blood as 
previously described by Ingram et al [89]. For isolation of hCB-ECs, umbilical cord blood 
was obtained from the Carolina Cord Blood Bank (n=5). Prior to receipt, all patient 
identifiers were removed. For isolation of hPB-ECs, peripheral blood samples were 
obtained from young healthy, non-smoking volunteers taking no medicine (n=1). The 
Duke University Institutional Review Board approved the protocol for collection and 
use of human blood employed in this study. 
After collection, blood was diluted 1:1 with Hanks Balanced Salt Solution (HBSS, 
Invitrogen), placed onto Histopaque 1077 (Sigma), and centrifuged at 740xg for 30 
minutes. Buffy coat mononuclear cells were collected and washed three times with 
“complete EC growth medium,” comprising 8% (vol/vol) fetal bovine serum (FBS) 
added to Endothelial Basal Media-2 (Cambrex) supplemented with Endothelial Growth 
Media-2 SingleQuots (containing 2% FBS plus growth factors, Cambrex), and 1% 
antibiotic/antimycotic solution (Invitrogen). Mononuclear cells were plated on plastic 6 
well 35 mm diameter plates coated with collagen I (rat tail, BD Biosciences) in complete 
EC growth medium. Medium was exchanged every 24 hours for the first week in 
culture, to remove non-adherent cells. Colonies of EPC-derived ECs appeared 7-10 days 
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after the initial isolation.  The colonies were trypsinized and 200 cells were plated onto a 
collagen-coated T-25 and labeled passage 1.  
Human aortic endothelial cells (HAECs) were obtained from Cambrex/Lonza. 
HAECs were obtained at passage 3 and, as noted by the supplier, had undergone 17 
total population doublings at the time of purchase. HAECs were also cultivated in 
complete EC growth medium.  
The hCB-ECs, hPB-ECs and HAECs were grown separately in T75 flasks using 
MCDB131 growth media supplemented with L-glutamine, penicillin/streptomycin, 
EGM2 Singlequots Kit, and 10% Fetal Bovine Serum (10% complete media).  Media was 
changed every other day until the time of experiment.  The hCB-ECs, hPB-ECs and 
HAECs were passaged 1:10 into new T75 flasks upon reaching confluence. Cells were 
then subsequently split 1:10.  The number of population doublings that occurred 
between each passage was adjusted based upon a 75% attachment rate and calculated 
according to the formula ln(10)/ln(2)*(4/3) = 4.43 as previously described [169].   
2.2.2 Flow Cytometry 
To characterize the hCB-ECs used in this study, flow cytometry was performed 
for surface markers CD31, CD34, CD45, and CD115 (10µL antibody per 100,000 cell 
sample, pre-conjugated with FITC and PE, Biolegend).  The hCB-ECs were passaged 
using 0.025% trypsin-EDTA (Invitrogen) at 80% confluence.  Approximately 100,000 
hCB-ECs were resuspended in 1% BSA buffered with DPBS with calcium and 
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magnesium (GIBCO). The hCB-ECs were incubated at room temperature in the dark for 
30 minutes with 2 µg of pre-conjugated antibody prior to a wash step with 1% BSA 
solution buffered in DPBS with calcium and magnesium (GIBCO). The cells were 
collected after centrifugation at 400 g for 7 minutes and fixed using 0.5% 
paraformaldehyde (J.T. Baker) before storage at -20°C until analysis. For each sample, 
9000 events were collected. Mouse IgG1 was used as the control (Biolegend).  
2.2.3 Permeability Experiments 
hCB-ECs or HAECs were seeded with 10% complete FBS media onto the luminal 
(top) chambers of 0.4m pore diameter, polyester, 12-well Transwell plates (Corning) at 
a density of 100,000 cells/cm2 which ensured the development of a confluent monolayer 
1 to 2 days post-plating.  The abluminal (bottom) chamber contained serum-free media.  
The permeability was measured 2, 3, and 7 days post-plating.  Prior to the experiment, 
the cells were incubated with serum-free media for 1 hour.  1 mg/mL of unlabeled 
bovine serum albumin (BSA) was added to the abluminal chamber and 1mg/mL of 
FITC-BSA was added to the luminal chamber at volumes that would ensure no 
differences in hydrostatic or osmotic pressure.  10µL samples were taken from the 
abluminal chamber every 20 minutes for 2 hours.  The change in hydrostatic pressure 
due to a decrease in the volume of the abluminal chamber was 1.5 Pa, a level that would 
generate a very low fluid flow relative to physiological pressure drops between 1333 and 
6667 Pa.  There was no change in osmotic pressure during the experiment because the 
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albumin concentration did not change with sampling.  Albumin content of the sample 
was determined by a fluorimeter using a calibration curve.  Permeability coefficients 
were determined using the following expression previously described by Albelda et 
al.[2] 
  (1) 
Where V1 and V2 are the volumes in the luminal and abluminal chamber, 
respectively.  C0 is the concentration of labeled albumin initially in the luminal chamber.  
C1 is the concentration of labeled albumin in the luminal chamber at time t.  P is the 
diffusive permeability and Am is the area of the membrane.  The permeability P was 
obtained from the slope of a linear regression of the natural logarithm of the bracketed 
term in equation (1) versus time for a given experiment.  The R2 value of the trendline 
ranged from 0.94 to 0.99 and was used to assess goodness of fit.  Figure 3 contains a 
representative plot.  The permeability coefficients were calculated from the slope of the 
trendline.  This permeability term represents contributions from both the cells and the 
membrane.  To calculate the permeability of the cells alone, the permeability of the cell 
layer and the membrane were treated as resistances in series. 
  (2) 
The permeability of the Transwell membrane alone was 3.1±0.2 x 10-5 cm/s (n=9), 
13-100 times greater than the endothelial permeability.  
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Figure 3: Representative plot of data from the Transwell permeability experiments.  A 
semi-log plot of the albumin concentration versus time using equation (1) was used to 
calculate the permeability.  This permeability coefficient represents contributions 
from both the membrane and the cells, which were treated as resistances in series 
(equation (2)) to determine the permeability of the cell layer alone. 
 
2.2.4 Proliferation Assays 
The Click-iT EdU Alexa Fluor 488 Imaging Kit (Invitrogen) was used to measure 
the number of cells in the S-phase.  Cells were plated on Transwell plates as described in 
the permeability experiments. The EdU label was incubated with the cells for 2 hours.  
Detection of the label was performed as described in the manufacturer’s protocol.  The 
Hoechst 33342 stain was used to detect all nuclei.  The membrane of the Transwell insert 
was cut out and mounted on a glass slide for imaging.  The stain was visualized with a 
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Nikon© Eclipse Inverted Microscope system. Cells in the M-phase of mitosis were 
distinguished based on typical morphological features including condensed and 
segregating chromosomes [97].  The percentage of cells in S-phase or M-phase was 
reported as the total number respectively of EdU labeled cells or M-phase cells divided 
by the total number of cells that contained the Hoechst 33342 stain.  
2.2.5 Western Blotting 
Western blots were performed to determine the expression of tight junction 
proteins occludin and ZO-2 in both cell types.  Cells were grown on T25 flasks for 4 days 
post-confluence.  Cells were harvested with a cell scraper and subjected to a solution of 
CellLytic-M (Sigma) and Protease Inhibitor Cocktail (Sigma).  Protein quantification was 
performed with the BCA Protein Assay Kit (Pierce).  10 µg of protein was loaded into 
each well for the SDS-polyacrylamide gel electrophoresis (10% gel, Biorad).  Afterwards, 
the protein bands were transferred to PVDF membranes.  The membranes were blocked 
with a Tris-Buffered Saline with 0.1% Tween 20 (TBST) solution containing 5% milk at 
room temperature for 1 hour.  Primary antibodies for mouse-ZO-2 (1:1000 dilution, clone 
3E8D9, Invitrogen), mouse-occludin (1:2000 dilution, clone OC-3F10, Invitrogen), and 
mouse-β-actin (1:1000 dilution, clone AC-15, Invitrogen) were diluted in a TBST solution 
containing 1% milk and incubated with the membrane overnight at 4°C.  The goat-anti-
mouse secondary antibody (1:2500 dilution, Invitrogen) was incubated with the 
membrane for 45 minutes at room temperature.  After washing, immunoreactive bands 
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were detected by luminography using Supersignal chemiluminescent substrate (Pierce). 
Subsequently, expression of phosphorylated occludin was detected by stripping the 
immunoblot and then reprobing with anti-mouse-β-actin (1:1000 dilution, Invitrogen) 
and mouse-anti-phosphotyrosine (1:500 dilution, clone PY-7E1, PY20, Invitrogen) 
diluted in a TBST solution containing 1% milk.  The secondary antibody and 
chemiluminescent substrates were added in the normal manner.  Integrated band 
density was determined by densitometry after scanning onto autoradiographic films 
(Kodak) and evaluated by ImageJ (NIH).  Protein expression was reported as a 
normalized intensity of the band of interest compared to the band of the housekeeping 
protein, β-actin.  
2.2.6 Immunofluorescence 
hCB-ECs and HAECs were seeded at a density of 100,000 cells/cm2 on 35 mm 
glass dishes.  At 6 days post plating, cells were fixed and permeabilized for 3 minutes 
with methanol.  Samples were then blocked with PBS/0.02% Tween 20 (Biorad)/10%goat 
serum (Gibco) for 1 hour at room temperature.  The samples were then incubated with 
antibodies to the mouse-occludin (1:250 dilution, clone OC-3F10, Invitrogen), mouse-
ZO-1 (1:250 dilution, clone ZO1-1A12, Invitrogen), or mouse-ZO-2 (1:250 dilution, clone 
3E8D9, Invitrogen) overnight at 4°C.  This was followed by appropriate secondary 
antibody incubation with goat anti-mouse Alexa Fluor 488 (1:250 dilution, Invitrogen) or 
goat anti-mouse Alexa Fluor 546 (1:250 dilution, Invitrogen) for 1 hour at room 
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temperature.  All antibodies were diluted in PBS/10% goat serum.  The stains were 
visualized with a Leica SP5 Confocal Microscope (Zeiss).  
2.2.7 β-Galactosidase Staining 
hCB-ECs were plated at 100,000 cells/cm2 on 24-well plates.  The cells were then 
fixed at 4 days post-plating.  For Resveratrol experiments, hCB-ECs were plated at 
100,000 cells/cm2 and cells were treated with 2 µM or 20 µM Resveratrol [66] 1 day post-
plating and were fixed 4 days post-plating. The senescence β-galactosidase Staining Kit 
(Cell Signaling Technology) was used according to the manufacturer’s protocol to stain 
for senescent cells.  The stain was visualized with a Nikon© Eclipse Inverted Microscope 
system.  The percentage of senescent cells was calculated as the total number of cells that 
contained the blue β-galactosidase stain divided by the total number of cells in the field 
of view.  
2.2.8 Telomerase Activity 
The TRAPEZE RT Telomerase Detection Kit (Millipore/Chemicon) was used to 
measure telomerase activity in cell samples.  100µL of lysis buffer was incubated with 
500,000 cells for 30 minutes.  The tube was then centrifuged at 4°C for 20 minutes.  The 
supernatant was removed and the protein was quantified using the BCA Assay Kit 
(Pierce).  200ng of protein was used in each sample and the samples were performed in 
triplicate.  A no template control of PCR grade water, minus telomerase control of lysis 
buffer, positive telomerase control cell line, and heat-inactivated samples were used as 
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controls.  The assay was completed according to the manufacturer’s protocol.  According 
to the manufacturer, the sensitivity of the assay is 0.004 attomoles.  
2.2.9 Statistical Analysis 
Values of n represent the number of cell donors. For Figures 4, 5, 6, and 8, 
ANOVA tests were performed to compare different data sets.  Post-hoc Tukey tests were 
performed for additional comparisons.  For Figure 9, a 2-factor repeated measures 
ANOVA for cell age and treatment followed by a post-hoc Tukey test was used.  For 
Tables 2 and 3, a repeated measures ANOVA followed by a post-hoc Tukey test was 
used.  All data presented represent mean ± SE.  A p<0.05 was interpreted to denote 
statistical significance. 
2.3 Results  
2.3.1 hCB-EC Characterization 
Flow cytometry showed that hCB-ECs and hPB-ECs were positive for the 
endothelial-specific CD31 and CD34, and negative for CD14, CD45 and CD115 found on 
monocytes or hematopoietic cells.  Immunofluorescence indicated that CD-31, platelet-
endothelial cell adhesion molecule, was present at the cell borders of hCB-ECs, HAECs, 
and hPB-ECs.  We previously characterized hCB-ECs and found that they expressed von 
Willebrand factor, CD31 and VE-cadherin [11]. Following exposure to 15 dyne/cm2 for 
24 or 48 hours, hCB-ECs aligned with the direction of flow [11, 20], increased nitric oxide 
production, and increased mRNA for endothelial cell specific genes sensitive to flow, 
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Kruppel-like factor 2, nitric oxide synthase III, cyclo-oxygenase 2, and thrombomodulin 
[11].  The level and organization of actin filaments are similar in hCB-ECs and HAECs as 
are the associated values of cell stiffness [20].  
2.3.2 Low Passage hCB-ECs Have Lower Permeability than HAECs 
The in vitro permeability of HAECs to BSA 7 days post plating (2.4 ± 0.6 x 10-6 
cm/s (n=3)) agrees with published values of 3.2 ± 0.4 x 10-6 cm/s for bovine aortic 
endothelial cells (BAECs) [18]  and 1.9 x 10-6 cm/s for human umbilical vein endothelial 
cells [21]. For hCB-ECs that underwent less than 44 population doublings since passage 
1, the average permeability 7 days post-plating (3.1 ± 0.5 x 10-7 cm/s (n=3)) was 
significantly less than the value obtained with HAECs that underwent less than 35 
population doublings (Figure 4A) (p<0.01). For hPB-ECs (P-11, 44 population doublings), 
the average permeability (5.3 ± 0.2 x 10-7 cm/s (n=2)) 7 days post-plating was between 
values for hCB-ECs and HAECs.  Differences in permeability between EC type are 
significant for each day (p<0.01), but, for each cell type, the permeability did not change 
significantly over time and was not dependent upon donor (p<0.60).   
2.3.3 Expression of Occludin and ZO-2 in Low Passage hCB-ECs and 
HAECs Does Not Explain Difference in Permeability 
Elevated occludin levels have been correlated with reduced permeability to 
14[C]sucrose in bovine brain microvascular endothelial cells [37].  To assess the degree of 
tight junction protein expression in low passage hCB-ECs and HAECs, Western blots 
were performed for the tight junction proteins zonula occludens 2 (ZO-2) (molecular 
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weight: 160kDa) [5] and occludin (molecular weight: 66 kDa) [4].  β-actin (molecular 
weight: 37kDa) served as a control (Figure 4B). The relative intensity for ZO-2 was 
virtually identical for hCB-ECs (0.3±0.2) and HAECs (0.4±0.2) (n=4).  Surprisingly, the 
relative intensity of occludin was less for hCB-ECs (1.4±0.1) than HAECs (2.5±0.6) 
(p<0.05) (n=4).    
2.3.4 Less Phosphorylated Occludin in Low Passage hCB-ECs than 
HAECs 
Although the amount of functional occludin is important in maintaining tight 
junction integrity, phosphorylation of occludin causes disruption of tight junctions [39].  
Therefore, cells with a lower permeability will have less phosphorylated occludin.  
Western blot and associated densitometry (Figure 4C) showed that the relative intensity 
of antiphosphotyrosine antibody colocalized to occludin was 25% lower for hCB-ECs 
than for the HAECs (p<0.01). Consistent with the lower level of occludin tyrosine 
phosphorylation in hCB-ECs than HAECs, immunofluorescence showed greater 
occludin localization at the periphery of hCB-ECs than HAECs (Figure 4D).  Although 
ZO-1 staining was not intense enough to permit quantification via densitometry, we 
could visualize ZO-1 by immunofluorescence. The greater localization of ZO-1 (Figure 
4E) to the periphery of hCB-ECs relative to HAECs is consistent with the role of occludin 
and ZO-1 at EC junctions in contributing to the reduced permeability of the hCB-ECs.  In 
contrast, (ZO-2) (Figure 4F) was not localized to the periphery in either hCB-ECs or 
HAECs suggesting additional mechanisms are involved in regulating permeability.  
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Figure 4: hCB-ECs that underwent less than 44 population doublings have lower 
permeability than HAECs that underwent less than 35 population doublings due to 
changes in phosphorylated occludin.  A) The albumin permeability of the hCB-ECs is 
significantly lower than that of the HAECs; B) Western Blot and quantitative analysis 
of occludin and ZO-2 protein expression normalized to β-actin; C) Western Blot and 
quantitative analysis of phosphorylated occludin. D) Occludin localization in hCB-
ECs and HAECs; E) ZO-1 localization in hCB-ECs and HAECs; F) ZO-2 localization in 
hCB-ECs and HAECs.  Data are presented as mean ± SE.  n=3-4;  *: p-value < 0.05   #: p-
value < 0.01. 
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2.3.5 Low Passage hCB-ECs Proliferate More than HAECs 
Since cells must break their junctions in order to divide [157], we hypothesized 
that a monolayer with a higher permeability would have more cells dividing at any one 
time.   However, on days 2, 3 and 7 after plating, hCB-ECs that underwent less than 44 
population doublings had a higher percentage of cells in the S-phase of mitosis than did 
HAECs that underwent fewer than 35 population doublings (Figure 5).  Differences in 
the percent of cells in S-phase between cell type were statistically significant for each 
day, but for each cell type, the percent of cells in S-phase did not change significantly 
over time.   
 
Figure 5: Percent of hCB-ECs that underwent less than 44 population doublings and 
HAECs that underwent less than 35 population doublings in S-phase for 2, 3, and 7 
Days Post Plating.  hCB-ECs proliferate at a higher rate than HAECs.  n=6-8; #: p-
value<0.017 
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While the percentage of cells in S-phase provides some indication of cell 
turnover, cells divide during the M-phase of mitosis, creating leaky junctions and 
enhancing permeability [97].  The percentage of cells in the M-phase significantly 
decreased over time after plating for low passage hCB-ECs and HAECs (p<0.017), but on 
each day, there was no difference between each cell type in the fraction of cells in the M-
phase (Figure 6).  The higher percentage of hCB-ECs in the S-phase can be attributed to 
the shorter doubling time of the hCB-ECs relative to the HAECs [11].  The low mitotic 
frequency of mitosis relative to cells in the S-phase reflects the duration of labeling and 
the relative amounts of time in the S and M phases. Because there are similar numbers of 
hCB-ECs and HAECs dividing, cell mitosis cannot explain the difference in permeability 
between the two cell types.   
 45 
 
 
Figure 6: Similar M-Phase Mitosis Rates in hCB-ECs that underwent less than 31 
population doublings and HAECs that underwent less than 35 population doublings. 
The percentage of cells in the M-phase was determined for HAECs and hCB-ECs 2,3 
and 7 days after plating.   n=3. 
2.3.6 Changes in hCB-EC Proliferation and Permeability with Cell 
Aging 
To characterize aging of hCB-ECs and HAECs, preliminary experiments were 
performed to measure the amount of telomerase in cells at different numbers of 
population doublings after the first passage.  Telomerase is a specialized reverse 
transcriptase that is necessary for the synthesis of telomeric DNA at the ends of 
chromosomes [54].  A lack of telomerase hinders the ability of the DNA polymerase to 
replicate the end of the lagging strand, causing the DNA to shorten by 25-100 base pairs 
with each round of cell division.  Thus, younger cells exhibit higher concentrations of 
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telomerase [54].  In general, the amount of telomerase decreased with increasing cell age 
in hCB-ECs (Table 1).  The amount of telomerase in HAECs at 35 population doublings 
was equivalent to the value of hCB-ECs at later passages, suggesting that HAECs are 
older than any of the hCB-ECs tested.  
Table 1: Telomerase Activity Decreases with Increasing Population Doublings in 
Culture.  The average telomerase level generally decreases with increasing population 
doublings.  The HAECs exhibit less telomerase than any of the hCB-ECs tested 
indicating that their relative age is higher than that of the hCB-ECs. Samples were run 
in triplicate. 
 
Cell Type Population Doublings Telomerase  (amoles/106 cells) 
hCB-EC 31 1.200 
hCB-EC 44 ≤0.004 
hCB-EC 71 ≤0.004 
   
hCB-EC 31 0.220 
hCB-EC 44 0.0280 
hCB-EC 71 0.0194 
   
HAEC 35 ≤0.004 
 
Next, we examined the effect of aging on hCB-EC permeability. Proliferation 
studies done in parallel with the permeability measurements indicate that the percent of 
cells in S-phase decreased with increasing cell age (Table 2), a result expected as cells 
become senescent [109].  
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Table 2: Percent of hCB-ECs in S-Phase With Increasing Population 
Doublings.  The percent of hCB-ECs in S-phase decreases as the population 
doublings increases.  Data are presented as mean±SE. n=3. *: p-value < 0.05 compared 
to 50 population doublings since passage 1. 
 
Population Doublings Since Passage 1 Percent of Cells in S-phase 
44 9.6±2.6 
58 6.4±1.2 
71* 4.5±1.8 
 
Consistent with the lower level of proliferation of older cells, β-galactosidase staining 
was greater in hCB-ECs that underwent 71 doublings since passage 1 than in hCB-ECs 
that underwent fewer doublings (Figure 7).   
 
Figure 7: Senescence associated-β-galactosidase staining of aging hCB-ECs.  A) hCB-
ECs at 18 doublings since passage 1; B) hCB-ECs at 71 doublings since passage 1; C) 
hCB-ECs at 71 doublings since passage 1 with 20µM Resveratrol; D) hCB-ECs at 71 
doublings since passage 1 with 2 µM Resveratrol. 
For hCB-ECs that had undergone 84 population doublings, the permeability was 1.5±0.9 
x 10-6 cm/s (mean ±SE, n = 3 donors), almost five times the value at lower passage (Figure 
4).   In a study with hCB-ECs from an additional donor, the permeability of hCB-ECs 
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increased monotonically with increasing age (Figure 8). The mean value for late passage 
hCB-ECs was lower than values obtained with the lower passage HAECs.   
 
Figure 8: Albumin Permeability of Cells Increases with Increasing Population 
Doublings.  Age is defined as population doublings since passage 1.  The 
permeability of the hCB-ECs from 1 isolation increases with increasing population 
doublings.  The permeability approaches that of the HAECs.    n=3; *: p-value <0.05 
compared to hCB-EC (<31 doublings)  #: p-value < 0.01 compared to hCB-EC (<31 
doublings) 
2.3.7 Resveratrol Treatment Decreases hCB-EC Permeability 
SIRT1 deacetylates proteins involved in regulating antioxidant activity.[25]  
SIRT1 levels decline with aging whereas elevation of SIRT1 improves endothelial cell 
function [41, 167].  To test the effect of SIRT1 levels on endothelial permeability in aging 
cells, we treated ECs with Resveratrol, which increases expression levels of SIRT1 
indirectly [41, 167].  
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While porcine aortic ECs [199] and human umbilical vein ECs [25] tolerated a 
dose of 100 µM Resveratrol for 16 hours, this dose was toxic to hCB-ECs after 48 hours.  
We found that hCB-ECs could tolerate doses less than or equal to 20 µM for 48 hours.  
Addition of 20 µM Resveratrol for two days prior to measurement decreased the 
permeability of hCB-ECs that underwent at least 57 population doublings by 
approximately 28% (p<0.05) while incubation of hCB-ECs monolayers with 2 µM 
Resveratrol, decreased the permeability of hCB-ECs by approximately 41% (p<0.05) 
(Table 3).  HAECs incubated with 2µM Resveratrol decreased the permeability by 
approximately 22%.  Doses of 2 µM and 20 µM Resveratrol had no significant effect on 
the percentage of cells in the S-phase or on β-galactosidase staining (Figure 7C, Figure 
7D).  
2.3.8 Activation of the Epac1-Rap1 Pathway Reduces Permeability in 
Late Passage Cells 
The compound 8-pCPT-2'-O-Me-cAMP (007) is a membrane permanent activator 
of the exchange factor activated by cAMP, Epac1, which exerts the same effect on cell 
function as Resveratrol [128].  Treatment of cells with 100µM 8-pCPT-2'-O-Me-cAMP 
during the permeability experiment decreased the permeability of hCB-ECs that 
underwent at least 57 population doublings by approximately 26% (p<0.01) (Table 3). 
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Table 3: Resveratrol, 007 and Rolipram decrease hCB-EC Permeability.  Data 
are presented as mean±SE for n = 3, * p<0.05 and # p<0.01 relative to untreated control. 
 
Treatment Concentration Permeability Decrease (%) 
Resveratrol 20µM 28±7* 
Resveratrol 2µM 41±5* 
007 100µM 26±5# 
Rolipram 25µM 30±1# 
 
To confirm that the change in permeability is due to phosphodiestarase 4 which 
has been proposed as the mode of action of Resveratrol, we examined the permeability 
of hCB-ECs after treatment with Rolipram is a specific PDE4 inhibitor that increases 
cAMP levels at the membrane which then activates the Epac1-Rap1 pathway. Consistent 
with the role of Resveratrol as a phosphodiesterase 4 (PDE4) inhibitor [128], treatment of 
hCB-ECs that underwent at least 57 population doublings with 25 µM Rolipram caused 
the permeability to decrease about 30% (Table 3).  Taken together, these results suggest 
that Resveratrol alters permeability in aging cells by increasing membrane associated 
cAMP.  
2.3.9 Increased Expression of ZO-2 and Phosphorylated Occludin in 
Aging hCB-ECs 
Because addition of Resveratrol decreased the permeability of the aged hCB-ECs 
(Table 3), we examined the tight junction protein expression and localization for cells 
treated with 2 µM Resveratrol for 48 hours.  Both occludin and phosphorylated occludin 
levels decreased significantly as hCB-ECs went from population doubling 35 to 71, but 
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then increased between population doubling 71 and 84 (Figure 9A and Figure 9B) 
(p<0.01).  Cells that underwent 84 population doublings and were treated with 2 µM 
Resveratrol had decreased levels of occludin and phosphorylated occludin (p<0.05) 
(Figure 9D and Figure 9E).  The change in phosphorylated occludin is consistent with 
the increase in hCB-EC permeability with increasing cell age and the reduced 
permeability of hCB-ECs after treatment with Resveratrol.   
Like occludin, ZO-2 levels increased for hCB-EC population doublings between 
71 and 84 (Figure 9C) (p<0.01).  Treatment with Resveratrol did not significantly affect 
levels of ZO-2 expression (Figure 9C).  From these results, we conclude that higher levels 
of tyrosine phosphorylation of occludin are associated with the elevated permeability of 
the aging hCB-ECs and Resveratrol decreases permeability, in part, by reducing the level 
of tyrosine phosphorylated occludin. 
Unlike early passage hCB-ECs (Figure 4D, Figure 4E, and Figure 4F) localization 
of occludin, ZO-1, and ZO-2 in hCB-ECs that underwent 57 population doublings since 
passage 1 was not at the cell junctions (Figure 9F).  The tight junction proteins were 
diffusely distributed in the cells and the staining resembled that of the HAECs (Figure 
2.2).  In contrast, the hCB-ECs that underwent fewer than 44 population doublings 
exhibited localization of occludin and ZO-1 to cell junctions (Figure 4D).  The results 
indicate that there is a change in localization of tight junction protein in hCB-ECs of 
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increasing age, which correlates with the increase in permeability with increasing cell 
age. 
 
Figure 9: Change in occludin, ZO-2 and phosphorylated occludin with increasing cell 
age.  The increase is mitigated with the addition of 2 µM Resveratrol for 48 hours.  A) 
Western Blot of tight junction proteins probed with antibodies for occludin and ZO-2; 
B) Western blot of phosphotyrosine with control β-actin; C) Quantitative analysis 
ofZO-2.  Values are the band intensity normalized by the intensity of the β-actin 
band; D) Quantitative analysis of phosphorylated occludin; E) Quantitative analysis 
of occludin. F) Immunofluorescence of tight junction proteins occludin, ZO-1 and ZO-
2 in hCB-ECS after 44 population doublings. Data are presented as mean ± SE.  n=3; *: 
p-value < 0.05   #: p-value < 0.01 
2.4 Discussion  
To our knowledge, these studies demonstrate for the first time that the 
permeability of low passage hCB-ECs is significantly lower than that of HAECs and that 
the permeability of hCB-ECs increases with increasing population doublings due to 
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elevation of tyrosine phosphorylation of occludin and alteration of Epac1 activity. 
Additionally, the early passage hCB-EC permeability values are close to those reported 
for large vessel endothelium permeability to serum albumin in vivo [6, 10].  For instance, 
the permeability of the porcine abdominal aorta to albumin ranges from 8.6 x 10-7 to 27 x 
10-7 cm/s [6] and the permeability of the rabbit aorta to albumin is reported as 0.6 x 10-7 
cm/s [10] and 0.8 x 10-7 cm/s [106]. This is the first type of cultured endothelial cell for 
which in vitro permeability to macromolecules is close to in vivo values for large vessels.   
The permeability values measured in this study were obtained under diffusive 
conditions, whereas in vivo values represent the combined effect of diffusion and 
convection. Albumin is transported across endothelium by a vesicular pathway, through 
endothelial junctions, and across leaky endothelium. In vitro, about 80% of water 
transport occurs through the junctions and 20% across leaky junctions [18].  For 
transport through the junctions and across the leaky endothelium, convection and 
diffusion modify the endothelial permeability through each pathway Pe as follows [18]: 
  Pe =
PoPe
e
Pe
−1
+ Jv 1− σ( )
   (3)
 
where Po is the diffusive permeability, Jv is the fluid flux, σ is the osmotic reflection 
coefficient and Pe is the Peclet number, Pe = Jv(1-σ)/Po. Convective transport is 
dependent upon Jv and (1-σ), which represents the drag exerted upon the 
macromolecule by interaction with the junction proteins. For a given macromolecule, the 
value of σ is sensitive to the radius and volume fraction of junction fibers. A value of Jv = 
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1.8 x 10-6 cm/s was measured in the rabbit aorta [106]. For this value of Jv and an in vitro 
value of σ= 0.49 for albumin [18], Pe = 2.6 for early passage hCB-ECs and 0.6 for late 
passage hCB-ECs. Convection would have a more significant effect upon Pe for early 
passage hCB-ECs than for late passage hCB-ECs, although Pe is smaller for early passage 
ECs (9.9 x 10-7 cm/s) than late passage ECs (2.0 x 10-6 cm/s).  Future studies will need to 
examine the relative importance of each of these pathways in early and late passage 
hCB-ECs and the manner in which transport is affected by applied pressures across the 
endothelium.  
We examined several possible reasons for the lower permeability of the hCB-
ECs: increased levels and tyrosine phosphorylation of tight junction proteins, reduced 
levels of cell mitosis and alterations in Epac1 activity.  Occludin, when linked to ZO-1 
and ZO-2 regulates transport through the endothelial cell tight junctions [157].  While 
we found that expression of ZO-2 and occludin were not reduced in hCB-ECs relative to 
HAECs, occludin exhibited reduced levels of tyrosine phosphorylation and was 
redistributed to the cell junctions in the hCB-ECs.  Mitosis levels also did not correlate 
with the reduced permeability of the hCB-ECs, which is consistent with published 
results and indicates that cell mitosis is less important than other factors, such as 
apoptosis, in raising EC permeability [19]. 
The amount of functional occludin, in the form of non-phosphorylated occludin, 
as well as its localization to junctions between ECs are important to maintain the tight 
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junction barrier in hCB-ECs [39]. Ser-490 phosphorylation and ubiquination of occludin 
is associated with increased permeability of primary bovine retinal endothelial cells due 
to a loss of occludin from EC-EC junctions and its movement towards lysosomes [116].  
Elevated albumin permeability was associated with increased occludin tyrosine 
phosphorylation and the elevation in permeability was blocked with tyrosine 
phosphatase and protein kinase inhibitors [39].  This finding was further supported by 
the result that activation of c-Src by oxidative stress increased phosphorylation of 
tyrosine residues 398 and 402, which prevented occludin from assembling in the tight 
junctions and led to an increase in permeability [52].  Treatment of human umbilical vein 
endothelial cells with tyrosine phosphatase inhibitors led to selective occludin 
proteolysis and redistribution and increased permeability[173]. When bovine brain 
microvascular ECs were exposed to shear stress for just a few hours, hydraulic 
permeability and phosphorylation of tyrosine sites in occludin increased [178]. 
Correspondingly, exposure of confluent monolayers to shear stress for 24 hours, led to a 
decrease in tyrosine phosphorylation and an associated decrease in permeability [178]. 
Incubation of ECs with the protein tyrosine phosphatase activity inhibitor dephostatin 
led to smaller reductions in endothelial permeability after exposure to shear stress [178].  
In the current study, we found that there was significantly less phosphorylated occludin 
in the hCB-ECs compared to the HAECs, which is consistent with the reduced 
permeability of the hCB-ECs.  While our results are consistent with published studies 
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which show that increased occludin tyrosine phosphorylation causes the permeability to 
increase, phosphorylation of serine and threonine residues on occludin and other 
junction proteins could also affect permeability [47]. 
The amount of phosphorylated occludin increased as hCB-ECs underwent more 
population doublings and this was associated with an increase in hCB-EC permeability.  
Treatment with Resveratrol decreased hCB-EC permeability and produced a decrease in 
expression of phosphorylated occludin.  However, significant increases in occludin 
tyrosine phosphorylation were not observed until the hCB-ECs underwent 71 
population doublings (Figure 9D), while permeability increased at earlier passages 
(Figure 8).  Because the changes in permeability precede the changes in phosphorylated 
occludin, additional pathways, such as transport through leaky junctions and vesicular 
transport [18, 105], are likely to influence the permeability of hCB-ECs.       
Other factors, besides occludin and ZO-1 localization and the extent of 
phosphorylated occludin in hCB-ECs, likely contribute to the lower permeability of the 
hCB-ECs.  Apoptosis is known to be elevated in senescent cells [99], and would produce 
an increase in the number of leaky junctions and increase permeability [19].  The 
glycocalyx is composed of several membrane-bound macromolecules on the surface of 
ECs and may regulate transport of water and macromolecules. Actin-myosin contraction 
can cause the breakdown of intercellular junctions leading to elevations of permeability 
[105]. 
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Aging at the cellular level is associated with replicative senescence or stress-
induced senescence.  For replicative senescence, after a certain number of population 
doublings, cells cease to replicate [17].  A leading theory for the cause of replicative 
senescence is telomere shortening.  After the telomere is shortened to a certain degree, 
the cell becomes senescent and do not divide any further to protect against mutation of 
its genetic code [54].  Similarly, stress-induced senescence causes cells to cease to divide.  
It is primarily caused by environmental stresses such as intracellular oxidative stress, 
DNA damage by radiation, or chromatin decondensation.  Our finding that hCB-EC 
permeability increasing with increasing population doublings indicates that cell aging 
and cell senescence play an important role in the regulation of albumin transport. 
While the ECs divide more rapidly in vitro than in vivo, there is evidence that ECs 
at lesion prone sites have undergone replicative senescence by their size, shape and 
telomere length [13, 123].  The use of 44 or more population doublings to show an effect 
of cell replication on albumin is not an absolute number, but the data present a general 
trend at which cells become more susceptible to aging. 
Resveratrol has been used to reduce age-associated metabolic phenotypes [128].  
We found that addition of 2 µM Resveratrol for 48 hours was more effective than 20 µM 
Resveratrol at decreasing the permeability.  Relative to 60 µM, Resveratrol at 1 µM was 
more effective at promoting adhesion and migration of early outgrowth EPCs and low 
doses of resveratrol promoted reendothelization [66].  Incubation of early outgrowth 
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EPCs with Resveratrol doses between 10 and 50 µM for three days reduced β-
galactosidase staining, and increased migration, proliferation and telomerase activity, 
suggesting a reversal of senescence, while a dose of 100 µM increased apoptosis [188].  
While endothelial cells can tolerate 100 µM Resveratrol for short periods of time, our 
results suggest that lower doses of Resveratrol can reduce permeability without 
necessarily reducing senescence.    
Resveratrol acts upon SIRT1 via competitive inhibition of phosphodiesterase 4 
which causes elevated cAMP levels [128].  Park et al. showed that the resulting elevation 
of cAMP activates effector protein Epac1, and sequentially increases Rap1, intracellular 
Ca2+ and activates the CamKKβ-AMPK pathway to activate SIRT1 [128].  Interestingly, 
elevated cAMP levels cause a decrease in endothelial permeability by activation of 
protein kinase A which then inactivates myosin light chain kinase [105] or through Epac-
mediated Rap1 activation [59].  Further, membrane associated cAMP bound to Epac1 
interacts with phosphodiesterase 4, to bind to VE-cadherin [137] and regulates 
endothelial permeability by redistributing tight junction molecules to cell junctions [42].  
Thus, in addition to regulating occludin phosphorylation, Resveratrol may influence 
permeability through Epac1-Rap1 interactions with VE-cadherin.  We showed that 8-
pCPT-2'-O-Me-cAMP, a cAMP analog which specifically activates the Epac1-Rap1 
pathway, and Rolipram, a specific PDE4 inhibitor, both decrease hCB-EC permeability 
in a manner similar to Resveratrol.  These results, along with results in Park et al., 
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indicate that Resveratrol is acting as a PDE4 inhibitor, which activates membrane-bound 
cAMP, which stimulates the Epac1-Rap1 pathway, which ultimately upregulates SIRT1 
levels. 
The incidence of cerebral vascular disease increases with increasing age and can 
ultimately lead to stroke or dementia [55].  Increases in blood-brain barrier permeability 
play an important role in the pathophysiology of the diseases due to leakage of blood 
components into white matter and the vessel wall [162]. These age-related white matter 
changes are associated with increased incidence of stroke [90].  Levels of circulating 
EPCs are decreased in patients with these age-related white matter changes.  Taken 
together, these results indicate that increases in age-associated permeability can lead to 
cerebral vascular disease development.   
Using EPCs in vitro as a model of cell aging may be a useful tool for studying the 
development and progression of atherosclerosis and cerebrovascular diseases. We have 
found that when ECs are cultured on quiescent vascular smooth muscle cells that EC 
proliferation is greatly reduced [174].  This coculture system could then be used to 
mimic the vessel wall structure and reduce hCB-EC proliferation towards in vivo values. 
2.5 Conclusion  
The results of these studies suggest that cell age may be a key biological 
mechanism for the observed permeability differences between hCB-ECs and HAECs.  
The study also shows that hCB-ECs may be a suitable model for cell aging as they can be 
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used to represent very young cells after isolation and they can be passaged a significant 
number of times until they can be used as a model for older, senescent cells.  This is 
important as the permeability of the endothelium is higher in regions prone to the 
initiation of atherosclerosis.  Additionally, senescent cells are known to be present in 
areas with atherosclerosis.  ECs in these regions undergo more cycles of replication and, 
due to the local hemodynamics, are more sensitive to extracellular stresses. These 
environmental conditions can ultimately lead to senescence that increases permeability, 
either due to alterations in signaling pathways within individual ECs or increased 
apoptosis leading to leaky junctions. 
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Chapter 3. SIRT1 Regulates Glycocalyx and VE-Cadherin 
to Modulate Response of Senescent Endothelial Cells to 
Shear Stress 
3.1. Introduction 
Endothelium at lesion-prone sites and on atherosclerotic lesions show signs of 
senescence, including evidence of giant cells,[13] elevated levels of β-galactosidase,[108] 
and telomere shortening.[123] In atherosclerotic regions in both humans and animals, 
endothelial cells (ECs) experience high cell turnover and high oxidative stress, leading to 
replicative[13, 123] and stress-induced senescence.[54]  Interestingly, senescent ECs were 
not found in arteries from the same individuals which were free of atherosclerosis, 
suggesting that senescence was not systemic and was due to local changes to ECs.[108] 
Senescence affects several EC functions including decreased expression of endothelial 
nitric oxide synthase (eNOS)[32, 102] and increased permeability.[26, 27]  In ECs, 
changes in eNOS mRNA expression levels from shear stress results from alterations in 
the EC response to mechanical forces, leading to modifications in signaling pathways 
and overall cell function.[31]  Increased EC permeability with increased cell age likely 
results from disruptions in tight junction protein localization and phosphorylation.[27] 
While replicative and stress induced senescence arise by different mechanisms, 
the two pathways converge in ECs by elevating the tumor suppressor p53,[108] which is 
negatively regulated by the deacetylase SIRTUIN1 (SIRT1). Further, senescent cells 
exhibit reduced cell replication and SIRT1 levels. In LDL receptor deficient mice fed a 
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cholesterol diet, p53 positive senescent ECs are present at higher levels at lesion-prone 
sites.[182]  Activation of SIRT1 reverses several senescent-associated cell phenotypes.[26, 
27, 128, 199]  SIRT1 overexpression in ECs decreased atherosclerosis in ApoE-knockout 
mice.[198]  SIRT1 expression is also sensitive to changes in shear stress.[24]  When ECs 
were subjected to atheroprotective flow, SIRT1 expression levels increased and led to a 
corresponding increase in nitric oxide (NO) production and availability.[24]  SIRT1 may 
regulate key ECs functions such as permeability and response to flow through cell 
junctions, including occludin[27] and VE-cadherin.[42]   
VE-cadherin[40] and the glycocalyx[57, 192] are mechanosensors which regulate 
the response to fluid shear stress. Myosin-dependent tension across VE-cadherin is 
decreased after exposure to shear stress.[40]  Disturbed flow alters VE-cadherin 
localization and expression.[32]  VE-cadherin phosphorylation elevates permeability 
through uncoupling of p120-catenin or β-catenin.[135]  The glycocalyx is associated with 
reduced endothelial permeability and increased NO production in response to shear 
stress.[57, 192]  In regions of disturbed flow and atherogenesis, the glycocalyx is 
disintegrated.[168] Interestingly, SIRT1 levels are reduced by low and oscillating shear 
stresses present at vessel branches,[24] suggesting a possible link between 
mechanosensing and SIRT1. 
 
While changes in endothelial structure and function lead to the development of 
atherosclerosis, it is unclear whether EC senescence is a cause or effect of these EC 
 63 
 
functional changes. In this study, we tested the hypothesis that the response to steady 
shear stress is decreased in aging-induced senescent ECs due to impairment of 
antioxidant regulator SIRT1, which leads to alteration in the abundance and thickness of 
the glycocalyx and phosphorylation of VE-cadherin.  We use human cord blood-derived 
ECs (hCB-ECs) as a model for cell aging because of their low, physiological permeability 
at low population doublings, high proliferative potential in subconfluent cultures,[27] 
and similarity to arterial ECs.[11]  We examined the response of aging hCB-ECs to shear 
stress with and without activators and inhibitors of SIRT1.  We also examined the effect 
of SIRT1 on mechanotransducers, glycocalyx and VE-cadherin. 
3.2 Methods 
3.2.1 Cell Culture 
Human umbilical cord blood derived endothelial cells (hCB-ECs) were isolated 
from blood as previously described by Ingram et al.[89] For isolation of hCB-ECs, 
umbilical cord blood was obtained from the Carolina Cord Blood Bank (n=3 donors). 
Prior to receipt, all patient identifiers were removed.  The Duke University Institutional 
Review Board approved the protocol for collection and use of human blood employed in 
this study.  For all experiments, we found no statistically significant effect of the donor 
on the results. 
After collection, blood was diluted 1:1 with Hanks Balanced Salt Solution (HBSS, 
Invitrogen), placed onto Histopaque 1077 (Sigma), and centrifuged at 740xg for 30 
 64 
 
minutes. Buffy coat mononuclear cells were collected and washed three times with 
“complete EC growth medium,” comprising 8% (vol/vol) fetal bovine serum (FBS) 
added to Endothelial Basal Media-2 (Cambrex) supplemented with Endothelial Growth 
Media-2 SingleQuots (containing 2% FBS plus growth factors, Cambrex), and 1% 
antibiotic/antimycotic solution (Invitrogen). Mononuclear cells were plated on plastic 6 
well 35 mm diameter plates coated with collagen I (rat tail, BD Biosciences) in complete 
EC growth medium. Medium was exchanged every 24 hours for the first week in 
culture, to remove non-adherent cells. Colonies of EPC-derived ECs appeared 7-10 days 
after the initial isolation.  The colonies were trypsinized and cells were plated onto a 
collagen-coated T25 and labeled passage 1.  
The hCB-ECs were grown in T75 flasks using EBM2 basal media supplemented 
with penicillin/streptomycin, EGM2 Singlequots Kit, and 10% Fetal Bovine Serum (10% 
complete media).  Media was changed every other day until the time of experiment.  The 
hCB-ECs were passaged 1:10 into new T75 flasks upon reaching confluence. Cells were 
then subsequently split 1:10.  The number of population doublings (PDLs) that occurred 
between each passage was adjusted based upon a 75% attachment rate and calculated 
according to the formula ln(10)/ln(2)*(4/3) = 4.43 as previously described.[169] 
3.2.2 EC Characterization 
The hCB-ECs with fewer than 31 population doublings (PDL) have been 
extensively studied and function very similar to vascular ECs.[11, 20, 27, 88, 89] The 
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hCB-ECs are positive for the endothelial-specific CD31 and CD34, and negative for 
CD14, CD45 and CD115 found on monocytes or hematopoietic cells.[27] We previously 
characterized hCB-ECs and found that they also expressed von Willebrand factor and 
VE-cadherin.[11] Following exposure to 15 dyne/cm2 for 24 or 48 hours, hCB-ECs 
aligned with the direction of flow,[11, 20] increased nitric oxide production, and 
increased mRNA for endothelial cell specific genes sensitive to flow, KLF2, eNOS, cyclo-
oxygenase 2, and thrombomodulin.[11]  The level and organization of actin filaments are 
similar in hCB-ECs and human aortic ECs (HAECs) as are the associated values of cell 
stiffness[20].  hCB-ECs < 31 PDL had high levels of telomerase and low levels of 
senescence-associated β-galactosidase staining, so we refer to them as “young” ECs.[27]  
hCB-ECs > 44 PDL had low levels of telomerase and high levels of senescence-associated 
β-galactosidase staining compared to hCB-ECs < 31 PDL, so we refer to them as “aged” 
ECs.[27] 
3.2.3 Flow Experiments 
hCB-ECs were plated at a density of about 50,000 cells/cm2 in slide flasks 
(Thermo Scientific) for flow experiments and in 6-well plates (BD) for static controls.  
hCB-ECs were grown to confluence for 24 hours.  The slides with cells were carefully 
assembled into a parallel plate flow chamber and exposed to a steady wall shear stress 
of 15 dyne/cm2 for 24-48 hours before RNA isolation or immunofluorescence. At the 
same time, control samples were maintained under static conditions in the incubator for 
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24-48 hours.  All static and flow experiments were performed with flow medium 
(DMEM/F12 with 15 mmol/L HEPES, 3.3% FBS, and 1× ITS). 
3.2.4 Quantitative real-time RT-PCR 
RNA purity and quantity were measured using a NanoDrop Spectrophotometer 
(NanoDrop Technologies).  Total RNA (50 ng) was reverse transcribed using the cDNA 
Synthesis Kit (Bio-Rad) and a MyIQ Cycler (Bio-Rad) thermal cycler. One cycle of 5 min 
at 25°C, 30 min at 43°C, and 5 min at 85°C was performed. Primers, RNAse-free water, 
and IQ SYBR Green Supermix (Bio-Rad) were combined with the cDNA samples and 
placed in a MyIQ single color real-time PCR detection system (Bio-Rad). A two-step 
cycle configuration was performed with an initial denaturation for 3 min at 95°C and 50 
cycles at 95°C for 15 s and 61°C for 1 min. All samples were performed in triplicate for 
all genes. The 2−ΔΔCT method was used to determine the relative gene expression.[98] 
Primers were selected based on the gene sequence (PubMed) of interest as previously 
described.[177] The primers (IDT Technologies) used to complete the studies were 1) β2-
microglobulin: 5′-GGC TAT CCA GCG TAC TCC AAA G-3′ and 5′-CAA CTT CAA TGT 
CGG ATG GAT G-3′; 2) KLF2: 5′-GCA CGC ACA CAG GTG AGA AG-3′ and 5′-ACC 
AGT CAC AGT TTG GGA GGG-3′; and 3) eNOS: 5′-GTG ATG GCG AAG CGA GTG 
AAG-3′ and 5′-CCG AGC CCG AAC ACA CAG AAC-3′.  Melting curves were plotted 
following each reaction to verify that only the target cDNA was amplified.  Reference 
RNA, collected from a large batch of ECs at 18 population doubling, was used as a 
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common reference for all samples tested. The reference RNA was isolated, aliquoted, 
and stored at −80°C until needed.  
3.2.5 Immunofluorescence 
hCB-ECs were seeded at 50,000 cells/cm2 on 6-well plates.  At 2 days post plating, 
cells were fixed and permeabilized for 3 minutes with methanol or for 10 minutes with 
2% paraformaldehyde.  Samples were then blocked with PBS/0.02% Tween 20 
(Biorad)/3% bovine serum albumin (Sigma) for 1 hour at room temperature.  The 
samples were then incubated with antibodies to mouse-PECAM (1:250 dilution, lot 
#986831A, clone MEM-05, Invitrogen), goat-VE-cadherin (1:250 dilution, lot #D0312, 
Santa Cruz Biotechnology), or mouse-heparan sulfate proteoglycan (1:250 dilution, clone 
7E12, Thermo Scientific), or mouse-heparan sulfate (1:100 dilution, clone 10E4, US 
Biological) for 1-2 hours at room temperature.  This was followed by appropriate 
secondary antibody incubation with goat anti-mouse Alexa Fluor 546 (1:250 dilution, 
Invitrogen), or goat anti-mouse Alexa Fluor 488 (1:250 dilution, Invitrogen), or rabbit 
anti-goat Alexa Fluor 488 (1:250 dilution, Invitrogen) for 1 hour at room temperature.  
All antibodies were diluted in PBS/1% BSA.  The stains were visualized with a Zeiss 510 
Upright or Inverted Microscope. 
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3.2.6 Glycocalyx Thickness and Density Measurements 
The heparan sulfate component of the glycocalyx and the nucleus were stained 
as described above.  To measure glycocalyx thickness, z-stack images were taken on the 
Zeiss 510 Upright Confocal Microscope at 63x (for static samples) or on the Zeiss 510 
Inverted Confocal Microscope at 40x (for flow samples) at 0.33µm intervals as 
previously described by others.[51]  The Zeiss LSM Image Browser was used for 
generation of z-stack images, 3-D reconstructions, and cross-sectional images.  With the 
cross-sectional images, heparan sulfate thickness was measured for each individual EC 
for the region over the center of the cell nucleus.  Only cells that were completely in the 
field of view and whose surface glycocalyx was continuous were included in the 
data.[51]  For each condition, at least 3 fields of view are analyzed.  Within each field of 
view, at least 5 cells are analyzed. 
To measure the glycocalyx density, images were taken on the Zeiss 510 Upright 
Confocal Microscope at 63x (for static samples) or on the Zeiss 510 Inverted Confocal 
Microscope at 40x (for flow samples).  Fluorescence intensity of the samples was 
measured with ImageJ (NIH).  An IgG isotype control was used to determine 
background fluorescence values.  For each condition, at least 5 fields of view were 
analyzed.  At least 2 replicates were performed for each sample. 
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3.2.7 Modulation of SIRT1 Activity 
Modulation of SIRT1 activity was performed using an inhibitor, EX-527 
(5µmol/L, Sigma) for 6 hours prior to the start of the experiment, or with an activator 
SRT1720 (0.16µmol/L, Sigma) for 1 hour prior to the start of the experiment.  Indirect 
activation of SIRT1 through Epac1 was performed using 8-pCPT-2'-O-Me-cAMP (“007”, 
100µmol/L, Biolog) for 2 days prior to the start of the experiment.  None of these agents 
are present when the cells are exposed to flow. 
3.2.8 Knockdown of SIRT1 
Transient transfection was performed as previously described[24] with 
Lipofectamine RNAiMAX (Invitrogen). The hCB-ECs were grown to 70% confluency in 
T-75 flasks.  Flasks were then transfected with either SIRT1 (Qiagen, SI00098434) or 
scramble (negative control) siRNA (Qiagen, 1022076) at 20nM in Opti-MEM (Gibco).  
Untransfected cells were used as a control.  Four hours after transfection, the medium 
was changed back to fresh 10% complete medium.  The cells were then cultured for 24 
hours before the start of the experiment. 
3.2.9 Modulation of Glycocalyx 
Degradation of the glycocalyx was performed with Flavobacterium heparinum 
heparinase III (Sigma) for 2 hours prior to the start of the experiment.[22, 64, 126, 192]  
Angiopoietin-1 (R&D Systems) was incubated at 100ng/mL for 30 minutes prior to the 
start of the experiment to increase the thickness of the glycocalyx.[149]  Brefeldin A is a 
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specific Golgi translocation inhibit that works within minutes.[146]  Co-perfusion of 
Brefeldin A with angiopoietin-1 reduces angiopoietin-1 mediated increases in glycocalyx 
thickness and mass.[149]  Brefeldin A (Sigma) was incubated at 100 µmol/L for 30 
minutes prior to the start of the experiment.  None of these agents are present when the 
cells are exposed to flow. 
3.2.10 Inhibition of NADPH Oxidase 
Inhibition of NADPH oxidase was performed incubating the cells with 5 µmol/L 
of the specific inhibitor VAS2870 (Sigma)[185] for 30 minutes prior to the start of the 
experiment. This agent was not present when the cells are exposed to flow. 
3.2.11 Western Blotting 
Western blots were performed to determine the expression of phosphorylated 
VE-cadherin and SIRT1.  Cells were seeded at a density of 50,000 cells/cm2 on to slide 
flasks and grown for 24 hours.  The cells were then subjected to 15 dynes/cm2 of steady 
shear stress for 48 hours.  For the SIRT1 knockdown experiments, cells were seeded at 
50,000 cells/cm2 on to 6-well plates and grown for 24 hours.  Cells were harvested with a 
cell scraper and subjected to a solution of CellLytic-M (Sigma) and Protease Inhibitor 
Cocktail (Sigma).  Protein quantification was performed with the A280 Protein 
Quantification Method.  For SIRT1 knockdown experiments, samples were boiled for 5 
minutes at 100°C.  20 µg of protein was loaded into each well for the SDS-
polyacrylamide gel electrophoresis (10% gel, Biorad).  Afterwards, the protein bands 
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were transferred to PVDF membranes.  The membranes were blocked with a Tris-
Buffered Saline with 0.1% Tween 20 (TBST) solution containing 1% BSA or 5% milk at 
room temperature for 1 hour.  Primary antibodies for rabbit-SIRT1 (1:250, 120kDa, Santa 
Cruz Biotechnology), goat-VE-cadherin (1:2000 dilution, 132kDa, Santa Cruz 
Biotechnology) and mouse-β-actin (1:2000 dilution, 42kDa, Santa Cruz Biotechnology) 
were diluted in a TBST solution containing 1% milk or 1% BSA and incubated with the 
membrane overnight at 4°C.  Goat-anti-mouse (1:2500 dilution, Invitrogen) goat-anti-
rabbit (1:500 dilution, Invitrogen) and donkey anti-goat (1:2500 dilution, Santa Cruz 
Biotechnology) secondary antibodies were incubated with the membrane for 45 minutes 
at room temperature.  After washing, immunoreactive bands were detected by 
luminography using Supersignal chemiluminescent substrate (Pierce). Subsequently, 
expression of phosphorylated VE-cadherin was detected by stripping the immunoblot 
and then reprobing with mouse-β-actin (1:2000 dilution, 42 kDa, Santa Cruz 
Biotechnology), rabbit-pTyr658-VE-cadherin (1:500 dilution, 120kDa, Millipore), diluted 
in a TBST solution containing 1% BSA overnight at 4°C.  Goat-anti-mouse (1:2500 
dilution, Invitrogen) or goat anti-rabbit (1:500 dilution, Invitrogen) secondary antibody 
diluted in TBST with 1% BSA was incubated with the membrane for 45 minutes at room 
temperature.  Chemiluminescent solutions (Pierce) were added for 5 minutes to cover 
the membrane.  Integrated band density was determined by densitometry after scanning 
onto autoradiographic films (GE Healthcare) and evaluated by ImageJ (NIH).  Protein 
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expression was reported as a normalized intensity of the band of interest compared to 
the band of the housekeeping protein, β-actin.  There was no significant effect of any of 
the conditions on the protein expression of loading control, β-actin.   
3.2.12 Quantification of Cell Alignment 
hCB-EC PECAM images were analyzed with ImageJ to quantify cell alignment.  
For each experiment, at least 4 fields of view were analyzed per well.  The freehand trace 
tool was used to trace the perimeter of each cell. The orientation angle was determined 
using the fit ellipse analysis tool.  This angle was converted to a first quadrant angle 
between 0 and 90 degrees.  The direction of fluid flow was defined as 0 degrees, while 
the direction perpendicular to fluid flow was defined as 90 degrees. 
3.2.13 Quantification of Trabecular VE-cadherin 
hCB-EC VE-cadherin images were analyzed using ImageJ to quantify the amount 
of trabecular VE-cadherin as previously described.[56]  Briefly, we traced the trabecular 
junction with the freehand tracing tool and calculated its area using the analysis tool.  
The percentage cell area covered by the reticular junction was measured and expressed 
as percentage of total cell perimeter area. 
3.2.14 Permeability Experiments 
Permeability experiments were performed as previously described.[27]  Briefly, 
hCB-ECs or HAECs were seeded with 10% complete FBS media onto the luminal (top) 
chambers of 0.4µm pore, polyester, 12-well Transwell plates (Corning) at a density of 
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100,000 cells/cm2 which ensured the development of a confluent monolayer 1 to 2 days 
post-plating.  The abluminal (bottom) chamber contained serum-free media.  The 
permeability was measured 7 days post-plating.  Prior to the experiment, cells in some 
wells were incubated with an agent that modifies the glycocalyx – heparinase or 
angiopoietin-1.  1 mg/mL of unlabeled bovine serum albumin (BSA) was added to the 
abluminal chamber and 1mg/mL of FITC-BSA was added to the luminal chamber at 
volumes that would ensure no differences in hydrostatic or osmotic pressure.  10µL 
samples were taken from the abluminal chamber every 20 minutes for 2 hours.  Albumin 
content of the sample was determined by a fluorimeter using a calibration curve.  
Permeability coefficients were determined using the expression previously described by 
Albelda et al.[2]  The permeability term represents contributions from both the cells and 
the membrane.  To calculate the permeability of the cells alone, the permeability of the 
cell layer and the membrane were treated as resistances in series. 
3.2.15 Statistical Analysis 
All data presented represent mean ± SE with the number of experiments (n) 
noted in the legend.  A p<0.05 was interpreted to denote statistical significance. For 
Figure 10A, a two-factor ANOVA for cell age and presence of flow was performed, 
followed by a post-hoc Tukey test.   For Figure 10B, an ANOVA for cell age and flow, 
followed by a post-hoc Tukey test was used to determine differences in gene expression 
levels between young and old cells.  For Figure 11, a 2-factor ANOVA for treatment 
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condition and age was performed.  For Figure 12, a 2-factor ANOVA was used to 
determine the effect of flow and treatment on gene expression in hCB-ECs.  For Figure 
14, a 2-factor ANOVA for treatment condition and flow was performed, followed by a 
post-hoc Tukey test was used to determine differences in gene expression levels for the 
different treatment and control groups tested.  For Figure 16, an ANOVA for cell age 
followed by a post-hoc Tukey test was performed to determine differences in glycocalyx 
thickness and intensity for each cell age.  For Figure 17, an ANOVA followed by a post-
hoc Tukey test was used to determine the influence of treatment groups.   In Figure 18, a 
2-factor ANOVA for flow and treatment was performed followed by a post-hoc Tukey 
test.  For Figure 20, a t-test was used to determine whether there was a significant 
difference of age (Figure 20D) or treatment (Figure 20E) on amount of trabecular VE-
cadherin.   For Figure 21, an ANOVA was performed on log-normal data (to ensure a 
normal distribution) to determine the effect of age and treatment on protein expression.  
This was followed by a post-hoc Tukey test to discern the effect of different treatments.  
For Figure 22, a 2-factor ANOVA was performed on log-normal data (to ensure a normal 
distribution) to determine the effect of age and treatment.  This was followed by a post-
hoc Tukey test to discern the effect of different treatments.  For Table 1, a paired t-test 
comparing treated ECs to untreated ECs was used to determine whether treatment 
affected the glycocalyx thickness or density.  For Figure 23, a 2-factor ANOVA for flow 
and treatment was performed for each gene, followed by a post-hoc Tukey test.  All 
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statistical analysis was performed using JMP (SAS).  Results represent data from at least 
3 different isolations of ECs.  Values of n indicate the number of experiments performed.  
Values of N represent the number of cells or fields of view analyzed. 
3.3 Results 
3.3.1 Less Alignment to Flow in Aged hCB-ECs than Young hCB-ECs 
We previously found that hCB-ECs with fewer than 31 population doublings 
(PDL) had high levels of telomerase and low levels of senescence-associated β-
galactosidase staining,7 and refer to them as “young” ECs. In contrast, hCB-ECs with 
more than  44 PDL had low levels of telomerase and high levels of senescence-associated 
β-galactosidase staining compared to hCB-ECs < 31 PDL, and refer to them as “aged” 
ECs, while noting the specific range of PDL examined. 
Because early passage ECs align in the direction of flow,[96] we compared the 
effect of 24 hours of 15 dynes/cm2 steady uniform, laminar shear stress on alignment of 
young and aged hCB-ECs.  Both young (13 PDL) and aged (49 PDL) hCB-ECs aligned in 
the direction of flow compared to static conditions (Figure 10A, p<0.05). Under static 
conditions ECs were randomly oriented, averaging 47±5 degrees with respect to the flow 
direction.  Young hCB-ECs exposed to flow aligned at 10±1 degrees, whereas aged hCB-
ECs aligned to a lesser extent, 21±3 degrees (Figure 10A, p<0.05). 
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Figure 10: Aged hCB-ECs have a decreased response to shear stress.  A) Young 
hCB-ECs (13 PDL) align more in the direction of fluid flow than aged hCB-ECs (49 
PDL). (n=3, N= 27-59 cells per experiment); B) Under steady laminar, unidirectional 
shear (15 dynes/cm2) old hCB-ECs (58 PDL) exhibit a smaller increase in eNOS and 
KLF2 mRNA levels compared to young hCB-ECs (18 PDL) under shear stress and aged 
hCB-ECs under static conditions  *: p<0.05; #: p<0.01 (n=4). 
3.3.2 Aged hCB-ECs Have Decreased Response to Steady Shear 
Stress 
Next, we examined in young and aged ECs the flow-mediated enhancement of 
KLF2, a transcription factor that mediates anti-inflammatory and anti-thrombotic 
properties of ECs, and eNOS, an EC-specific isoform of nitric oxide synthase regulated 
by KLF2.  For young hCB-ECs (18 PDLs), KLF2 mRNA levels increased 14-fold in 
response to 15 dynes/cm2 for 24 hours compared to ECs exposed to static conditions for 
the same duration (Figure 10B, p<0.01).  In contrast, aged hCB-ECs (58 PDLs) exposed to 
15 dyne/cm2 for 24 hours exhibited no change in KLF2 compared to static conditions 
(Figure 10B), indicating that these aged hCB-ECs are not responsive to shear stress.  
Additionally, the KLF2 mRNA levels are 5 times lower for aged hCB-ECs than young 
hCB-ECs under shear stress (Figure 10B, p<0.05).  When pooling control samples from 
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all experiments, KLF2 was significantly lower in aged (> 44 PDL) compared to young (< 
31 PDL) hCB-ECs under flow conditions (p<0.05).   
While eNOS mRNA was upregulated 2-fold in young hCB-ECs exposed to shear 
stress compared to static controls (Figure 10B, p<0.05), eNOS levels were reduced in 
aged cells under flow compared to young cells under flow (Figure 10B, p<0.05).  
Furthermore, eNOS mRNA in aged hCB-ECs under flow is 7 times lower than that of the 
corresponding static conditions, indicating that eNOS generation is inhibited by flow in 
aged hCB-ECs (Figure 10B, p<0.05).  When pooling control samples from all 
experiments, eNOS levels were significantly lower in aged (> 44 PDL) compared to 
young (< 31 PDL) hCB-ECs under flow conditions (p<0.05).  ET-1, a vasoconstrictor, is 
not normally upregulated by shear stress and was used as a control.  Its levels were 
downregulated for young hCB-ECs under shear stress compared to static controls 
(Figure 10B, p<0.01), but there was no significant effect of age.  Thus, aged hCB-ECs 
exhibit a decreased response to steady shear stress due to little or no upregulation of 
atheroprotective genes KLF2 and eNOS. 
3.3.3 SIRT1 Levels Are Reduced in Aging hCB-ECs 
Because SIRT1 has been shown to be important in age-associated pathologies, we 
measured SIRT1 levels in aging hCB-ECs.  We found that SIRT1 levels were high in 
young hCB-ECs and were significantly reduced in aged hCB-ECs (Figure 11).  Because 
SIRT1 levels were high in young hCB-ECs, we investigated the effects of a SIRT1 
 78 
 
inhibitor on young hCB-ECs.  Treatment of young hCB-ECs with EX-527, a SIRT1 
inhibitor, had no significant effect on SIRT1 protein levels (Figure 11).  However, others 
have shown that EX-527 does not alter protein levels, but does alter SIRT1 activity 
levels.[155]   Because SIRT1 levels are low in aged hCB-ECs, we investigated the effects 
of a SIRT1 activator on aged hCB-ECs.  Activation of SIRT1 with SRT1720 in aged hCB-
ECs elevated SIRT1 levels compared to untreated controls (Figure 11). 
 
Figure 11: SIRT1 levels are reduced in aged hCB-ECs.  A) Representative 
Western blot of SIRT1 with loading control β-actin.  B) SIRT1 levels are significantly 
lower in aged hCB-ECs.  Activation of SIRT1 with SRT1720 increases SIRT1 levels.  
However, there is no significant effect on SIRT1 levels when EX-527 is used to inhibit 
SIRT1.  C) Representative Western blot of SIRT1 with loading control β-actin. D) 
SIRT1 levels are lower in aged hCB-ECs after activation with 007. *p<0.05. (n=3) 
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3.3.4 Modulation of SIRT1 Regulates hCB-EC Response to Shear 
Stress 
The deacetylase antioxidant regulator SIRT1 decreases with increasing cell age[9, 
136] and in regions of accelerated EC aging in the vasculature.[24] To determine whether 
inhibition of SIRT1 decreased the hCB-EC response to shear stress, young hCB-ECs were 
exposed to 5 µmol/L EX-527, a specific SIRT1 inhibitor,[63] for 6 hours prior to the start 
of flow experiments.[155, 191]  For all flow experiments, flow media did not contain any 
pharmacological treatments.  EX-527 led to a 5-fold decrease in KLF2 levels under static 
(Figure 12A, p<0.01) conditions and a 3-fold decrease under flow conditions (Figure 12A, 
p<0.05).  Likewise, EX-527 treatment decreased eNOS levels under both static and flow 
conditions (Figure 12B). 
 
Figure 12: Inhibition of SIRT1 with 5 µmol/L EX-527 in < 31 PDL hCB-ECs 
reduces A) KLF2 and B) eNOS in response to shear stress.  *: p<0.05; #: p<0.01 (n=3). 
  Treatment with siRNA to SIRT1 caused complete knockdown of SIRT1 protein 
(Figure 13) and reduced KLF2 levels under static conditions (Figure 14A), but KLF2 still 
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increased in response to flow.  However, siRNA knockdown of SIRT1 completely 
abolished eNOS mRNA under both static and flow conditions (Figure 14B). 
 
Figure 13: Representative Western blot to confirm knockdown of SIRT1 with 
siRNA. 
To determine whether indirect activation of SIRT1 through Epac1 improves the 
response to flow in aging hCB-ECs, we used cyclic AMP analog 007, which ameliorates 
aging-related metabolic phenotypes[128] and increases VE-cadherin junctional 
localization.[42]  Treatment with 100 µmol/L 007 of aged hCB-ECs under static 
conditions or after exposure of aged ECs to 15 dynes/cm2 shear stress for 24 hours did 
not significantly affect KLF2 levels (Figure 14C).  However, addition of 007 to old hCB-
ECs under shear stress significantly increased KLF2 levels by 3-fold compared to flow 
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conditions (Figure 14C, p<0.01).  Treatment with 007 had a similar effect on eNOS levels 
(Figure 14D). 
 
Figure 14: Modulation of SIRT1 regulates response to shear stress.  Treatment 
of  young hCB-ECs (< 31 PDL) with SIRT1 siRNA  under static conditions caused a 
decrease in KLF2 (A) and B) eNOS mRNA levels; Treatment with 100 µmol/L 8-pCPT-
2'-O-Me-cAMP (007) to indirectly activate SIRT1 increased KLF2 (C) and eNOS 
mRNA levels (D) for aged hCB-ECs (> 44 PDL); Directly activating SIRT1 with 0.16 
mol/L SRT1720 increased  KLF2 (E) and eNOS (F) mRNA levels for aged hCB-ECs .  
*: p<0.05; #: p<0.01 (n=3). 
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Relative to untreated aged hCB-ECs, direct activation of SIRT1 with 0.16 µmol/L 
SRT1720[107] led to an increase in KLF2 levels in aged hCB-ECs under both static 
(Figure 3E, p<0.05) and flow (Figure 14E, p<0.05) conditions.  However, levels of KLF2 
with SRT1720 treatment under both static and flow conditions were not significantly 
different indicating that SRT1720 was not sufficient in restoring the flow responsiveness.  
SRT1720 had a similar effect on eNOS levels (Figure 14F). 
3.3.5 Glycocalyx Thickness and Density Decrease with Increasing 
Cell Age 
To determine whether age-related changes to the glycocalyx are a cause of 
decreased response to shear stress in aged ECs, we examined the heparan sulfate 
component and the perlecan core protein component of the glycocalyx with increasing 
cell age for ECs from a single isolation.  Although perlecan is a core protein, it has been 
shown to be present in the glycocalyx[72] and has been used to measure glycocalyx 
thickness.[77]  Isotype control antibodies were used to assess background fluorescence 
(Figure 15).   
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Figure 15: Representative image of fluorescence produced by treatment of 
hCB-ECs with IgG isotype control (red) and nuclei (blue) in A) planar and B) cross-
sectional views. 
Confocal images of perlecan immunofluorescence in 22 PDL (Figure 16A) and 49 
PDL hCB-ECs (Figure 16B) under static conditions showed that the perlecan density, as 
measured by the fluorescence intensity, decreased significantly in aged ECs (Figure 16F, 
p<0.01). Likewise, perlecan thickness also decreased with increasing cell age (Figure 
16E).  Consistent with this trend, confocal images of heparan sulfate 
immunofluorescence in young hCB-ECs (Figure 16C) and aged hCB-ECs (Figure 16D) 
indicate an increased heparan sulfate density in young hCB-ECs. 
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Figure 16: Confocal image of hCB-EC heparan sulfate core protein, perlecan, 
(red), heparan sulfate (green), and nuclei (blue) to measure perlecan density for A) 22 
PDL and B) 49 PDL; heparan sulfate density for C) 31 PDL and D) 62 PDL; E) Change 
in perlecan thickness with increasing cell age. #: p<0.01 compared to 27 PDL static 
control (n=3, N=15-27 cells); D) Change in perlecan intensity with increasing cell age.  
Dotted line represents intensity of isotype control (see Supplemental Figure 3). ^: 
p<0.05 compared to 22 PDL static control; ^^: p<0.01 compared to 22 PDL static control 
(n=3).  Scale bar =50 µm. 
We confirmed that these age-related changes in heparan sulfate fluorescence are 
comparable to changes in glycocalyx thickness and abundance found with agents 
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known to enhance or reduce the glycocalyx. A 2 hour 15mU/mL heparinase treatment 
prior to exposure of young hCB-ECs to exposed to 15 dyne/cm2 for 48 hours led to a 
significant 16% decrease in glycocalyx fluorescence intensity compared to untreated 
controls (Table 4, p<0.05), but no change in the glycocalyx thickness (Table 4).  This 
agrees with previously reported results demonstrating that heparinase alters glycocalyx 
density rather than thickness.[51]  For aged hCB-ECs, a 30 minute treatment with 
100ng/mL angiopoietin-1[149] prior to exposure to flow led to a 165% increase in 
glycocalyx thickness (Table 4, p<0.05), which is consistent with previously reported 
results for ECs.[149] 
  
 
8
6
 
  
Table 4: Effect of treatments on glycocalyx density and thickness after 24 - 48 hour steady shear stress.  *:p<0.05 compared 
to untreated control; #:p<0.01 compared to untreated control.  n=3-4. 
Treatment Age (PDL) Quantity Measured Percent Change 
Heparinase < 31 PDL Density -16 ± 4* 
Heparinase < 31 PDL Thickness -11 ± 17 
EX-527 < 31 PDL Density -47±13* 
EX-527 < 31 PDL Thickness -55±5* 
SIRT1 siRNA < 31 PDL Density -54±6* 
SIRT1 siRNA < 31 PDL Thickness -86±8* 
Angiopoietin-1 > 44 PDL Density 9 ±32 
Angiopoietin-1 > 44 PDL Thickness 165 ± 27* 
Brefeldin A > 44 PDL Density -69 ± 15* 
Brefeldin A > 44 PDL Thickness -33 ± 9* 
007 > 44 PDL Density -11 ± 27 
007 > 44 PDL Thickness 224 ± 110* 
SRT1720 > 44 PDL Density 30 ± 3# 
SRT1720 > 44 PDL Thickness 44 ± 30 
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Addition of glycosaminoglycans to the surface of ECs occurs through 
translocation of Golgi vesicles.[149, 181]  To verify this and support that angiopoietin-1 
acts upon the glycocalyx to regulate the response to shear stress, aged cells were treated 
with Golgi translocation inhibitor, Brefeldin A.  Treatment with 100 µmol/L Brefeldin A 
for 30 minutes prior to the start of the flow experiment led to a significant decrease in 
both glycocalyx thickness and density in aged hCB-ECs (Table 4, p<0.05).  While aged 
hCB-ECs treated with angiopoietin-1 had an increase in mean fluorescence after 
exposure to shear stress compared to untreated aged hCB-ECs (Figure 17, p<0.05), this 
angiopoietin-1 mediated response was inhibited when Brefeldin A was co-administered 
(Figure 17, p<0.01).  These results show that angiopoietin-1 improves the response to 
shear stress in aged hCB-ECs by increased Golgi translocation of glycosaminoglycans to 
the cell surface. 
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Figure 17: Inhibition of Golgi translocation with Brefeldin A reduces the effect 
of angiopoietin-1 on KLF2 levels in aged hCB-ECs.  *:p<0.05; #:p<0.01 (n=3). 
3.3.6 SIRT1 Regulates Glycocalyx Thickness and Density 
Given the decrease in glycocalyx thickness and density with increasing cell age 
(Figure 16E and Figure 16F), we examined whether altering SIRT1 activity affects the 
hCB-EC glycocalyx.  Untreated hCB-ECs exposed to 15 dyne/cm2 for 48 hours were used 
as baseline references.  Inhibition of SIRT1 in young hCB-ECs by treatment with 5 
µmol/L EX-527 for 6 hours prior to the start of the flow experiment led to a 55±5% 
decrease in heparan sulfate thickness (Table 4, p<0.05) and a 47±13% decrease in heparan 
sulfate density (Table 4, p<0.05) compared to the untreated flow control.  Knockdown of 
SIRT1 in young hCB-ECs with siRNA led to a 86±8% decrease in heparan sulfate 
thickness (Table 4, p<0.05) and a 54±6% decrease in heparan sulfate density (Table 4, 
p<0.05).  Conversely, indirect activation of SIRT1 in aged hCB-ECs with 100µmol/L 007, 
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led to a 224±110% increase in heparan sulfate thickness (Table 4, p<0.05), but there was 
no significant effect on heparan sulfate density (Table 4).  Direct activation of SIRT1 in 
aged hCB-ECs with 0.16µmol/L SRT1720 led to a 30±3% increase in heparan sulfate 
intensity (Table 4, p<0.01), but there was not a statistically significant effect on heparan 
sulfate thickness (Table 4).  These results suggest that SIRT1 alters the heparan sulfate 
thickness and density. 
3.3.7 Glycocalyx-Dependent Response of Aging hCB-ECs to Steady 
Shear Stress 
To establish whether alteration of hCB-EC glycocalyx affected the response to 
shear stress in a similar manner to ECs undergoing cell senescence, we measured the 
response to shear stress after ECs were treated with agents that enhance or reduce the 
glycocalyx.  Young and aged hCB-ECs were subjected to 15 dynes/cm2 of shear stress for 
48 hours.  Some samples were treated with 15mU/mL heparinase for 2 hours prior to the 
flow experiment to ensure degradation of the glycocalyx, whereas other samples were 
treated with 100ng/mL angiopoietin-1 for 30 minutes prior to the flow experiment to 
increase glycocalyx thickness (Table 4).  Untreated and static samples were used as 
controls.  Heparinase-treated young hCB-ECs had significantly lower levels of KLF2 
(Figure 18A) and eNOS (Figure 18B) mRNA than untreated cells for both static (Figure 
5A and 5B, p<0.01) and flow (Figure 18A and Figure 18B, p<0.05) conditions.  This result 
is consistent with the role of the glycocalyx in NO generation through eNOS[57] and 
establishes a role for the glycocalyx in regulating KLF2.  Conversely, angiopoietin-1 
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treated aged hCB-ECs had significantly higher mRNA levels of KLF2 (Figure 18C) than 
untreated cells in both static (Figure 18C, p<0.05) and flow (Figure 18C, p<0.05) 
conditions.  eNOS mRNA levels also increased in angiopoietin-1 treated hCB-ECs 
compared to untreated cells under both static (Figure 18B, p<0.01) and flow (Figure 18B, 
p<0.01) conditions.  These results suggest that depletion of the glycocalyx alter the 
response to shear stress in a manner similar to age. 
 
Figure 18: Effect of treatments to the glycocalyx upon KLF2 and eNOS levels 
following exposure to steady shear stress.  A) Heparinase decreases KLF2 in young (< 
31 PDL) hCB-ECs; B) Heparinase decreases eNOS in young hCB-ECs; C) 
Angiopoietin-1 increases KLF2 in aged (> 44 PDL) hCB-ECs; D) Angipoietin-1 
increases eNOS in aged  hCB-ECs *:p<0.05; #p<0.01 (n=3-4). 
 91 
 
3.3.8 VE-cadherin Localization and Structure Under Shear Stress is 
Primarily Age-Dependent  
High levels of trabecular VE-cadherin interact with PECAM to produce low EC 
permeability in areas of low actomyosin-mediated tension.[56]  For 22 PDL hCB-ECs 
exposed to 15 dynes/cm2 shear stress for 24 hours, VE-cadherin was localized to cell 
junctions (Figure 19) and 43%±1% of the junctional area was trabecular VE-cadherin.   
Glycocalyx disruption with heparinase in young hCB-ECs under flow conditions 
decreased trabecular VE-cadherin to 30%±2% compared to untreated flow control 
(p<0.01) and decreased localization at cell-cell junctions (Figure 19B).  For 62 PDL hCB-
ECs exposed to 15 dynes/cm2 for 24 hours, VE-cadherin was diffuse within the cell, with 
only a small amount localized to cell junctions (Figure 19C).  Only 7.9%±1% of the 
junctional area in the aged hCB-ECs was trabecular VE-cadherin.  This was significantly 
less than that found with young hCB-ECs (p<0.01) and hCB-ECs treated with heparinase 
(p<0.01), indicating that cell age affects the trabecular structure and localization of VE-
cadherin more than presence of the glycocalyx.  Treatment of aged hCB-ECs with 007 to 
activate SIRT1 through Epac1 under flow conditions almost doubled the percentage of 
trabecular VE-cadherin to 13%±1% compared to the untreated ECs (n=3; p<0.01).  
Additionally, there was increased VE-cadherin localization to cell junctions after 007 
treatment (Figure 19D). 
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Figure 19: Trabecular VE-cadherin for hCB-ECs exposed for 24 hours to flow 
that produced a wall shear stress of 15 dyne/cm2.  A) 22 PDL hCB-ECs; B) 22 PDL 
hCB-ECs treated with 15mU/mL heparinase; C) 62 PDL hCB-ECs; D) 62 PDL hCB-ECs 
treated with 100 µmol/L 8-pCPT-2'-O-Me-cAMP.  White arrows indicate trabecular 
VE-cadherin. Scale bar = 50m (n=3). 
Trabecular VE-cadherin was present in hCB-ECs of all population doublings 
under static conditions (Figure 20A-C, white arrows).  hCB-ECs that underwent 27 PDL 
had significantly  more trabecular VE-cadherin than 49 PDL hCB-ECs (Figure 20D, 
p<0.01).  Treatment of aged hCB-ECs with 007 under static conditions had no effect on 
the amount of trabecular VE-cadherin (Figure 20E).  While SIRT1 can influence the 
localization and organization of VE-cadherin after exposure of young and aged cells to 
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flow, trabecular VE-cadherin under static conditions is not significantly affected by 
indirect activation of SIRT1. 
 
Figure 20: Decrease in trabecular VE-cadherin in aged hCB-ECs under static 
conditions.  VE-cadherin (green) and Hoechst 33342 (blue).  A) 27 PDL hCB-ECs; B) 49 
PDL hCB-ECs; C) 49 PDL hCB-ECs treated with 100 µmol/L 8-pCPT-2'-O-Me-cAMP 
(007).  D) Quantification of trabecular VE-cadherin for 27 and 49 PDL hCB-ECs.  
White arrows in panels A, B and C indicate trabecular VE-cadherin. #: p<0.01 (n=3, 
N=26-52 cells). 
 
3.3.9 SIRT1 Mediates Phosphorylation of VE-cadherin at Tyr-658 
Phosphorylation of VE-cadherin at Tyr-658 plays an important role in 
mechanotransduction through inhibition of EC migration and increasing permeability 
by uncoupling VE-cadherin from p120-catenin.[135]  hCB-EC age led to a higher fraction 
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of Tyr-658 phosphorylation (Figure 21A and Figure 21B, p<0.05).  Inhibition of SIRT1 
with EX-527 in young hCB-ECs significantly increased the fraction of Tyr-658 
phosphorylation (Figure 21, p<0.05). Knockdown of SIRT1 with siRNA also elevated the 
fraction of Tyr-658 expression (Figures 6E and 6F, p<0.05).  
 
Figure 21: Phosphorylation of VE-cadherin at Tyr-658 is dependent on SIRT1 
under static and flow conditions. A) Representative Western blot for treatment with 
EX-527 and 007 under flow conditions; B) Quantification of Tyr-658 phosphorylation 
for treatment with EX-527 and 007 under flow conditions; C) Representative Western 
blot for treatment with SRT1720 under flow conditions; D) Quantification of Tyr-658 
phosphorylation with SRT1720 treatment under flow conditions; E) Representative 
Western blot for treatment with siRNA under static conditions with boiled sample; F) 
Quantification of Tyr-658 phosphorylation for SIRT1 siRNA treatment under static 
conditions with boiled sample *:p<0.05  (n=3-5). 
 
Indirect activation of SIRT1 through Epac1 with 007 in aged hCB-ECs 
significantly decreased the fraction of Tyr-658 expression (Figure 21B, p<0.05). Direct 
activation of SIRT1 with SRT1720 significantly decreased the fraction of Tyr-658 
expression in aged hCB-ECs compared to untreated aged hCB-ECs (Figure 21C and 
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Figure 21D, p<0.05). These results show that SIRT1 regulates tyrosine phosphorylation of 
VE-cadherin at Tyr-658. 
3.3.10 Glycocalyx Mediates Phosphorylation of VE-cadherin at Tyr-
658 
To determine whether the glycocalyx affects VE-cadherin phosphorylation, aged 
hCB-ECs were treated with angiopoietin-1 and young hCB-ECs were treated with 
heparinase and subjected to 48 hours shear stress at 15 dynes/cm2.  Untreated samples 
exposed to the same shear stress served as controls.   Phosphorylation of VE-cadherin at 
Tyr-658 increased in young hCB-ECs after heparinase treatment and in aged hCB-ECs 
(Figure 22B and Figure 22C, p<0.05).  Conversely, phosphorylation at Tyr-658 in aged 
hCB-ECs decreased after angiopoietin-1 treatment (Figure 22A and Figure 22B, p<0.05). 
These results indicate that phosphorylation of VE-cadherin at Tyr-658 depends on both 
glycocalyx and age. 
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Figure 22: Tyrosine phosphorylation of VE-cadherin is glycocalyx-dependent 
under flow conditions. A) Representative Western blot; B) Quantification of Tyr-658 
phosphorylation.*:p<0.05, #:p<0.01  (n=4-6). 
3.3.11 Modulation of Glycocalyx Affects EC Permeability Under Static 
Conditions 
We previously showed that hCB-EC permeability to albumin increases with 
increasing cell age.[27]  Since increasing age decreases both glycocalyx thickness and 
density (Figure 16) and disrupts VE-cadherin phosphorylation (Figure 18 and Figure 21) 
and localization (Figure 20), we sought to determine whether changes to the glycocalyx 
affected EC permeability.  Treatment of young ECs (< 31 PDL) with heparinase, which 
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reduces heparan sulfate density, led to an increase in EC permeability by 47±10% 
(p<0.05).  Treatment of aged ECs (>44 PDL) with angiopoietin-1, which increases the 
glycocalyx thickness, led to a 42±7% decrease in EC permeability to albumin (p<0.05).  
Taken together with the results in Figure 21, these results suggest that the glycocalyx 
functions as both a physical barrier and as a mechanosensor acting together with 
phosphorylation of VE-cadherin. 
3.3.12 Inhibition of NADPH Oxidase Increases Glycocalyx Thickness 
and Density in Aged ECs, but Is Not Sufficient to Improve Response 
to Shear Stress 
Elevated levels of SIRT1 inhibit NADPH oxidase.[194]  In atheroprone regions, 
aging is accelerated and the glycocalyx has been shown to be sensitive to oxidants.[168] 
After treatment of ECs with 200 µM H2O2 for 4.5 hours, young (< 31 PDL) ECs exhibited 
a 22±5% decrease in heparan sulfate thickness (p<0.05) and 11±4% decrease in intensity 
(p<0.05).  Following H2O2 treatment, aged ECs did not exhibit any change in glycocalyx 
thickness or intensity relative to untreated ECs at the same age.  To examine whether 
SIRT1 alters the glycocalyx through an NADPH oxidase-dependent mechanism, we 
treated aged hCB-ECs with NADPH oxidase inhibitor 5µM VAS2870 for 30 minutes 
prior to the start of the flow experiment.  Inhibition of NADPH oxidase increased both 
glycocalyx thickness by 123±29%(p<0.01) and density by 156±34% (p<0.05) in aged ECs. 
When aged ECs under shear stress were treated with VAS2870, KLF2 levels were 
significantly upregulated (Figure 23, p<0.01).  However, there was no significant effect 
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on KLF2 levels in static conditions and no significant effect on eNOS levels for static or 
flow conditions.  Therefore, restoration of the glycocalyx through inhibition of NADPH 
oxidase was not sufficient to fully restore the response to shear stress. 
 
Figure 23: Inhibition of NADPH oxidase elevates KLF2 in aged ECs under 
flow conditions, but has no significant effect on eNOS.  While inhibition of NADPH 
oxidase does enhance glycocalyx thickness (24%) and density (94%) in aged ECs, it is 
not sufficient to restore response to shear stress. #p<0.01 (n=3). 
 
3.4 Discussion 
In young ECs, increased levels and activity of SIRT1 in response to steady, 
unidirectional flow provides a protective mechanism against oxidative stress 
damage.[24, 182]  SIRT1 activation under atheroprotective flow enhances deacetylation 
of eNOS and increases bioavailability of NO.[24]  Regions of disturbed flow accelerate 
local replication and oxidative stress, leading to senescence of ECs, which promote 
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endothelial dysfunction.  SIRT1 protects ECs from senescence induced by disturbed flow 
via p53.[182]  The findings of the current study suggest that reduced SIRT1 levels, which 
occur during stress-induced and replicative senescence, result in reduced responsiveness 
to flow by reduction of the glycocalyx and phosphorylation of VE-cadherin.  We 
demonstrate that as ECs age their responsiveness to steady shear stress declines, in part, 
due to the reduced effectiveness of the cell mechanotransducers, the glycocalyx and VE-
cadherin.  The decreased response to steady shear stress in aged hCB-ECs can be 
mitigated by indirect or direct activation of SIRT1. Increasing the level of SIRT1 in older 
ECs increases the thickness and density of heparan sulfate in aged cells and restores the 
expression of KLF2 and eNOS. Additionally, SIRT1 plays an important role in VE-
cadherin mechanotransduction.  Alteration of SIRT1 affects VE-cadherin localization, 
trabecular structure, and phosphorylation at site Tyr-658.   
The glycocalyx is degraded in atheroprone regions of mice and even in regions 
away from branches in the apoE mouse.[168]  Further, a pro-oxidant environment can 
reduce the thickness of the glycocalyx.[108]  Elevated levels of SIRT1 inhibit NADPH 
oxidase and protect the cells from oxidative damage.[194]  Reduced SIRT1 activity in 
older cells led to higher levels of NADPH oxidase, which produces oxygen radicals that 
damage the glycocalyx. We showed that inhibition of NADPH oxidase in aged ECs 
restored the thickness and density of the glycocalyx, suggesting that SIRT1 may 
influence the response to flow by limiting reactive oxygen species damage, leading to 
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increased glycocalyx.  While elevated SIRT1 activity did increase KLF2 levels under 
flow, it was not sufficient to restore eNOS levels.  Thus, SIRT1 regulation of the 
glycocalyx may differentially affect KLF2 and eNOS. In young ECs, inhibition of 
NADPH oxidase also substantially altered the glycocalyx density, but the change was 
smaller than in the aged ECs (unpublished observation).  These results show that in 
aged ECs, oxidative damage alters mechanotransduction via the glycocalyx.  Restoration 
of the function can be partly achieved by activating SIRT1 which then inhibits NADPH 
oxidase.  
The heparan sulfate and perlecan thickness of the aged ECs measured in this 
study is comparable to the previously measured value of 1.38±0.07µm in bovine aortic 
ECs.[51] While perlecan is a core protein of the glycocalyx, there is evidence that it is 
secreted in the glycocalyx[72] and it has been used to measure glycocalyx thickness.[77]  
We also further supported these results by staining for heparan sulfate, and found that 
the results are consistent.  There are several limitations to measuring the glycocalyx with 
confocal microscopy including low resolution and high background fluorescence.[51]  
An alternative way to visualize the glycocalyx is with cryo-TEM as this eliminates the 
need for aldehyde fixation or alcohol dehydration, which are associated with confocal 
microscopy or traditional TEM.[51] In this study, we only examined the heparan 
sulphate and perlecan components of the glycocalyx.  However, transmembrane 
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syndecans also are important in mechanotransduction. They have been shown to be 
important in age-related maintenance of skeletal tissue[131] and skin tissue.[100] 
After depletion with heparinase, the glycocalyx regrows in 20 hours under static 
and 12 hours under flow conditions.[64]  This subsequently leads to a normal response 
to shear stress.  However, the results from the study by Giantsos-Adams et al. were 
obtained after only a 10-minute pretreatment with heparinase,[64] which removed less 
glycocalyx than the 2-hour treatment used in this study.  We have demonstrated that the 
heparan sulfate component of the glycocalyx is moderately depleted even 48 hours after 
treatment (Table 4) and that heparinase treatment lowers KLF2 and eNOS gene 
expression levels in aged hCB-ECs under flow compared to young hCB-ECs (Figure 16).  
Because of this, it is likely that the difference in results is due to the longer heparinase 
exposure time used in this study.   
Although we used ECs derived from human umbilical cord blood, others and we 
have found that the hCB-ECs function very similarly to vascular ECs.[11, 20, 27, 88, 89] 
As noted, the changes to the glycocalyx induced by heparinase and angiopoietin1 are 
similar to those reported for vascular cells.  A key difference and a reason for their 
choice in this study, is that hCB-ECs can undergo many more population doublings 
before senescence.  
Other signaling pathways could affect the aging EC response to flow besides 
SIRT1-mediated mechanosensing.  Epac1 can bind directly to VE-cadherin to stabilize 
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VE-cadherin on actin bundles via interactions with α-catenin and β-catenin.[121]  Shear-
mediated activation of PI3-kinase has been shown to lead to the activation of Nrf2[43]  
which influences KLF2 activation.[84]   Flow-mediated signaling through PI3-kinase and 
Akt-dependent pathways may also be altered through aging.[163]  In soleus muscle feed 
arteries, NO-mediated dilation of the vessel declines with increasing age.[163]  This 
decline was attributed to reduced potential for PI3-kinase/Akt-dependent 
phosphorylation of eNOS on Ser1177.[163]  These studies suggest a role for a PI3-
kinase/Akt-dependent mechanism in regulating the aging EC response to shear stress. 
Application of aortic intraluminal pressure of 200 mmHg led to a significant increase in 
phosphorylation of focal adhesion kinase in young rat aortas, but not in aged rat 
aortas.[145]   
During cell senescence, levels of SIRT1 are reduced which also reduces a number 
of anti-thrombotic and anti-inflammatory genes, including eNOS. [24, 108]  In this study, 
we extend previous work and demonstrate that SIRT1 also impacts KLF2 gene 
expression (Figure 24).  Furthermore, we show a novel role for SIRT1 in regulating 
mechanosensing through the glycocalyx and VE-cadherin, leading to the altered 
response to shear stress (Figure 24).   Based on these results, it is likely that SIRT1 plays a 
central role in the regulation of aging EC response to fluid flow (Figure 24). 
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Figure 24: SIRT1 plays a central role in regulating the EC response to shear 
stress.  Shear stress is sensed by the glycocalyx,[57] leading to alteration in KLF2 and 
eNOS levels.  eNOS is in a positive feedback loop with SIRT1,[24] which can alter the 
glycocalyx thickness and density and lead to an altered response to shear stress.  An 
external activator of membrane-bound cAMP to activate Epac1-Rap1 can lead to 
activation of SIRT1[129] and an improved response to flow.  Furthermore, binding of 
membrane-bound cAMP to Epac1 to activate SIRT1 leads to increased junctional 
localization of VE-cadherin[42] in young cells.  In aged hCB-ECs, phosphorylation of 
VE-cadherin at site 658 leads to uncoupling from p120 catenin.[135]  The glycocalyx 
also regulates binding of VE-cadherin to both p120 catenin and β-catenin through 
tyrosine phosphorylation at 658 and 731, respectively.[135]  SIRT1 inhibits NADPH 
oxidase,[194] leading to improved cell resistance to free radicals that can damage the 
glycocalyx. 
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Chapter 4. Endothelial Cell Senescence Increases 
Traction Forces due to Age-Associated Changes in the 
Glycocalyx and SIRT1 
4.1 Introduction 
Atherosclerosis is the primary pathology underlying cardiovascular disease and 
its development has been attributed to both changes in the local mechanical 
environment and endothelial cell (EC) aging.  Changes in vessel composition and 
structure have been linked to the development and progression of atherosclerosis.[170]  
There is also evidence of accelerated aging in atheroprone regions, including the 
presence of giant cells,[13] elevated levels of β-galactosidase staining,[108] and telomere 
shortening.[123]  Aging in atheroprone regions is likely due to high oxidative stress[54] 
which causes apoptosis.  The resulting increase in cell turnover leads to an increase in 
EC replication.  The increased oxidative stress and EC replication can lead to localized 
senescence.  Further, aging endothelium has been shown to have increased permeability 
to macromolecules[29] and increased sensitivity to oxidative stress.[26]  A localized 
increase in the permeability of the endothelial layer to proteins[79] is one of the earliest 
events in atherosclerosis development and influences the progression of 
atherosclerosis.[118, 158] 
Traction forces in ECs play an important role in cell migration and adhesion, 
with forces being highest at the periphery of the cell.[140]  Bovine aortic ECs on stiff 
substrates had increased cell traction forces and permeability compared to those seeded 
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on soft substrates.[87]  This result correlated with increased actomyosin contractility for 
cells isolated from old mice.  This increase in contractility, traction force, and 
permeability could be reversed through inhibition of the Rho-associated kinase (ROCK) 
pathway.[87]   
Chemically, the environment surrounding the lesion tends to be highly 
oxidative.  This is due to local variations in shear stress leading to the development of 
oscillatory and reversing flows that increase oxidative stress through NADPH-
dependent oxidase,[153] and is exacerbated by elevated levels of lipids and cholesterol.  
Exposure of ECs to oxidative stress from H2O2 treatment elevated their permeability.[14, 
26, 124]   Reactive oxygen species regulate the dynamics of the actin cytoskeleton[110] 
and cell traction forces.[94]   Oxidative stress can disrupt the glycocalyx – a thin layer of 
glycoproteins and proteoglycans on the surface of endothelial cells both in vitro and in 
vivo.[168],[101]   Damage to the glycocalyx can increase endothelial permeability and 
impair shear-mediated NO production.[142, 150, 168] 
SIRT1 is a deacetylase that regulates antioxidant activity and the cellular energy 
balance.  Levels of SIRT1 are reduced during aging or due to exposure to oxidative stress 
and disturbed fluid flow in atheroprone regions.[24]  Activation of SIRT1 reverses 
several age-associated phenotypes.[26, 29, 128, 199]  In ApoE-knockout mice, 
overexpression of SIRT1 in ECs decreased atherosclerosis.[128]  Furthermore, SIRT1 may 
regulate permeability through regulation of cell junction proteins, such as occludin.[29] 
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While changes in the mechanical environment and cell aging are known to 
impact atherosclerosis development, the relationship between the two remains unclear.  
In this study, we tested the hypothesis that age-associated changes in the EC glycocalyx 
or SIRT1 increase cell traction forces due to changes in actin localization and stress fiber 
thickness.  To test this hypothesis, we used human cord blood-derived ECs (hCB-ECs) as 
a model for cell aging because of their low, physiological permeability at low population 
doublings,[29] high proliferative potential in subconfluent cultures,[29] and similarity to 
arterial ECs.[11]  We examined traction forces of aging ECs and assessed their 
dependence on activators and inhibitors of SIRT1 and heparan sulfate. We also 
examined the effect of these agents on the actin cytoskeleton. 
4.2 Methods 
4.2.1 Cell Culture 
Human umbilical cord blood derived endothelial cells (hCB-ECs) were isolated 
from blood as previously described by Ingram et al.[89] For isolation of hCB-ECs, 
umbilical cord blood was obtained from the Carolina Cord Blood Bank (n=3 donors). 
Prior to receipt, all patient identifiers were removed.  The Duke University Health 
System IRB has determined that the following protocol meets the definition of research 
not involving human subjects as described in 45 CFR 46.102(f), 21 CFR 56.102(e) and 21 
CFR 812.3(p) and satisfies the Privacy Rule as described in 45CFR164.514. 
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After collection, blood was diluted 1:1 with Hanks Balanced Salt Solution (HBSS, 
Invitrogen), placed onto Histopaque 1077 (Sigma), and centrifuged at 740xg for 30 
minutes. Buffy coat mononuclear cells were collected and washed three times with 
“complete EC growth medium,” comprising 8% (vol/vol) fetal bovine serum (FBS) 
added to Endothelial Basal Media-2 (Cambrex) supplemented with Endothelial Growth 
Media-2 SingleQuots (containing 2% FBS plus growth factors, Cambrex), and 1% 
antibiotic/antimycotic solution (Invitrogen). Mononuclear cells were plated on plastic 6 
well 35 mm diameter plates coated with collagen I (rat tail, BD Biosciences) in complete 
EC growth medium. Medium was exchanged every 24 hours for the first week in 
culture, to remove non-adherent cells. Colonies of EPC-derived ECs appeared 7-10 days 
after the initial isolation.  The colonies were trypsinized and 200 cells were plated onto a 
collagen-coated T25 and labeled passage 1.  
The hCB-ECs were grown in T75 flasks using EBM2 basal media supplemented 
with penicillin/streptomycin, EGM2 Singlequots Kit, and 10% Fetal Bovine Serum (10% 
complete media).  Media was changed every other day until the time of experiment.  The 
hCB-ECs were passaged 1:10 into new T75 flasks upon reaching confluence. Cells were 
then subsequently split 1:10.  The number of population doublings (PDLs) that occurred 
between each passage was adjusted based upon a 75% attachment rate and calculated 
according to the formula ln(10)/ln(2)*(4/3) = 4.43 as previously described.[169] 
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4.2.2 EC Characterization 
hCB-ECs with fewer than 31 population doublings (PDL) have been extensively 
studied and function very similar to vascular ECs.[11, 20, 34, 88, 89] The hCB-ECs are 
positive for the endothelial-specific CD31 and CD34, and negative for CD14, CD45 and 
CD115 found on monocytes or hematopoietic cells.[29] We previously characterized 
hCB-ECs and found that they also expressed von Willebrand factor and VE-
cadherin.[11] Following exposure to 15 dyne/cm2 for 24 or 48 hours, hCB-ECs aligned 
with the direction of flow,[11, 20] increased nitric oxide production, and increased 
mRNA for endothelial cell specific genes sensitive to flow, KLF2, eNOS, cyclo-oxygenase 
2, and thrombomodulin.[11]  The level and organization of actin filaments are similar in 
hCB-ECs and human aortic ECs (HAECs) as are the associated values of cell stiffness.  
hCB-ECs with 31 or fewer PDL had high levels of telomerase and low levels of 
senescence-associated β-galactosidase staining, so we refer to them as “young” ECs.[29]  
hCB-ECs with 44 or more PDL had low levels of telomerase and high levels of 
senescence-associated β-galactosidase staining compared to hCB-ECs < 31 PDL, so we 
refer to them as “aged” ECs.[29]  
4.2.3 Synthesis of Variably Compliant Polyacrylamide Gels 
Coverslips were prepared as previously described.[139, 175, 180] Briefly, square 
glass coverslips (No. 2, 22 × 22 mm, VWR) were coated with 0.1 N NaOH (Sigma), and 
allowed to dry. The coverslips were coated with 3-aminopropyl-trimethoxysilane 
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(Sigma), washed in deionized water, and incubated with a coating of a 0.5% solution of 
glutaraldehyde (Sigma) in phosphate-buffered saline without calcium and magnesium 
((PBS), Invitrogen) at room temperature for 30 min. The coverslips were washed with 
deionized water and allowed to dry. 
Polyacrylamide gels with a Young’s modulus of 15,000 Pascals were made with 
12% acrylamide/0.13% bis-acrylamide ratio in the gel solution mixture.[193] The 
solutions were adjusted to pH 6.0 with 1N HCl (Sigma) and degassed for 30 min to 
remove oxygen that may inhibit polymerization.  0.5 µm diameter fluorescent beads 
(Invitrogen) were added to the gel for traction force experiments.  Polymerization was 
initiated by the addition of a 0.1% ammonium persulfate (Bio-Rad) solution in water to 
the acrylamide mixture. A total of 20 µL of the mixture was pipetted onto an activated 
coverslip and a circular coverslip (No. 2, 18 mm diameter, VWR) was used to flatten the 
drop. Polymerization was allowed to occur for 30 min at room temperature. The circular 
coverslip was removed, and the gel was glutaraldehyde-immobilized[93] with 10 µg/mL 
of fibronectin (Sigma) for two hours at 4 °C. Gels were washed with DI water and stored 
in DI water in 35mm petri dishes at 4°C.  Gels were used for experiments within two 
weeks. 
4.2.4 Traction Force Microscopy 
Traction force microscopy was performed as previously described.[81-83, 140]  
Briefly, low or high passage hCB-ECs were seeded at 100,000 cells on 15,000 Pascal 
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polyacrylamide gels embedded with 0.5-µm-diameter fluorescent beads.  The cells were 
allowed to adhere for 24 hours.  Cells were imaged with differential interference contrast 
microscopy and the fluorescent bead field beneath the cell was imaged immediately 
after with a XD Spinning Disk Confocal Microscope (Andor). A second fluorescent 
image of the bead field was taken after the cells were removed with 0.025% 
trypsin/EDTA (Invitrogen). Removal of the cells with trypsin takes less than 5 minutes.  
Bead displacements were used to compute cellular traction vectors, T, by using a 
gradient-based digital image correlation technique to map the displacement fluorescent 
beads in the gel.[83] The displacement map was converted to the stress distribution, 
using a numerical algorithm based on the integral Boussinesq solution.  The root mean 
square of the force, |F|, was calculated using the individual components of the traction 
vectors integrated over the cell area, 
 (4) 
where T(x,y) = [Tx(x,y), Ty(x,y)] is the continuous field of traction stress vectors 
defined at any spatial position (x,y) within the cell.[139]  Because the cells have 
negligible acceleration, the sum of forces should equal zero in order to satisfy Newton’s 
first law of motion.  In these studies, the sum of the force on the cell was about 0.01pN, 
far below the reported root mean square force. 
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For each experiment, at least 5 cells were examined per condition.  These traction 
forces were averaged together to obtain results for a single experiment.  
4.2.5 Actin Immunofluorescence 
For these experiments, each coverslip with a gel was attached to six-well plates 
with vacuum grease (Corning).  ECs were plated on polyacrylamide for these 
experiments to maintain consistency with traction force measurements which were 
performed on gels.  hCB-ECs were seeded at 100,000 cells/well on 6-well plates.  At 24 
hours post plating, cells were fixed with 3.7% formaldehyde for 30 minutes at room 
temperature and permeabilized with 1% Triton in PBS for 5 minutes at room 
temperature.  The cells were then incubated with fluorescein phalloidin (1:40, 
Invitrogen) to stain for F-actin for 1 hour at room temperature.  Hoechst 33342 
(Invitrogen) was used to stain for cell nuclei (1:2000).  The stains were visualized with a 
Zeiss 510 Upright Microscope.   
4.2.6 Immunofluorescence 
hCB-ECs were seeded at 100,000 cells on 15,000 Pa polyacrylamide gels for 
consistency with traction force measurements which were performed on gels.  At 24 
hours post plating, cells were fixed and permeabilized for 3 minutes with methanol or 
fixed with 2% formaldehyde.  Samples were then blocked with PBS/0.02% Tween 20 
(Biorad)/3% bovine serum albumin (Sigma) for 1 hour at room temperature.  The 
samples were then incubated with mouse antibody against heparan sulfate 
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proteoglycan, perlecan (1:250 dilution, clone 7E12, Thermo Scientific) or with mouse 
antibody against heparan sulfate (1:100 dilution, clone 10E4, US Biological) for 1-2 hours 
at room temperature.  This was followed by secondary antibody incubation with goat 
anti-mouse Alexa Fluor 546 (1:250 dilution, Invitrogen) or goat anti-mouse Alexa Fluor 
488 (1:250 dilution, Invitrogen) for 1 hour at room temperature.  All antibodies were 
diluted in PBS/1% BSA.  The stains were visualized with a Zeiss 510 Upright 
Microscope.  To examine localization of the   antibodies, some samples were not 
permeabilized. 
4.2.7 Glycocalyx Thickness and Density Measurements 
The heparan sulfate and perlecan core protein components of the glycocalyx and 
the nucleus were stained as described above.  To measure glycocalyx thickness, z-stack 
images were taken on the Zeiss 510 Upright Confocal Microscope at 63x at 0.33µm 
intervals.  The results we obtained with this method are similar to other established 
methods to measure the glycocalyx thickness in cultured ECs using fluorescence and 
optical sectioning. [51, 159]  The Zeiss LSM Image Browser was used for generation of z-
stack images, 3-D reconstructions, and cross-sectional images.  With the cross-sectional 
images, heparan sulfate or perlecan thickness was measured for each individual EC for 
the region over the center of the cell nucleus.  Only cells that were completely in the field 
of view and whose surface glycocalyx was continuous were included in the data.[51]  
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For each condition, at least 2 fields of view are analyzed.  Within each field of view, at 
least 5 cells are analyzed. 
To measure the glycocalyx density, images were taken on the Zeiss 510 Upright 
Confocal Microscope at 63x.  Fluorescence intensity of the samples was measured with 
ImageJ (NIH).  An IgG isotype control was used to determine background fluorescence 
values.  For each condition, at least 5 fields of view were analyzed.  In each field of view, 
there are 4-5 cells. 
4.2.8 Quantification of Actin Stress Fibers 
Distribution of actin was determined by drawing a line perpendicular to the 
direction of actin fibers at random locations with ImageJ.  This plot profile was saved as 
a text file and imported into a custom Matlab program to replot the data as a function of 
the percentage of distance across the cell in the direction perpendicular to the actin 
fibers.  The fiber thickness was calculated by measuring the distance between line scan 
peaks at 1/3 of the maximum fluorescence intensity. 
4.2.9 Modulation of SIRT1 
Modulation of SIRT1 activity was performed using an inhibitor, EX-527 
(5µmol/L, Sigma) for 6 hours prior to the start of the experiment, or with an activator 
SRT1720 (0.16µmol/L, Sigma) for 1 hour prior to the start of the experiment.  
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4.2.10 Modulation of Glycocalyx 
Degradation of the glycocalyx was performed with Flavobacterium heparinum 
heparinase III (Sigma) at 15 mU/mL for 2 hours prior to the start of the experiment.[22, 
64, 126, 192]  Cells were incubated with Angiopoietin-1 (R&D Systems) at 100 ng/mL for 
30 minutes prior to the start of the experiment to increase the thickness of the 
glycocalyx.[149] 
4.2.11 Statistical Analysis 
For Figure 25B and 25C, an ANOVA was performed to determine whether cell 
age significantly affected hCB-EC traction forces.  This was followed by a post-hoc 
Tukey test to determine between the different ages examined.  For Figure 27, a two-
factor ANOVA was performed to determine the effect of treatment and age on 
glycocalyx and cell traction force, respectively.  For Figure 29A, a 2-factor ANOVA was 
performed to determine the effect of treatment and age on cell traction force.  For Figure 
29B, a two-factor ANOVA was performed to determine the effect of treatment and age 
on junction tension. For Tables 5-7, a two-factor ANOVA for age and treatment was 
performed to determine the effect of both factors on stress fiber thickness or number of 
fibers per cell width.  A post-hoc Tukey test was then performed to determine 
differences between treatment groups.  All statistical analysis was performed in JMP.  
The value of n represents the number of experiments performed.  All data is reported as 
mean ± S.E. 
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4.3 Results 
4.3.1 Aged hCB-ECs from Multiple Isolations Exhibit Increased 
Traction Forces 
To determine whether traction forces differed between young and old hCB-ECs, 
we measured the traction forces for isolated young (< 31 PDL) and aged (> 44 PDL) hCB-
ECs from 3 separate isolations. For these experiments, hCB-ECs of all ages were seeded 
on 15 kPa gels.  In our method, the resolution of the displacement is 0.1 pixel and the 
resolution of the traction stress is 10Pa. While the distribution pattern of traction stresses 
are similar for young and old hCB-ECs on 15kPa gels, (Figure 25A), aged hCB-ECs 
exhibited total traction forces that were about 50% higher than young hCB-ECs (Figure 
25B, p<0.05). There was no statistically significant effect of EC donor on the traction 
forces.  
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Figure 25: Aged hCB-ECs exhibit increased traction forces and altered actin 
localization.  A) Representative contour plot of cell traction stresses; B) Aged (> 44 
PDL) hCB-ECs have higher total traction force than young (< 31 PDL) hCB-ECs; n=4-5. 
*p<0.05.C) Traction forces increase with increasing cell age for cells from one 
isolation. n=4. *:p<0.05. 
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4.3.2 Traction Forces Increase with Increasing Cell Age for hCB-ECs 
from One Isolation 
To eliminate any effect of the donor on the traction force results, we examined 
traction forces with increasing cell age for hCB-ECs from a single isolation and seeded 
on 15,000 Pa gels.  The traction forces significantly increased with increasing cell age 
(Figure 25C, p<0.05).  Older hCB-ECs at 40 PDL and 44 PDL exhibited significantly 
higher forces than younger hCB-ECs at 22 PDL (p<0.05).  These results show that aging 
of hCB-ECs increases their traction forces for cells from a single isolation. 
4.3.3 Modulation of Glycocalyx Alters hCB-EC Traction Forces 
Because the glycocalyx plays an important role in regulation of endothelial 
mechanotransduction[168], we examined whether the glycocalyx differed between 
young and old cells and whether disruption of the glycocalyx in isolated cells led to 
elevated traction forces.  To examine the glycocalyx, we quantified immunofluorescence 
for both a heparan sulfate core protein, perlecan, and heparan sulfate.  Both of these 
proteins have been used to measure glycocalyx thickness and density and are secreted 
onto the endothelial cell surface.[51, 73, 77]  The glycocalyx thickness was determined 
from confocal Z-sections.  For young cells, a clear band was noticeable in the Z-sections 
for heparan sulfate (1.7 ± 0.2 µm, Figure 26A) and perlecan (2.0 ± 0.4 µm, Figure 26C). 
The difference in thickness of the two layers was not statistically significant.  The 
perlecan band was located on the luminal surface and the location of the perlecan layer 
was not affected by permeabilization of the cells.  Heparan sulfate was significantly 
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thicker (p<0.05) in young hCB-ECs (1.7 ± 0.2 µm, Figure 26A) compared to aged hCB-
ECs (1.2 ± 0.1 µm, Figure 26B).  Immunofluorescence for the heparan sulfate core 
protein, perlecan, was visible on the luminal surface of young cells (Figure 26C) and the 
fluorescence intensity was greatly reduced for older cells (Figure 26D). For both young 
and old cells, the fluorescence was above background isotype control values 
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Figure 26: Representative images of Z-stack images of heparan sulfate layer 
thickness for A) young hCB-ECs and B) old hCB-ECs. Heparan sulfate core protein 
perlecan for C) young hCB-ECs and D) young hCB-ECs after treatment with 
heparinase.  Z-stack images of perlecan layer thickness for E) young hCB-ECs and F) 
young hCB-ECs after treatment with heparinase. Representative images of heparan 
sulfate core protein perlecan for G) old hCB-ECs and H) old hCB-ECs after treatment 
with angiopoietin-1. Z-stack images of perlecan layer thickness for I) old hCB-ECs 
and J) old hCB-ECs after treatment with angiopietin-1.   
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In older cells, the perlecan thickness was 1.6 ± 0.2 µm (Figure 26I), which is a 20% 
decrease compared to young hCB-ECs (2.0 ± 0.4 µm, Figure 26E) (p<0.05).  Perlecan 
density also decreased noticeably by 47% in aged hCB-ECs (Figure 26G) compared to 
young (Figure 26C).  There was a significant effect of both age (p<0.05) and treatment 
(p<0.05) on perlecan immunofluorescence.   
Heparinase treatment decreased the perlecan density of < 31 PDL hCB-ECs by 
21±9% compared to untreated controls (Figure 26A and Figure 26B, p<0.05).  Heparinase 
did not significantly alter glycocalyx thickness which is consistent with previously 
reported results (Figure 26C and Figure 26D).[51]   Angiopoietin-1 treatment enhanced 
the perlecan thickness in > 44 PDL hCB-ECs by 90±11% compared to untreated controls 
(Figures 2G and 2H, p<0.05), but had no significant effect on perlecan density (Figure 
26E and Figure 26F).  Angiopoietin-1 has been shown to increase the perlecan thickness 
by increasing translocation of glycosaminoglycans from the Golgi.[149]  
We then applied these treatments to the cells to determine the effect of the 
glycocalyx on traction forces.  The heparinase treatment increased traction forces in < 31 
PDL hCB-ECs by 48% (Figure 27A, p<0.05).  Conversely, angiopoietin-1 decreased 
traction forces in > 44 PDL hCB-ECs by 51% (Figure 27A, p<0.05) compared to untreated 
controls.  HAECs, which have telomerase activity similar to older hCB-ECs (45-71 
doublings),[29] have substantially greater traction forces (Figure 27B).  Treatment with 
angiopoietin-1 also decreased traction forces in HAECs by 71% (Figure 27B, p<0.05).  
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Taken together, these results show that traction forces are lower for cells with thicker 
and/or more abundant heparan sulfate or perlecan in the glycocalyx. 
 
Figure 27: Traction forces are glycocalyx-dependent.  A) Heparinase, which 
degrades the glycocalyx, significantly increases traction forces in < 31 PDL hCB-ECs.  
Angipoietin-1, which increases the glycocalyx thickness, significantly decreases 
traction forces in > 44 PDL hCB-ECs; B) Angiopoietin-1 significantly decreases 
traction forces in HAECs.  n=3-5. *p<0.05. 
4.3.4 Modulation of Glycocalyx Alters Actin Stress Fiber Formation 
To determine whether altered traction forces due to disruption of the glycocalyx 
affect actin size and density, we examined actin stress fiber localization and thickness 
after treatment with agents known to alter the glycocalyx.  In 27 PDL hCB-ECs, actin 
was localized at the periphery of the cells (Figure 28A).  However, in 27 PDL hCB-ECs 
treated with heparinase to degrade the glycocalyx, there is some formation of actin 
stress fibers along the length of the cell (Figure 28B).   In 49 PDL hCB-ECs, actin stress 
fibers were present throughout the length of the cell (Figure 28C).   When these cells 
were treated with angiopoietin-1 to increases the thickness of the glycocalyx, actin stress 
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fibers appeared thinner and there was some increase in localization of actin to the 
periphery of the cell (Figure 28D).  
 
Figure 28: Actin localization is glycocalyx-dependent.  Actin is localized to the 
cell periphery in A) 22 PDL hCB-ECs, while fibers form along the length of the cell in 
B) 22 PDL hCB-ECs with heparinase.  Actin stress fibers are present throughout the 
cell in C) 49 PDL hCB-ECs, while fibers begin to localize to periphery in D) 49 PDL 
hCB-ECs with angiopioetin-1. 
 We also found that there was a significant effect of both age (p<0.01) and 
treatment (p<0.05) on actin stress fiber thickness (Table 5).  Heparinase led to an increase 
in actin stress fiber thickness compared to untreated cells (Table 5, p<0.05).  Actin fibers 
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in aged hCB-ECs were thicker than in 27 PDL hCB-ECs (Table 5, p<0.01), but became 
thinner in aged hCB-ECs treated with angiopoietin-1 compared to the untreated control 
(Table 5, p<0.05).   
Table 5: Glycocalyx Alters Stress Fiber Thickness. *:p<0.05 compared to 
untreated control; #:p<0.01 compared to < 31 PDL.  n=3. 
Condition Stress Fiber Thickness (µm) 
< 31 PDL 1.1 ± 0.2 
< 31 PDL + Heparinase 1.8 ± 0.1* 
> 44 PDL 2.2 ± 0.2# 
> 44 PDL + Angiopoietin-1 1.5 ± 0.1* 
 
We also found that there was a significant effect of age (p<0.05) and treatment 
(p<0.05) on the number of actin stress fibers per cell width (Table 6).  Treatment of aged 
hCB-ECs with angiopoietin-1 significantly reduced the number of actin stress fibers per 
cell width (Table 6, p<0.05).  Taken together, these results show that age-associated 
changes in the glycocalyx can alter actin stress fiber localization and thickness. 
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Table 6: Effect of Agents that Affect SIRT1 or the Glycocalyx on Number of 
Actin Stress Fibers per Cell Width. *:p<0.05 compared to > 44 PDL; ^:p<0.05 compared 
to < 31 PDL.  n=7-12.  
Condition Number of F-actin Fibers per Cell 
< 31 PDL 10.8 ± 0.9 
< 31 PDL + EX-527 9.7 ± 1.2 
< 31 PDL + Heparinase 12.8 ± 0.9 
> 44 PDL 15.7 ± 2.6^ 
> 44 PDL + SRT1720 10.4 ± 1.3 
> 44 PDL + Angiopioetin-1 8.3 ± 0.9* 
 
4.3.5 Effect of SIRT1 Treatments on Traction Forces 
Because elevating SIRT1 plays an important role in reversal of senescence-
associated phenotypes[26, 29, 42, 128, 199] and regulation of shear stress-induced 
eNOS,[24] we sought to determine whether modulation of SIRT1 altered cell traction 
forces.  Isolated aged ECs (> 44 PDL) had significantly higher traction forces compared 
to the untreated young (< 31 PDL) hCB-EC control (Figure 29, p<0.05).  Inhibition of 
SIRT1 in isolated young hCB-ECs with EX-527 had no significant effect on traction forces 
compared to the untreated young hCB-EC condition.  However, activation of SIRT1 with 
SRT1720 in aged (> 44 PDL) hCB-ECs did significantly reduce traction forces compared 
to the untreated aged hCB-EC control (Figure 29, p<0.05).   
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Figure 29: Effect of SIRT1 on traction forces.  For isolated cells, inhibition of 
SIRT1 in young (< 31 PDL) with 5µM EX-527 has no significant effect on traction 
forces compared to untreated control.  Elevation of SIRT1 in aged (> 44 PDL) with 
0.16µM SRT1720 decreases traction forces compared to untreated control n=3-7. 
*:p<0.05. 
4.3.6 Effect of SIRT1 Treatments on Actin Stress Fibers 
Aged (> 44 PDL) hCB-ECs exhibited more actin stress fibers present throughout 
the length of the cell (Figure 30C) compared to young (< 31 PDL) hCB-ECs (Figure 30A).  
Stress fibers in aged hCB-ECs were also significantly thicker than those in young hCB-
ECs (Table 7, p<0.05).  Treatment of young hCB-ECs with EX-527 to inhibit SIRT1 
increased the number of stress fibers present in the cell (Figure 30B) compared to the 
untreated condition (Figure 30A).  There was no statistically significant change in stress 
fiber thickness after treatment of young hCB-ECs with EX-527 (Table 7).  Treatment of 
aged hCB-ECs with SRT1720 to activate SIRT1 led to increased actin at the periphery of 
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the cells (Figure 30D) compared to the untreated aged hCB-ECs (Figure 30C).  Treatment 
with SRT1720 also significantly decreased actin stress fiber thickness compared to aged 
hCB-ECs (Table 7, p<0.05).  There was a significant effect of age (p<0.05) and treatment 
(p<0.05) on the number of actin stress fibers per cell width (Table 6).  These results 
suggest that activating SIRT1 in older cells may affect actin stress fiber formation and 
localization.  
Table 7: Effect of SIRT1 on Actin Stress Fiber Thickness. *:p<0.05 compared to 
>44 PDL; ^:p<0.05 compared to < 31 PDL.  n=3. 
Condition Stress Fiber Thickness (µm) 
< 31 PDL 1.4 ± 0.1 
< 31 PDL + EX-527 1.5 ± 0.1 
> 44 PDL 1.7 ± 0.1* 
> 44 PDL + SRT1720 1.4 ± 0.1* 
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Figure 30: Effect of SIRT1 on actin stress fibers.  A) Actin stress fibers localize 
to periphery in young hCB-ECs; B) Treatment of young hCB-ECs with 5µM EX-527 to 
inhibit SIRT1 leads to some formation of stress fibers throughout the length of the 
cell; C) Aged hCB-ECs have actin fibers present throughout the length of the cell; D) 
Aged hCB-ECs with 0.16µM SRT1720 have more actin localization at periphery of the 
cell. 
4.4 Discussion 
EC cell traction forces are affected by actin localization and actomyosin 
contractility,[30, 87, 133] integrin levels,[151] focal adhesion formation,[34], 17 and Rho 
activity.[87, 186]  Actin binding to vinculin is necessary for cell traction force 
generation.[160]  Furthermore, elevated Rho or Rho-associated kinase activity can 
stimulate cell contractility by modulating actomyosin contraction.  In this study, we 
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demonstrated that senescent hCB-ECs exhibited increased traction forces and thicker 
and more abundant stress fibers due to age-associated changes in the glycocalyx and 
SIRT1. The traction force increase in senescent hCB-ECs correlated with decreased 
glycocalyx intensity and thickness as well as increased actin fiber thickness.  Altering 
glycocalyx thickness and density affected actin stress fiber thickness and localization. 
Likewise, activating SIRT1 in aged EC led to a decrease in actin stress fiber thickness, 
although direct inhibition of SIRT1 with EX-527 for 6 hours prior to the start of the 
experiment was not sufficient to elevate traction forces or altering actin fiber thickness in 
young (< 31 PDL) hCB-ECs.  
hCB-ECs were used in this study because of their low, physiological 
permeability,[29] high proliferative potential,[29] and similarity to arterial ECs.[11]  
Traction forces for both young and aged hCB-ECs were low compared to those 
previously reported for BAECs.[16, 87]   For reference, we found that when attached to 
polyacrylamide gels with an elastic modulus of 15 kPa, the traction force for human 
aortic ECs were 0.78±0.09µN, which is close to previously reported values in BAECs.[87]  
This traction force result correlates with the reduced permeability in hCB-ECs compared 
to HAECs.[29]  Both hCB-ECs and HAECs exhibited a decline in traction force after 
exposure to angiopoietin-1.  
There is increasing evidence that the method of fibronectin immobilization can 
affect the interactions of fibronectin with integrins, which can modify cell adhesion to 
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polymer substrates.  It has been shown that varying linker density can affect collagen 
protein tethering on polyacrylamide gels.[184]  However, stiffness-induced stem cell 
differentiation was independent of changes to protein tethering or gel porosity.[184] 
The glycocalyx thickness of the aged ECs measured in this study using 
antibodies to either heparan sulfate or perlecan is comparable to the previously 
measured value of 1.38±0.07µm in bovine aortic ECs.[51] Additionally, we stained for 
both a heparan sulfate core protein, perlecan, and heparan sulfate.  We found that both 
stains yielded similar results and trends in the glycocalyx with age.  Although perlecan 
is a core protein, it has been shown to be secreted to the glycocalyx[73] and has been 
used as to measure glycocalyx thickness.[77]  Henderson-Toth et al show that treatment 
with heparinase does reduce the abundance of perlecan, which is consistent with our 
observations.[77]  This suggests that the heparan sulfate does have a role in anchoring 
perlecan to the endothelial glycocalyx on the abluminal surface. 
Z-stack sections of 0.33 µm were used to visualize the glycocalyx.  The resolution 
of the confocal microscope section images was calculated to be 0.7 µm,[84] which is less 
than the values of the glycocalyx thickness that we measured in this study. Using 
antibodies to different components of the glycocalyx, we were able to resolve the 
glycocalyx (Figure 26) and determine changes in both thickness and density with age.  
An alternative way to visualize the glycocalyx is with cryo-TEM as this eliminates the 
need for aldehyde fixation or alcohol dehydration.  The thickness of bovine aortic EC 
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glycocalyx measured by cryo-TEM was about 11 µm,[51] which is significantly thicker 
than any estimate obtained from confocal imaging or from functional measurements.  
Cryo-TEM would provide additional insight into the structure and appearance of the 
glycocalyx, but the trends with age and treatments would remain the same. 
There are several other factors that could contribute to elevated traction forces in 
aging hCB-ECs, including integrin levels and changes in Rho activity.  Integrin α5β1 
plays an important role in cell force generation through the RhoA-Rock pathway.[151]  
Integrin β4 has been shown to be elevated in a mouse model during aging and 
atherosclerosis.[156]  Knockdown of integrin β4 in the mouse attenuated the decrease in 
endothelial nitric oxide synthase associated with senescent ECs,[156] suggesting that the 
integrins may play an important role in aging EC mechanotransduction. 
Interaction between integrins and the extracellular matrix can lead to clustering 
and the formation of focal adhesions.[3, 7, 61, 147]  Focal adhesions mediate force 
transmission between integrins and the actin cytoskeleton.[34, 60]  Vinculin, a focal 
adhesion protein, has been demonstrated to be important in regulating myosin 
contractility dependent adhesions and traction forces.[49]  Senescent human umbilical 
vein ECs have inhibited migration due to an increased amount of focal adhesion 
sites.[62]  Therefore, it is possible that changes in the amount of focal adhesions in 
senescent ECs play a role in altering cell traction forces. 
 132 
 
Rho GTPases have also been shown to be important in mediating cell 
contractility and cell traction forces.  In human umbilical vein ECs, inhibition of RhoA 
and Rac1 decreased permeability, cell contractility, and assembly of actin stress 
fibers.[186]  Dominant-negative Cdc42 reduced stress fiber formation and contractility, 
but did not alter permeability.[186]  In bovine aortic ECs, increases in traction force and 
permeability on stiff substrates was attributed to increased activation of RhoA.[87]  
When downstream effector Rho-dependent kinase was inhibited, there was a reduction 
in monolayer permeability and cell traction force.[87] 
To fully understand the role of endothelial cell force generation in atherosclerosis 
development, the effect of shear stress and intracellular forces would have to be 
considered.  After exposure to flow for 16 hours, the traction force for confluent ECs was 
slightly greater for cells exposed to steady shear stress than for cells under static 
conditions or cells exposed to recirculating flow.[161]  Steady flow also caused the 
surface traction force vectors to align in the direction of flow and increased intracellular 
forces.[161]  Static conditions or recirculating flow did not alter alignment of surface 
traction forces.[161]  Interestingly, the tension induced by shear stress was significantly 
less than the intracellular tension,[161] suggesting that while changes to the intracellular 
tension are initiated by shear stress, the magnitude of the intracellular tension reflects 
both biochemical changes within the cell as well as cell-cell and cell-substrate 
interactions.   
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Under shear stress, the glycocalyx is necessary for rearrangement of the 
cytoskeleton and alignment in the direction of flow for ECs.[196]  Our results for cells 
under static conditions on soft substrates also show a relationship between the 
cytoskeleton and glycocalyx.  Modulation of the glycocalyx with heparinase or 
angiopoietin-1 altered both cell traction forces and actin localization and fiber thickness.  
There was also an age-related decline in glycocalyx thickness and density, suggesting 
that cell senescence can alter the mechanosensing ability of the actin cytoskeleton.   
In summary, we showed that senescence of isolated hCB-ECs increases traction 
forces.  Furthermore, traction forces can be modulated by altering the glycocalyx or 
SIRT1 in an age-associated manner.  Changes in actin localization and stress fiber 
thickness also correlated with changes in aging hCB-EC traction forces. 
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Chapter 5. Elevated Traction Forces in Senescent 
Endothelial Cell Clusters Due to SIRT1-Dependent 
Changes in Junction Tension and Actin Localization 
5.1 Introduction 
Atherosclerosis is the primary pathology underlying cardiovascular disease.  
Development of the atherosclerosis is likely due to changes in both the local mechanical 
environment and endothelial cell (EC) aging.  Changes in vessel composition and 
structure have also been linked to atherogenesis.[170]  There is also evidence of 
accelerated aging in lesion-prone sites, including presence of giant cells,[13] elevated 
levels of senescence-associated β-galactosidase staining,[108] and telomere 
shortening.[123]  In these sites, ECs are exposed to high oxidative stress leading to 
apoptosis.[54]  This can result in increased EC turnover and replication, which can lead 
to localized senescence.  Further, aging endothelium has been shown to have increased 
permeability to macromolecules,[29] which is one of the earliest events in atherosclerosis 
development, and increased sensitivity to oxidative stress.[26]   
Traction forces in ECs play an important role in cell migration and adhesion.  As 
cells migrate, changes in the distribution of traction stresses precede changes in the 
direction of migration.[115] Traction forces are not uniform on the cell substrate, with 
forces being highest at the periphery of the cell, likely due to redistribution of stresses at 
the leading edge of the cell as it migrates.[140]  Bovine aortic ECs on compliant 
substrates had reduced cell traction forces and permeability compared to those seeded 
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on stiff substrates.[87]  This result correlated with increased actomyosin contractility for 
cells isolated from old mice.  These changes in cell contractility, traction force, and 
permeability could be reversed through inhibition of the Rho-associated kinase (ROCK) 
pathway.[87]  While traction force measurements are typically done with isolated cells, 
traction force measurements have also been for pairs of cells[16] and confluent 
monolayers.[85]  These results provide additional data into how cells behave when cell-
cell junctions and cell-cell interactions are accounted for. 
Sirtuin1 (SIRT1) is a deacetylase that regulates antioxidant activity.  In 
atheroprone regions, levels of SIRT1 are reduced due to oxidative stress and disturbed 
fluid flow.[24]  Activation of SIRT1 reverses several age-associated phenotypes,[26, 29, 
128, 199] influences mechanosensing by regulating shear-induced endothelial nitric 
oxide synthase,[24] and regulates the structure and function of the glycocalyx.  In ApoE-
knockout mice, overexpression of SIRT1 in ECs decreased atherosclerosis.[128]  
Furthermore, SIRT1 regulates permeability through regulation of cell-cell junction 
proteins, such as occludin.[29] 
While changes in the mechanical environment and cell senescence are known to 
impact atherosclerosis development, the relationship between the two remains unclear.  
In this study, we tested the hypothesis that age-associated changes in SIRT1 increases 
cell traction forces and the junction tension of endothelial cell clusters due to changes in 
actin localization and junction tension.  To test this hypothesis, we used human cord 
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blood-derived ECs (hCB-ECs) as a model for cell aging because of their low, 
physiological permeability at low population doublings,[29] high proliferative potential 
in subconfluent cultures,[29] and similarity to arterial ECs.[11]  We examined traction 
forces of aging ECs in clusters or monolayers, and assessed their dependence on SIRT1 
activity. We also examined the effect of these agents on the actin cytoskeleton and 
junction tension. 
5.2 Methods 
5.2.1 Cell Culture 
Human umbilical cord blood derived endothelial cells (hCB-ECs) were isolated 
from blood as previously described by Ingram et al.[89] For isolation of hCB-ECs, 
umbilical cord blood was obtained from the Carolina Cord Blood Bank (3 donors). Prior 
to receipt, all patient identifiers were removed.  The Duke University Health System IRB 
has determined that the following protocol meets the definition of research not 
involving human subjects as described in 45 CFR 46.102(f), 21 CFR 56.102(e) and 21 CFR 
812.3(p) and satisfies the Privacy Rule as described in 45CFR164.514. 
After collection, blood was diluted 1:1 with Hanks Balanced Salt Solution (HBSS, 
Invitrogen), placed onto Histopaque 1077 (Sigma), and centrifuged at 740xg for 30 
minutes. Buffy coat mononuclear cells were collected and washed three times with 
“complete EC growth medium,” comprising 8% (vol/vol) fetal bovine serum (FBS) 
added to Endothelial Basal Media-2 (Cambrex) supplemented with Endothelial Growth 
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Media-2 SingleQuots (containing 2% FBS plus growth factors, Cambrex), and 1% 
antibiotic/antimycotic solution (Invitrogen). Mononuclear cells were plated on plastic 6 
well 35 mm diameter plates coated with collagen I (rat tail, BD Biosciences) in complete 
EC growth medium. Medium was exchanged every 24 hours for the first week in 
culture, to remove non-adherent cells. Colonies of EPC-derived ECs appeared 7-10 days 
after the initial isolation.  The colonies were trypsinized and 200 cells were plated onto a 
collagen-coated T25 and labeled passage 1.  
The hCB-ECs were grown in T75 flasks using EBM2 basal media supplemented 
with penicillin/streptomycin, EGM2 Singlequots Kit, and 10% Fetal Bovine Serum (10% 
complete media).  Media was changed every other day until the time of experiment.  The 
hCB-ECs were passaged 1:10 into new T75 flasks upon reaching confluence. Cells were 
then subsequently split 1:10.  The number of population doublings (PDLs) that occurred 
between each passage was adjusted based upon a 75% attachment rate and calculated 
according to the formula ln(10)/ln(2)*(4/3) = 4.43 as previously described.[169] 
5.2.2 EC Characterization 
hCB-ECs with fewer than 31 population doublings (PDL) have been extensively 
studied and function very similar to vascular ECs.[11, 20, 27, 88, 89] The hCB-ECs are 
positive for the endothelial-specific CD31 and CD34, and negative for CD14, CD45 and 
CD115 found on monocytes or hematopoietic cells.[27] We previously characterized 
hCB-ECs and found that they also expressed von Willebrand factor and VE-
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cadherin.[11] Following exposure to 15 dyne/cm2 for 24 or 48 hours, hCB-ECs aligned 
with the direction of flow,[11, 20] increased nitric oxide production, and increased 
mRNA for endothelial cell specific genes sensitive to flow, KLF2, eNOS, cyclo-oxygenase 
2, and thrombomodulin.[11]  The level and organization of actin filaments are similar in 
hCB-ECs and human aortic ECs (HAECs) as are the associated values of cell stiffness.  
hCB-ECs < 31 PDL had high levels of telomerase and low levels of senescence-associated 
β-galactosidase staining, so we refer to them as “young” ECs.[27]  hCB-ECs > 44 PDL 
had low levels of telomerase and high levels of senescence-associated β-galactosidase 
staining compared to hCB-ECs < 31 PDL, so we refer to them as “aged” ECs.[27] 
5.2.3 Synthesis of Variably Compliant Polyacrylamide Gels 
Coverslips were prepared as previously described.[139, 176, 179] Briefly, square 
glass coverslips (No. 2, 22 × 22 mm, VWR) were coated with 0.1 N NaOH (Sigma), and 
allowed to dry. The coverslips were coated with 3-aminopropyl-trimethoxysilane 
(Sigma), washed in deionized water, and incubated with a coating of a 0.5% solution of 
glutaraldehyde (Sigma) in phosphate-buffered saline without calcium and magnesium 
((PBS), Invitrogen) at room temperature for 30 min. The coverslips were washed with 
deionized water and allowed to dry. 
Polyacrylamide gels with a Young’s modulus of 15,000 Pascals were made with 
12% acrylamide/0.13% bis-acrylamide ratio in the gel solution mixture.[193] The 
solutions were adjusted to pH 6.0 with 1N HCl (Sigma) and degassed for 30 min to 
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remove oxygen that may inhibit polymerization.  0.5 µm diameter fluorescent beads 
(Invitrogen) were added to the gel for traction force experiments.  Polymerization was 
initiated by the addition of a 0.1% ammonium persulfate (Bio-Rad) solution in water to 
the acrylamide mixture. A total of 20 µL of the mixture was pipetted onto an activated 
coverslip and a circular coverslip (No. 2, 18 mm diameter, VWR) was used to flatten the 
drop. Polymerization was allowed to occur for 30 min at room temperature. The circular 
coverslip was removed, and the gel was immobilized with 10 µg/mL of fibronectin 
(Sigma) for two hours at 4 °C. Gels were washed with DI water and stored in DI water in 
35mm petri dishes at 4°C.  Gels were used for experiments within two weeks. 
5.2.4 Traction Force Microscopy 
Traction force microscopy was performed as previously described.[81-83, 140]  
Briefly, low or high passage hCB-ECs were seeded at 200,000 cells on 15,000 Pascal 
polyacrylamide gels embedded with 0.5-µm-diameter fluorescent beads.  The cells were 
allowed to adhere for 24 hours and formed clusters.  Clusters were imaged with 
differential interference contrast microscopy and the fluorescent bead field beneath the 
cell was imaged immediately after with a XD Spinning Disk Confocal Microscope 
(Andor). A second fluorescent image of the bead field was taken after the cells were 
removed with 0.025% trypsin/EDTA (Invitrogen). Removal of the cells with trypsin 
takes less than 5 minutes.  For large clusters that appeared as confluent monolayers, 
stage positions were used to take 4 overlaying images.  Bead displacements were used to 
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compute cellular traction vectors, T, by using a gradient-based digital image correlation 
technique to map the displacement fluorescent beads in the gel.[83] The displacement 
map was converted to the stress distribution, using a numerical algorithm based on the 
integral Boussinesq solution.  The root mean square of the force, |F|, was calculated 
using the individual components of the traction vectors integrated over the cell area, 
  (5) 
where T(x,y) = [Tx(x,y), Ty(x,y)] is the continuous field of traction stress vectors 
defined at any spatial position (x,y) within the cell.[139]  Because the cells have 
negligible acceleration, the sum of forces should equal zero in order to satisfy Newton’s 
first law of motion.  In these studies, the sum of the force on the cell was about 0.01pN, 
far below the reported root mean square force. 
Because traction forces are balanced by intracellular tensions, we used Equation 
6 to calculate intracellular tension as described by others.[85]  For two cells in contact 
with each other, the junction tension of cell 1 is equal and opposite to the junction 
tension on the second cell. In general, for a cell in contact with several cells, as in a 
confluent monolayer, the traction and junction forces balance:   
 
or
    
(6 a,b) 
Tj is the junction tension between the cells (N m-1 or dyne cm-1), σ is the stress 
between cell and substrate (N m-2 or dyne cm-2), T  is the traction vector (N or dyne), A 
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is the area of contact between the cell and the substratum, and lj is the length of the EC 
perimeter. The tension, which is the net force per unit length acting at the junctions, 
equals the spatially averaged traction vector divided by the cell perimeter length. 
5.2.5 Actin Immunofluorescence 
For these experiments, each coverslip with a gel was attached to six-well plates 
with vacuum grease (Corning).  hCB-ECs were seeded at 200,000 cells/well on 6-well 
plates.  At 24 hours post plating, cells were fixed with 3.7% formaldehyde for 30 minutes 
at room temperature and permeabilized with 1% Triton in PBS for 5 minutes at room 
temperature.  The cells were then incubated with fluorescein phalloidin (1:40, 
Invitrogen) to stain for F-actin for 1 hour at room temperature.  Hoechst 33342 
(Invitrogen) was used to stain for cell nuclei (1:2000).  The stains were visualized with a 
Zeiss 510 Upright Microscope.   
5.2.6 Modulation of SIRT1 Activity 
Modulation of SIRT1 activity was performed using an inhibitor, EX-527 
(5µmol/L, Sigma) for 6 hours prior to the start of the experiment, or with an activator 
SRT1720 (0.16µmol/L, Sigma) for 1 hour prior to the start of the experiment.  None of 
these agents are present when the cells are exposed to flow. 
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5.2.7 Knockdown of SIRT1 
Transient transfection was performed as previously described[24] with 
Lipofectamine RNAiMAX (Invitrogen). The hCB-ECs were grown to 70% confluency in 
T-75 flasks.  Flasks were then transfected with either SIRT1 (Qiagen, SI00098434) or 
scramble (negative control) siRNA (Qiagen, 1022076) at 20nM in Opti-MEM (Gibco).  
Untransfected cells were used as a control.  Four hours after transfection, the medium 
was changed back to fresh 10% complete medium.  The cells were then cultured for 24 
hours before the start of the experiment. 
5.2.8 Western Blot 
Western blots were performed to determine the expression of RhoA.  Cells were 
seeded at a density of 50,000 cells/cm2 on to 6 well plates and grown for 4 days.  Cells 
were harvested with a cell scraper and subjected to a solution of CellLytic-M (Sigma) 
and Protease Inhibitor Cocktail (Sigma).  Protein quantification was performed with the 
A280 Protein Quantification Method.  40 µg of protein was loaded into each well for the 
SDS-polyacrylamide gel electrophoresis (12% gel, Biorad).  Afterwards, the protein 
bands were transferred to PVDF membranes.  The membranes were blocked with a Tris-
Buffered Saline with 0.1% Tween 20 (TBST) solution containing 1% BSA at room 
temperature for 1 hour.  Primary antibodies for mouse-RhoA (1:250, 24kDa, Santa Cruz 
Biotechnology) and mouse-β-actin (1:2500 dilution, 42kDa, Santa Cruz Biotechnology) 
were diluted in a TBST and incubated with the membrane overnight at 4°C.  Goat-anti-
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mouse (1:5000 dilution, Invitrogen) secondary antibody was incubated with the 
membrane for 45 minutes at room temperature.  After washing, immunoreactive bands 
were detected by luminography using Supersignal chemiluminescent substrate (Pierce). 
Integrated band density was determined by densitometry after scanning onto 
autoradiographic films (GE Healthcare) and evaluated by ImageJ (NIH).  Protein 
expression was reported as a normalized intensity of the band of interest compared to 
the band of the housekeeping protein, β-actin.  There was no significant effect of any of 
the conditions on the protein expression of loading control, β-actin.   
5.2.9 Statistical Analysis 
For Figure 31, an ANOVA was performed to determine the effect of cell age and 
cell grouping on traction forces.  A post-hoc Tukey test was used to determine 
differences within factors.  For Figure 32B, a paired t-test was used to determine the 
effect of age on RhoA activity.  For Figure 33A, a 3-factor ANOVA was used to 
determine the effect of age, treatment, and cell grouping on traction forces.  For Figure 
33B, a 2-factor ANOVA was used to determine the effect of age and treatment on 
junction tension.  This was followed by a post-hoc Tukey test.  For Figure 34, an 
ANOVA was performed to determine the effect of treatment on traction forces or 
junction tension.  All statistical analysis was performed in JMP.  The value of n 
represents the number of clusters examined.  All data is reported as mean ± S.E. 
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5.3 Results 
5.3.1 Clusters Exhibit Higher Traction Forces Than Isolated ECs and 
Confluent EC Layers 
Using the Integral Boussinesq method to calculate cell traction forces,[83] the 
resolution of the traction stresses is about 10Pa and the resolution of the displacement is 
about 0.1 pixel.  The traction forces of endothelial cell clusters (groups of 2 or 3 cells) 
were about 3 times higher than for isolated cells for both young (p<0.05) and aged 
(p<0.05) hCB-ECs (Figure 31A).  However, large clusters of cells which appeared as 
confluent layers (groups of 20-30 cells), had reduced levels of traction forces compared 
to clusters for both young (p<0.05) and aged (p<0.05) hCB-ECs (Figure 31A).  This is 
likely due to increased junction tension in cell clusters compared to monolayers as was 
previously described.[86]  There was also a significant effect of age on cell traction forces 
(Figure 31A, p<0.05).  Elevated traction forces in aged hCB-ECs correlated with altered 
actin localization.  In young hCB-ECs, actin was localized primarily to the periphery of 
the cell (Figure 31B).  In aged hCB-ECs, actin was present throughout the length of the 
cell (Figure 31C).  These results show that aged hCB-ECs have elevated tractions and 
altered actin localization.  Additionally, groups of 2 or 3 cells cause increased traction 
forces, while large groups of cells reduces traction forces. 
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Figure 31: Aged hCB-ECs exhibit increased traction forces and altered actin 
localization regardless of cell number.  A) Traction forces are elevated with increased 
cell age.  Traction forces are highest for cells in clusters, but lower in monolayers.  n= 
20-25 cells, 6-12 clusters, 5-10 monolayers; *p<0.05, ^ p<0.05 compared to < 31 PDL 
condition; B) Representative image of F-actin for confluent 22 PDL hCB-ECs where 
actin is localized primarily at the periphery of the cell; C) Representative image of F-
actin for confluent 58 PDL hCB-ECs where actin is localized throughout the length of 
the cell. 
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5.3.2 Increased RhoA Activity in Aged hCB-ECs 
Because RhoA is important in cell contractility and mediation of cell traction 
forces, we examined RhoA activity in young and aged hCB-ECs.  We found that RhoA 
activity was higher in aged hCB-ECs than young hCB-ECs (Figure 32).  This result 
correlates with the elevated traction forces in aged hCB-ECs. 
 
Figure 32: RhoA activity is higher in aged hCB-ECs.  A) Representative 
Western blot of RhoA, GTP-RhoA, and loading control β-actin.  There was no 
statistically significant effect of age on the loading control, β-actin.  B) Quantification 
of Western blot.  RhoA activity is higher in aged hCB-ECs compared to young hCB-
ECs. (n=3) *: p<0.05 
5.3.3 Effect of SIRT1 Treatments on Traction Forces for Isolated Cells 
and Clusters 
Traction forces were elevated in cell clusters compared to isolated cells for all 
conditions (Figure 33A, p<0.05).  For isolated young cells, inhibition of SIRT1 with EX-
527 did not significantly alter traction forces compared to young hCB-ECs.  For isolated 
aged hCB-ECs, activation of SIRT1 with SRT1720 reduced traction forces by 2.6X 
compared to the untreated control (Figure 33A, p<0.05).  For young hCB-EC clusters, 
treatment with EX-527 increased traction forces by 100% in cell clusters compared to the 
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untreated condition (Figure 33A, p<0.05).  Treatment with SRT1720 on aged hCB-EC 
clusters reduced traction forces by 47% compared to the untreated control. 
Because EX-527 was effective at increasing traction forces in cell clusters, but not 
in isolated cells, it is likely that EX-527 may be acting on cell-cell junctions.  To confirm 
this, we calculated the junction tension using equation 6 in the Methods.  Junction 
tension in cell clusters was significantly elevated by inhibition of SIRT1 with EX-527 
(Figure 33B, p<0.05) and with age (Figure 33B, p<0.05).  Activation of SIRT1 with 
SRT1720 reduced junction tension (Figure 33B, p<0.05).  These results indicate that SIRT1 
alters cell-cell junctions, which may be a cause for the differences in cell traction force. 
 
Figure 33: Traction forces are dependent on SIRT1 for ECs in clusters.  A) 
Effect of SIRT1 on traction forces.  For isolated cells, inhibition of SIRT1 in young (< 
31 PDL) with 5µM EX-527 has no significant effect on traction forces compared to 
untreated control.  However, EX-527 did significantly elevate traction forces for young 
hCB-EC clusters.  Elevation of SIRT1 in aged (> 44 PDL) with 0.16µM SRT1720 
decreases traction forces compared to untreated control for both isolated and clusters 
of cells.  Traction forces are higher for clusters of cells than isolated cells for all 
conditions. n=10-28 clusters. *:p<0.05.  B) Junction tension in cell clusters is altered by 
SIRT1.  Inhibition of SIRT1 with EX-527 increases junction tension in < 31 PDL hCB-
ECs compared to untreated control.  Activation of SIRT1 with SRT1720 reduces 
junction tension in aged hCB-ECs compared to untreated control. 
 
 148 
 
5.3.4 Knockdown of SIRT1 Elevates Traction Forces 
To further confirm the role of SIRT1 on traction forces in young hCB-EC clusters, 
we used siRNA for SIRT1.  The effect of the SIRT1 siRNA was confirmed with Western 
blotting (Figure 34A).  The negative control (scrambled) siRNA did not significantly 
alter traction forces (Figure 34B).  In contrast, knockdown of SIRT1 significantly elevated 
traction forces compared to the untreated control (Figure 4B, p<0.05) and compared to 
the negative control (Figure 34B, p<0.01).  These responses corresponded with increased 
junction tension for SIRT1 siRNA treated hCB-ECs (Figure 4C, p<0.05).  Increased 
traction forces in the SIRT1 siRNA could also be attributed to increased cell area in 
SIRT1 siRNA treated ECs. 
 
Figure 34: Traction forces are dependent on SIRT1 for ECs in clusters.  A) 
Effect of SIRT1 on traction forces.  For isolated cells, inhibition of SIRT1 in young (< 
31 PDL) with 5µM EX-527 has no significant effect on traction forces compared to 
untreated control.  However, EX-527 did significantly elevate traction forces for young 
hCB-EC clusters.  Elevation of SIRT1 in aged (> 44 PDL) with 0.16µM SRT1720 
decreases traction forces compared to untreated control for both isolated and clusters 
of cells.  Traction forces are higher for clusters of cells than isolated cells for all 
conditions. n=10-28 clusters. *:p<0.05.  B) Junction tension in cell clusters is altered by 
SIRT1.  Inhibition of SIRT1 with EX-527 increases junction tension in < 31 PDL hCB-
ECs compared to untreated control.  Activation of SIRT1 with SRT1720 reduces 
junction tension in aged hCB-ECs compared to untreated control. 
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5.3.5 Knockdown of SIRT1 Alters Actin Localization 
To determine whether changes in traction forces and junction tension in SIRT1 
knockdown cells correlated with changes in F-actin, we examined actin localization.  In 
young hCB-ECs, F-actin was localized primarily at the periphery of the cell (Figure 35A).  
Treatment of young hCB-ECs with the negative control (scrambled) siRNA had no effect 
and actin was localized to the periphery of the cell (Figure 35B).  However, knockdown 
of SIRT1 altered actin localization and caused fibers to be present throughout the length 
of the cell (Figure 35C).  These results show that SIRT1 affects actin localization, which 
correlates with the elevated traction forces and increased junction tension observed in 
SIRT1 siRNA-treated young hCB-ECs. 
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Figure 35: Effect of SIRT1 knockdown on F-actin.  Representative images of A) 
F-actin localized to periphery in young hCB-ECs (< 31 PDL); B) Treatment of young 
hCB-ECs with negative control (scrambled) siRNA also has F-actin localized primarily 
to the periphery of the cell; C) Knockdown of SIRT1 with siRNA in young hCB-ECs 
causes F-actin formation throughout the length of the cell.  Scale bar = 50 µm. 
5.4 Discussion 
There are several factors known to influence cell traction forces for isolated ECs 
including changes in actin localization and actomyosin contractility,[30, 87, 133] integrin 
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levels,[151] focal adhesion formation,12, 17 and Rho activity.[87, 186]  There have also been 
some studies measuring cell traction forces for cell pairs[16] or confluent 
monolayers.[85]  In this study, we demonstrated that senescent hCB-ECs exhibited 
elevated traction forces, increased junction tension, and more abundant F-actin fibers 
due to age-associated changes in SIRT1.  We also show that traction forces are higher for 
hCB-ECs in clusters compared to isolated cells, which is consistent with previously 
reported results.[16]  The traction force increase in senescent hCB-EC clusters correlated 
with increased junction tension, altered actin localization, and increased levels of RhoA.  
While inhibiting SIRT1 had no significant effect on traction forces for isolated, young 
hCB-ECs, inhibition of SIRT1 did elevate traction forces in clusters of young hCB-ECs.  
This also led to a corresponding increase in junction tension.  Furthermore, siRNA 
knockdown of SIRT1 elevated traction forces, increased junction tension, and altered 
actin localization.  Conversely, activation of SIRT1 reduced traction forces and junction 
tension in aged hCB-ECs.  These results indicate an important role for SIRT1 in 
regulating aging EC traction forces. 
hCB-ECs were used in this study because of their low, physiological 
permeability,[29] high proliferative potential in subconfluent cultures,[29] and similarity 
to arterial ECs.[11]  Traction forces for both isolated young and aged hCB-ECs were low 
compared to those previously reported for BAECs.[16, 87]   When young and aged hCB-
ECs formed cell clusters, their traction forces increased by about 3x, which is consistent 
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with results obtained by other groups.[16]  We also found that junction tension in young 
hCB-ECs was about 4800 pN/µm, which is close to values reported by others.[85]  When 
the ECs became senescent, the junction tension significantly increased.  Because traction 
forces are highest for cell clusters rather than cell monolayers, these results also suggest 
that cell-substrate interactions are important for clusters of cells, but that cell-cell 
interactions are more important for cells in monolayers.  Hur et al demonstrate that 
junction tension is elevated in cell pairs compared to cell monolayers,[85] which 
demonstrates that cell-cell and cell-substrate interactions are dependent on cell number.  
Our measurement of monolayer traction forces utilizes large clusters of cells (20-30 
cells).  We found no significant effect of cell number on traction forces for these large 
clusters.  To examine traction forces for a true monolayer, another method of measuring 
traction forces would need to be used. Polio et al. have developed a technique that 
addresses the limitations of the traction force microscopy technique used in this 
study.[132]  By patterning fluorescent dots in a regularized array, the need for 
trypsinization of the cells is eliminated.[132] 
Rho GTPases are important in mediating cell contractility and cell traction forces.  
In cells on stiff polyacrylamide gels, permeability of ECs was elevated along with Rho 
activity.[87]  We found that elevated traction forces in aging hCB-ECs correlated with 
increased levels of total RhoA in senescent cells.  Similarly, others have found that in 
human umbilical vein ECs, inhibition of RhoA and Rac1 decreased permeability, cell 
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contractility, and assembly of actin stress fibers.[186]  In bovine aortic ECs, age-related 
matrix stiffening caused an increase in permeability and traction forces due to RhoA 
activity.[87] 
In summary, we showed that senescence of hCB-ECs increases traction forces, 
which correlates with changes in localization of actin and elevated levels of RhoA.  
Traction forces are elevated for cell clusters, but reduced in monolayers.  Additionally, 
aged hCB-EC traction forces can be modulated by altering SIRT1.  This led to 
corresponding changes in junction tension and altered actin localization. 
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Chapter 6. Dissertation Summary & Future Work 
6.1 Dissertation Summary 
Overall, the results within this dissertation provide the novel results that (1) 
human cord blood-derived endothelial cells exhibit low, physiological permeability at 
low passages and this permeability increases with increasing cell senescence, (2) aging of 
endothelial cells decreases their response to steady shear stress by altering 
mechanotransduction through the glycocalyx and VE-cadherin, and (3) traction forces 
are increased in senescent cells due to changes in actin structure and localization.  The 
results from this work demonstrate that SIRT1 regulates the glycocalyx and cell-cell 
junctions.  SIRT1 treatments modulated permeability via cell junctions, altered the 
response to shear stress by affecting cell mechanotransduction of the glycocalyx and VE-
cadherin, and affected cell traction forces through changes in junction tension and the 
actin cytoskeleton.  These results also demonstrate the use of human cord blood-derived 
endothelial cells as model to study cell aging and age-associated diseases. 
The global hypothesis that motivated this research was that senescence of ECs 
would alter permeability and mechanotransduction, key events in atherogenesis.  The 
proposed research tested the following hypotheses: (1) hCB-EC permeability was low at 
low population doublings, but increases with increasing cell age due to changes in cell 
junctions, (2) aged hCB-ECs would have inhibited flow-induced levels of KLF2 and 
eNOS that can be reversed through activation of SIRT1 which affects the structure and 
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function of the glycocalyx and VE-cadherin, (3) traction forces in isolated aging hCB-ECs 
increases because of changes to actin, and (4) traction forces in clusters of aging hCB-ECs 
is elevated compared to isolated cells, and SIRT1 acts on cell junctions to alter tractions. 
Chapter 2 results showed that hCB-EC permeability was about 3.1 x 10-7 cm/s, 
which is close to previously reported values for permeability of endothelium in vivo.  
The permeability of HAECs was about 1-2 x 10-6 cm/s at low passages, indicating that 
this model is not as physiologically accurate as hCB-ECs.  We verified that increased 
population doublings of hCB-ECs led to increased senescence by examining levels of 
senescence-associated β-galactosidase and telomerase.  The permeability increased 
monotonically with increasing cell age.  While tight junction protein expression was not 
significantly altered with age, we found that phosphorylation of occludin was increased 
in aged hCB-ECs.  Occludin and ZO-2 were localized to the periphery in young cells, but 
were primarily cytosolic in aged cells.  The percentage of cells in S-phase or M-phase 
also positive correlated with the increase in permeability in senescent ECs.  We used 
several different indirect activators of SIRT1, including Resveratrol, 007 and Rolipram.  
Activation of SIRT1 decreased permeability and reduced phosphorylation of occludin, 
but did not significantly alter the amount of senescence.  This result suggests that SIRT1 
may be altering other biochemical pathways in the cell, rather than directly affecting the 
senescent state.  The results from this chapter confirm our hypothesis that hCB-ECs have 
a low permeability that increases with increasing age due to changes in tight junctions.  
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However, phosphorylation of tight junctions, rather than total amount of junction 
protein, was more directly related to permeability changes in senescent cells. 
Results from Chapter 3 show that young hCB-ECs align better in the direction of 
fluid flow than aged hCB-ECs.  Young hCB-ECs also had flow-induced increases in 
KLF2 and eNOS.  However, aged hCB-ECs do not have this increase in KLF2 and eNOS 
gene expression, suggesting a decreased ability to sense shear stress.  We then 
investigated how cell senescence alters mechanotransducers, the glycocalyx and VE-
cadherin.  We found that the decreased flow responsiveness of aged hCB-ECs correlated 
with decreased glycocalyx and thickness and density, decreased trabecular VE-cadherin, 
and increased phosphorylation of VE-cadherin.  Furthermore, agents that affect the 
glycocalyx also altered the response to shear stress and VE-cadherin.  Our findings 
suggest an important relationship between cell aging and mechanotransduction. 
Because of our findings on SIRT1 in chapter 2, we then investigated how SIRT1 
altered cell mechanotransduction and the response to shear stress.  Inhibition or 
knockdown of SIRT1 decreased flow-induced KLF2 and eNOS in young hCB-ECs.  It 
also reduced glycocalyx thickness and/or density and increased phosphorylation of VE-
cadherin.  Conversely, activation of SIRT1 in aged cells elevated KLF2 and eNOS 
compared to untreated conditions.  SIRT1 activation also restored the glycocalyx 
thickness and/or density and reduced phosphorylation of VE-cadherin.  The results from 
this chapter support our hypothesis that aging ECs are less sensitive to shear stress as 
 157 
 
measured by changes in KLF2 and eNOS.  Our findings show an important role for 
SIRT1 in regulating the senescent EC functional response to shear stress through 
changes to the glycocalyx and VE-cadherin. 
Results from Chapter 4 indicate that for isolated ECs, traction forces increase 
with increasing cell age.  This increase correlated with an increase in actin stress fiber 
formation and altered actin localization.  Reduction of the glycocalyx led to increased 
traction forces and increased actin fiber width and density.   Changes to the glycocalyx 
also significant altered EC monolayer permeability.  This suggests that age-associated 
changes in the glycocalyx can alter cell contractility through actin, which affects cell 
tractions and permeability.  We further showed a relationship between SIRT1 and cell 
tractions, whereby SIRT1 activation in aged hCB-ECs reduced traction forces and 
thickness of actin.  However, inhibition of SIRT1 in young hCB-ECs did not have any 
significant effect on cell tractions or actin.  Inhibition of SIRT1 though did significant 
elevate permeability in young hCB-ECs compared to the untreated condition.  One 
reason for this discrepancy may be that permeability was measured for a confluent layer 
of cells, whereas the traction experiments were done for single, isolated cells.  This result 
also suggests that EX-527, SIRT1 inhibitor, may be acting upon cell junctions.  The 
results of this study support our hypothesis that increased cell age elevates traction 
forces due to changes in actin.  We further demonstrate that age-associated changes in 
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the glycocalyx and SIRT1 may also play a role in elevated traction forces and 
permeability. 
Results from Chapter 5 show that traction forces are significantly higher for cell 
clusters than for individual, isolated cells.  This result could be due to increased cell 
contractility for cells in contact.  It has been shown that actin stress fiber organization 
occurs with cell-cell contacts [193].  Increased actin stress fiber organization could 
facilitate increased cell contractility for cell clusters, resulting in increased forces in cell 
clusters compared to individual cells.  However, large cell clusters that behaved like 
monolayers, had reduced levels of cell tractions compared to isolated cells.  The trend of 
elevated traction forces with increased senescence that we observed in Chapter 4 was 
also present for both cell clusters and monolayers.  Furthermore, we also found a 
correlation between elevated traction forces in aged cell monolayers and altered actin 
fiber localization.  These results indicate that the magnitude of the cell traction force 
changes depending on the number of cells, but that the trend of changes in traction force 
with increasing age remains the same.   Because of the importance of SIRT1 in regulating 
permeability and shear-induced gene expression and mechanotransduction, we 
examined whether SIRT1 treatments affected cell clusters.  While the SIRT1 inhibitor, 
EX-527, did not affect traction forces for isolated ECs (Chapter 4), it did increase traction 
forces when young ECs formed clusters.  Activation of SIRT1 also reduced traction 
forces in older cells.  These changes in traction force also correlated with changes in 
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junction tension.  Both age and inhibition of SIRT1 increased junction tension, while 
activation of SIRT1 reduced junction tension.  These results suggest that SIRT1 may be 
acting on cell-cell junctions to alter traction forces.    We confirmed these results by using 
siRNA for SIRT1 and see similar trends for traction forces, actin, and junction tension.  
Because RhoA plays an important role in cell contractility, we examined levels of RhoA 
in aging hCB-ECs to determine whether senescent cells were more contractile, thus 
leading to their elevated permeability.  Western blots showed that RhoA was 
significantly higher in aged hCB-ECs than young hCB-ECs, suggesting that differences 
in the contractile state of the cell may be causing the elevated traction forces and altered 
actin structure. 
6.2 Strengths & Weaknesses of Work 
In Chapter 2, we demonstrated that young hCB-ECs had a low permeability of 
about 3.1 x 10-7 cm/s [28].  This was the first time that the permeability of cultured 
endothelium has been shown to be close to those obtained in vivo for large arteries.  We 
also found that permeability of hCB-ECs increased with increasing cell age.  This 
increase could be mitigated by treatment with different SIRT1 activators.  However, the 
duration and concentration of the treatments was not fully optimized.  Instead, we relied 
on values from the literature for the treatments.  It is possible that other treatment 
conditions could have shown a greater effect of SIRT1 on permeability.  However, we 
found that high doses of Resveratrol were toxic to the cells, suggesting that additional 
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activation of SIRT1 may not be efficacious.  To address the limitation of using 
pharmacological agents to alter SIRT1, we examined the effect of several different 
activators of SIRT1.  In Chapter 5, we also use SIRT1 knockdown to show a stronger 
relationship between SIRT1 and permeability.   
Our findings demonstrate that elevated permeability in senescent hCB-ECs is 
due to altered tight junction protein expression and occludin phosphorylation, but we 
did not examine phosphorylation of tight junction proteins other than occludin.  It is 
possible that the age-associated changes in permeability also involve other tight junction 
proteins or adherens junction proteins like VE-cadherin.  In Chapter 3, we show that VE-
cadherin phosphorylation is altered with age.  This result indicates that changes in VE-
cadherin function with increasing cell age are likely a cause of elevated permeability in 
senescent ECs.  VE-cadherin phosphorylation at Tyr 658 regulates its binding to p120-
catenin, which can alter cell junction tension through changes to cytoskeletal actin.  This 
could lead to alteration in actin filaments and traction forces that we observed in 
Chapters 4 and 5.   To further test the impact of cell age on VE-cadherin or occludin 
phosphorylation, we could mutate phosphorylation sites to block binding and then 
measure changes in permeability with age.  This would allow us to determine whether 
age-associated increases in permeability are dependent on junction protein 
phosphorylation.   
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While the study examined senescence in aging cells, we did not determine how 
cell apoptosis changes with increased age.  Increased amounts of apoptotic cells could 
also lead to increased permeability and disruption of cell-cell junctions.[19]  To address 
this, I would visualize the number and location of apoptotic cells in hCB-ECs of different 
ages.  I would then see if the location of the apoptotic cells were localized in regions of 
elevated permeability.  Insights into whether regions of elevated permeability are due to 
presence of apoptotic or senescent cells would provide additional information into how 
aging affects monolayer permeability. 
Another limitation of the study is the use of hCB-ECs as a model to study cell 
aging.  Replicative senescence in vitro is done by passaging of cells.  However, this is not 
necessarily representative of the in vivo cell turnover and oxidative stress experienced by 
cells in atherosclerotic regions.  Additionally, the age and behavior of hCB-ECs is donor-
dependent and also depends on the original number of cells isolated.  The number of 
population doublings from isolation to passage 1 varies and could lead to variability in 
hCB-EC permeability results.  Using cells isolated from aging animals would provide a 
different perspective on how cell behavior changes with increased chronological age.  A 
limitation of this approach would be that cells from aging animals may not be 
representative of accelerated aging of ECs observed in atheroprone areas.  However, our 
model does provide better insights into aging at the cellular level, which is not 
necessarily related to aging of the organism as a whole. 
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In spite of these limitations, the work was consistent with findings in the 
literature.  The permeability values of HAECs were about 1-2 x 10-6 cm/s, which is 
similar to what has been reported in vitro for bovine aortic ECs.  Additionally, the 
relationship that we demonstrate between permeability and tight junction protein 
phosphorylation is also well-established in the literature.  While we saw changes in cell 
turnover, this did not seem to be a major factor in the altered permeability, which agrees 
with what others have reported.  Therefore, our studies built upon previous findings in 
the literature and led to new important information, demonstrating that hCB-ECs have 
very low permeability values that can increase with increasing cell age due to changes in 
cell junctions. 
In Chapter 3, key findings are that SIRT1 regulates the aging EC response to 
shear stress through alteration of cell mechanotransducers, the glycocalyx and VE-
cadherin.  We show a strong relationship between SIRT1, gene expression, and the 
abundance of heparan sulfate component of the glycocalyx.  However, there are several 
other components of the glycocalyx, such as syndecan-1, that may be important in 
mechanotransduction and the response to shear stress.  Because syndecan-1 is a 
transmembrane protein that is linked to the cell cytoskeleton,[50] and the cytoskeleton is 
important in mechanosensing during exposure to shear stress, it is possible that 
syndecan-1 may be important in aging EC mechanotransduction.   To address this 
question, we could knockdown syndecan-1 in young hCB-ECs and examine how this 
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alters the flow-induced levels of KLF2 and eNOS.  Furthermore, we could examine 
whether there is a relationship between syndecan-1 and SIRT1. 
Another limitation of this study is in our visualization of the glycocalyx.  We 
used immunofluorescence to stain and visualize the heparan sulfate component of the 
glycocalyx.  While this is one established way to view the glycocalyx, the preparation of 
samples for immunofluorescence requires aldehyde fixation which can cause 
dehydration of the sample.  However, in our studies, we were interested in seeing 
whether age or SIRT1 would cause relative changes to the glycocalyx, so the 
immunofluorescence technique was sufficient.  If we were to determine the absolute 
thickness of the glycocalyx, we could use cryo-TEM as this does not require aldehyde 
fixation or graded-ethanol dehydration of samples.  This technique would give us more 
insights into the structure and components of the glycocalyx and how they change with 
samples from cells of increasing age.  However, this method is time consuming and 
requires specialized skill.   While several conclusions are based upon our use of 
pharmacological agents that affect SIRT1, we used several different activators and 
inhibitors to strengthen the argument.  Additionally, we used SIRT1 siRNA to 
knockdown SIRT1 in young cells as a way to more specifically investigate the effects of 
SIRT1 on the response to shear stress. 
Other important aspects of this chapter are the novel finding that SIRT1 regulates 
the aging EC response to shear stress.   Our finding that flow-induced KLF2 and eNOS is 
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elevated in young hCB-ECs are consistent with the previously literature.  We also show 
that the glycocalyx is decreased in thickness and density with increasing age, which is 
similar to what is seen in atheroprone regions of the blood vessel.  The heparan sulfate 
thickness that we measured was also similar to what has been reported for bovine aortic 
ECs in vitro.  The results show a strong relationship between SIRT1 activity and eNOS 
levels are also consistent with findings published by other groups.  We also found that 
by using agents known to enhance or reduce the glycocalyx, we are able to alter KLF2 
and eNOS expression levels.  This agrees with previous research demonstrating that the 
glycocalyx is an important mechanosensor and that its degradation can impair shear-
mediated increases in KLF2 and eNOS. 
In this study, we exposed hCB-ECs to steady shear stress of 15 dynes/cm2.  In 
atheroprone regions of the blood vessel, which are curved or branched, there is 
disruption in the local fluid flow patterns.  Further studies investigating the effects of 
oscillatory or reversing flows could provide additional insights into how aging EC 
mechanotransduction is altered in response to disturbed flow. 
In Chapter 4, we demonstrate that cell traction forces increase with increasing 
population doublings due to age-associated changes in the glycocalyx and SIRT1.  For 
this study, we used isolated cells on 15kPa polyacrylamide gels to measure cell traction 
forces.  We found that young hCB-ECs on 10kPa gels did not exhibit any traction forces, 
so the stiffness of the gel was increased to 15kPa.  A limitation of the study is that we did 
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not optimize protein type.  In these experiments, we used 10µg/mL of fibronectin.  
Immobilizing with a different protein, such as collagen, or a different protein 
concentration could have led to different results.  Additionally, immobilizing with a 
different covalent linker, such as N6 or sulfo-SANPAH could also alter results by 
altering how cells adhere to the substrate.  While polyacrylamide is highly tunable for 
Young’s modulus, cells do not readily adhere to the surface, which is why protein 
immobilization is required.[165]  A different material surface that would deform, but 
that allows for cell adhesion without protein deposition, could allow for better 
measurement of cell traction forces because of changes in the cell’s affinity for receptors.   
While SIRT1 inhibitor, EX-527, had no significant effect on traction forces or actin 
for individual cells, we believe that the inhibitor works primarily on cell junctions.   In 
Chapter 5, we explored the effect of SIRT1 on clusters of hCB-ECs to account for the 
presence of cell junctions.   
The traction forces we measured for HAECs was about 0.78 µN, which is 
significantly higher than that of hCB-ECs.  However, it is very close to traction forces for 
bovine aortic ECs measured by others [16, 87].  Additionally, we see a strong correlation 
between increases in traction forces and changes in the actin cytoskeleton, which is 
consistent with results reported by others.[74, 87]  Age associated-changes in the 
glycocalyx thickness and density are also consistent with what we have previously 
reported in Chapter 3 and what is shown in atheroprone regions in vivo.   
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In Chapter 5, we found that cell aging increased traction forces for hCB-EC 
clusters and monolayers.  Strengths of the work include consistency with previously 
reported data in the literature.  We show that tractions are almost 3 times higher for cell 
clusters compared to individual cells, which agrees with results from others [16].  
Because traction forces are highest for cell clusters rather than cell monolayers, these 
results also suggest that cell-substrate interactions are important for clusters of cells, but 
that cell-cell interactions are more important for cells in monolayers.  Further 
experiments would need to be done to investigate the role of cell-substrate interactions 
to determine which factors are important for traction forces of different cell groups.  
While we did examine the effect of SIRT1 on cell junctions by measuring junction, we 
did not examine specific junction proteins.  However, we did try to address this question 
by measuring cell junction tension.  Besides using SIRT1 activators and inhibitors, we 
performed experiments with SIRT1 siRNA to more specifically inhibit SIRT1 and 
provide more conclusive evidence of the role of SIRT1 on traction forces.  Additional 
work examining adherens junctions, like VE-cadherin, which connect to the actin 
cytoskeleton, could provide additional insights into the mechanism of action of SIRT1.  
In Chapter 3, we show that phosphorylation and localization of VE-cadherin is altered in 
aging cells in a SIRT1-dependent manner.   
Another limitation of the work is that we examined large clusters of cells that 
appeared as monolayers.  The current traction force method requires areas in the field of 
 167 
 
view which do not have any bead displacement and trypsinization of the cells since the 
polymerization of the gel cause the beads to be randomly dispersed.  The development 
of a traction force microscopy which uses fiduciary markers, similar to one used by Polio 
et al [132], would eliminate the need for trypsinization and would include markers that 
are not displaced.  This would allow us to further study traction forces for confluent 
monolayers.  The development of a surrogate measure of cell traction forces would also 
allow us to determine whether cell tractions are altered in vivo.  If changes in cell shape 
could be related to changes in traction forces, then it could potentially be used to detect 
areas of elevated cell traction in blood vessels.  One could then determine whether areas 
of high cell traction are also areas of elevated EC permeability. 
6.3 Implications for Treatment of Atherosclerosis 
 Overall, the results from this study present novel insights into endothelial cell 
aging.  We demonstrate that hCB-ECs are a suitable model for studying cell aging 
because of their high proliferative potential in subconfluent cultures and their low, 
physiological permeability [28].  Permeability of hCB-EC monolayers increases with 
increasing population doublings due to changes in tight junction protein 
phosphorylation and localization.  Because ECs in atheroprone regions exhibit 
accelerated aging and elevated permeability, these results further support the use of 
hCB-ECs as a model to study age-associated pathologies.  To reverse the elevated 
permeability at high population doublings, we used several different agents known to 
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modulate SIRT1.  By activating SIRT1, we saw a decrease in permeability in aged hCB-
ECs.  This result implicates a possibility for using SIRT1 activators in treatment of 
atherosclerosis.  Furthermore, the results demonstrate that SIRT1 alters permeability by 
acting upon cell-cell junctions to alter localization and phosphorylation. 
 We further implicate SIRT1 by describing its role in regulating 
mechanotransduction through the glycocalyx and VE-cadherin.  We demonstrate that 
aged hCB-ECs have a decreased response to shear stress, a thinner glycocalyx, and 
elevated VE-cadherin phosphorylation.  Activation of SIRT1 alters all of these responses.  
Conversely, inhibition or knockdown of SIRT1 in younger hCB-ECs caused them to 
behave like older hCB-ECs.  The results from this study show that SIRT1 can directly 
modulate the response to fluid flow in aging ECs.  We further demonstrate that SIRT1 
can directly affect mechanotransduction of ECs.  Changes in mechanotransduction can 
be attributed to the effect of SIRT1 on phosphorylation and localization of adherens 
junction protein, VE-cadherin.  SIRT1 may be a viable target for treatments for 
atherosclerosis because of its ability to restore mechanosensitive properties in senescent 
cells. 
 Furthermore, SIRT1 plays an important role in cell traction forces and the actin 
cytoskeleton.  Elevated traction forces in aged hCB-ECs correlated with increased 
permeability and increased actin fiber thickness.  While inhibition of SIRT1 did not have 
a significant effect on young hCB-ECs, activation of SIRT1 did restore function in aged 
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hCB-ECs.  The relationship between the glycocalyx and SIRT1 in mediating cell traction 
forces is consistent with our finding that the glycocalyx and SIRT1 can both mediate the 
hCB-EC response to shear stress.  Extending our results for isolated EC traction forces, 
we examined traction forces for cells in clusters or confluent monolayers to account for 
the presence of cell junctions.  Here, SIRT1 is able to alter the traction forces, junction 
tension, the actin cytoskeleton, and levels of cell contractility protein RhoA.  SIRT1 plays 
an important role in mediating integrity cell-cell junctions.  Through changes in 
phosphorylation of occludin and VE-cadherin, SIRT1 alters actin structure, leading to 
corresponding changes in cell traction forces and permeability. 
 As a whole the results from this dissertation implicate an important role for 
SIRT1 in regulating aging EC function (Figure 36).  We used several different 
approaches to demonstrate how SIRT1 regulates permeability, cell-cell junctions, and the 
glycocalyx.  Treatments that target SIRT1 may be a suitable option for preventing the 
permeability increases that are associated with early stages of atherosclerosis.  Further 
studies would need to be done to fully characterize the role of SIRT1.  Extensive in vivo 
testing of different SIRT1 activators and inhibitors would also be needed to determine its 
efficacy on reducing or preventing atherosclerosis. 
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Figure 36: SIRT1 levels alter permeability and mechanotransduction in aging 
hCB-ECs.  A) Young hCB-ECs have high levels of SIRT1, which inhibits NADPH 
oxidase and protects the glycocalyx from damage from free radicals.  An intact 
glycocalyx and high SIRT1 levels increase levels of atheroprotective genes, eNOS and 
KLF2 when cells are exposed to shear stress. Furthermore, SIRT1 and glycocalyx help 
maintain the endothelial barrier by preserving cell-cell junctions.  This also results in 
lower traction forces.  B) Aged hCB-ECs have low levels of SIRT1, which does not 
allow for protection of the glycocalyx from free radicals.  The damaged glycocalyx and 
low levels of SIRT1 causes aged hCB-ECs to not be as responsive to shear stress, thus, 
having lower levels of KLF2 and eNOS.  Additionally, low levels of SIRT1 and the 
glycocalyx cause cell junctions to be phosphorylated, leading to degradation of the EC 
barrier.  This elevates permeability, causes an increase in traction forces and leads to 
the formation of actin stress fibers. 
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Appendix A: EC Media 
Materials 
• EBM-2 
• EGM2 Singlequots 
• 5mL of AB/AM 
• FBS (if needed) 
 
Procedure 
1. Add EGM2 singlequots, and AB/AM to bottle of EBM-2. 
2. Remove 50mL of media mixture. 
3. Add 50mL of FBS (10mL from singlequots and 40mL from freezer aliquots) 
4. Write name, date, and label on the bottle. 
 
Note: AB/AM and FBS (all frozen) are always aliquoted for use.  EGM2 and EBM2 must 
be purchased from CCF. 
 172 
 
Appendix B: EC Passage and Seeding 
Materials 
• Media 
• Sterile PBS without Calcium/Magnesium 
• Trypsin (0.025%) 
• T75 flask 
• 50mL tube labeled “cell suspension” 
• 15mL tubes labeled with experimental conditions 
• 5mL pipettes 
• 10mL pipettes 
• Hemacytometer 
• Micropipettes 
  
Procedure 
1. Put all materials in hood 
2. Label a T75 with cell line, passage number (n+1), date, name 
3. Add 10mL of media to T75 and put aside 
4. Remove cells from incubator and suck out media 
5. Wash cells twice with PBS (5-10mL) 
6. Add 2mL of trypsin 
• Wait for cells to detach (5 minutes at 37C), rap gently; use scope to check 
7. Add 8mL of media for a final volume of 10mL 
8. Pipette up and down gently but mix thoroughly 
9. Add 1mL of suspension to fresh T75 (pass 1:10) 
• Put this flask in the incubator 
• Rock back and forth gently 
 
10. Remove remaining cell suspension and place in 50mL tube labeled “cell 
suspension” 
11. Mix thoroughly, and seed a hemacytometer with 15uL per side 
12. Count cells with the scope (count individual squares, average, multiply by 10,000 
to get cells/mL) 
13. Calculate total cells needed by multiplying the number of wells by the number of 
cells you want per well 
14. Mix suspension thoroughly and remove amount of cells needed to put in 50mL 
tube(s) labeled experimental conditions 
15. Mix thoroughly, and seed each plate/well 
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Appendix C: Generating Calibration Curve for Plate 
Reader for Transwell Permeability Assay 
Materials: 
FITC-BSA (A9771-100MG from Sigma, ordered through CCF) 
EC Serum Free Media 
1 50mL conical labeled FITC 1 mg/mL 
1 50mL conical labeled 1mg/mL unlabeled BSA  
1 15mL conical labeled 3 ug/mL 
5 Small Eppendorf tubes labeled 0, 0.2, 0.5, 0.6, 1.0 
Micropipettes (2-20, 20-200, and 100-1000) 
Pipettes (1 25mL, 3 5mL) 
1 96 well plate 
Foil 
 
Procedures: 
1. Make stock solution (1 mg/mL) of FITC-BSA in EC serum-free media. 
a. Weigh out about 6 mg (if using 12 wells of Transwell plate) of FITC-BSA onto 
a 50mL conical tube cover.  Keep covered with foil to prevent bleaching. 
b. Add 6 mL of EC media to make a final concentration of 1 mg/mL. 
c. Mix well! 
2. Make stock solution (1 mg/mL) of unlabeled BSA in EC serum-free media. 
a. Weigh out about 18 mg (if using 12 wells of Transwell plate) of BSA onto a 
50mL conical tube cover.  Keep covered with foil to prevent bleaching. 
b. Add 18 mL of EC media to make a final concentration of 1 mg/mL. 
c. Mix well! 
3. Dilute stock FITC-BSA solution to 3ug/mL to make lower calibration concentrations. 
a. Add 15uL of stock into 5mL of EC media in a 15mL conical tube.  Keep 
covered with foil to prevent bleaching. 
b. Mix well! 
4. Use the table below to dilute to the desired concentrations. 
 
Desired Conc 
(ug/mL) 
Vol of stock (3ug/mL) in 
uL 
Vol of media in 
uL 
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0.2 10 140 
0.5 25 125 
0.6 30 120 
1.0 50 100 
 
5. Add above volumes to small eppendorf tubes.  Each eppendorf tube will have 150 
uL of solution.  Note: add media first, then the stock volumes. 
6. Mix solution in eppendorf tubes well.  Then, add 50uL each concentration to the 
prepared 96-well plate.  Cover with foil to prevent bleaching. 
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Appendix D: EC Permeability Plating and Experiment 
Protocol 
Day 1 Supplies 
• Media 
• PBS (-, -) for passaging 
• Trypsin (5mL) 
• TNS (5mL) 
• 50mL sterile centrifuge tube labeled “Cell Suspension” 
• 15mL tube labeled 8 x 105 cells (8 wells times number of cells per well), 4mL (8 
wells times 0.5mL sol’n per well) 
• Hemocytometer 
• 1 Transwell Plate 12-well  (VWR: 29442-078) 
• T-75 flask 
• Marker 
• Pipettes and Pipette Aids 
• Micropipettes 
• Sterile Tweezer 
 
Day 2 Supplies (once cells are confluent on the Transwell plate) 
• 1 Regular 96-well Plate for sampling and calibration 
• 1 15mL conical tube labeled “waste” 
• FITC-BSA when starting experiment and other materials for “Generating 
Calibration Curve” Protocol 
• Serum-Free Media 
• Micropipettes 
• Timer 
• Foil 
 
Day 1 
1. Grow Cells in T-75 to Confluence 
2. Passage and Seed Cells for Experiment 
3. During passaging, centrifuge cells at 1000rpm for 5 minutes after the TNS step. 
4. Plate Cells in Transwell Permeable Support Plates (12 well) 
a. Add Total Volume for Plate Well (abluminal) = 1.5mL [from Transwell 
booklet] 
b. Count cells with hemocytometer 
i. Hemocytometer gives cells/1 mL (= cells/cm3) 
c. Seed at density of 105 cell/mL [from Ji dissertation] for each well (luminal) 
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i. Set up ratio 
 
Where h=number of cells counted from hemocytometer 
 x=amount of cell solution to add to each well in a 12-well 
plate 
ii. Total volume for Transwell Insert (luminal) = 0.5mL 
 
Where y=amount of media that needs to be added per well 
 x= from step i. 
iii. Set up 15mL tube labeled 8 x 105 cells (8 wells times number of 
cells per well), 4mL (8 wells times 0.5mL sol’n per well) 
d. Seed 8 wells (see below) with 0.5mL sol’n each 
e. Cells C1-C3 will be used for membrane permeability (if needed for the 
experiment) 
f. C4 will be a control with media only. 
Transwell Plate 
 
1 2 3 4 
EC 1-1 EC1-2 EC1-3 EC1-4 
EC1-5 EC1-6 EC1-7 EC1-8 
Membrane Membrane Membran
e 
Control 
 
Day 2 
5. Aspirate the media from each well using a 100-1000uL micropipette.  Add the 
discarded media to the 15mL conical labeled “waste.”  Be sure to aspirate from 
the side of the well and not from directly on top of the cells. 
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6. Add 0.5mL of serum-free media to each well.  Let this incubate for 1 hour. 
7. Add 0.5mL of prepared 1 mg/mL FITC-BSA solution to top well.  Add 1.5mL of 
prepared 1 mg/mL unlabeled BSA solution bottom well (see “Generating 
Calibration Curve Protocol”.  This is the start of the experiment. 
8. Take 10 ul samples from abluminal (bottom) chamber at 0, 20, 40, 60, 80, 100, 120 
minutes.  Dilute the samples with 40ul media. 
a. The samples will only contain media that has FITC-BSA, so this should be 
placed into a normal 96 well plate. 
b. Notation: ECX-Y X = experiment number; Y=sample number 
9. The samples for the calibration curve will be in row H of the plate (see  
“Generating Calibration Curve Protocol”) 
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Appendix E: EdU Assay for 8 wells of a Transwell Plate 
Materials 
• One Click-IT Alexa Fluor Imaging Kit containing components A-G. 
• PBS +/+ 
• Small eppendorf tubes 
• Deionized water 
• 100% Methanol (in freezer) 
• Transwell plate with cells 
• 1 15mL conical labeled “media” 
• 1 15mL conical labeled “media + Component A” 
• 1 dark 50mL conical labeled “reaction cocktail” 
• 1 dark 50mL conical labeled “1:2000 Component G” 
• Vectashield 
• 8 glass slides 
• 8 22x22mm coverslips 
• Forceps 
• Scalpel 
• 2 large petri dishes 
• 1 filter paper 
 
Procedure 
Pre-plating Steps (do in dark) 
1. Need to prepare four stock solutions.  Use solutions immediately or store as 
designated. 
2. 10mM EdU solution: add 2 mL of DMSO (Component C) to the EdU vial.  
Mix well with vortex.  Store at -20 degrees Celsius/-4 degrees F. 
3. Azide solution: add 70ul of DMSO (Component C) to the azide vial.  Mix well 
with vortex.  Store at -20 degrees Celsius/-4 degrees F. 
4. 1X buffer: Transfer all of component D into a falcon tube filled with 36mL of 
deionized water.  Mix well with vortex.  
5. 10x buffer: add 2mL of deionized water  
6. Make 50uL aliquots of components A and F.  Store these aliquots in small 
eppendorf tubes. 
 
Labeling Cells with EdU (in dark, in cell-culture hood) 
7. Prepare a 2X working solution of EdU by diluting the 10mM stock solution 
using cell culture media to obtain a concentration of 10uM. 
i. For the 12-well Transwell inserts, this is 250uL of media/well and 
250 uL of solution/well. 
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ii. Two 15mL conicals 
1. Media: 2mL 
2. Stock: 2mL Media, 4uL component A 
8. Incubate at 37C for 2 hours. 
 
Fixing and Permeabilizing Cells 
9. Aspirate media and rinse 3x with PBS +/+. 
10. Add 100% methanol to the wells (add just enough to cover the bottom of the 
well). 
11.  Incubate for 2-3 minutes. 
 
Detecting EdU-Reaction (in dark) 
12. Prepare the 1X click-iT EdU buffer by diluting 10x solution, 1:10 in deionized 
water (90uL DI water, 10uL component F). 
13. Prepare reaction cocktail (1000uL total) in the following order 50mL conical 
in the following volumes: 
i. Component D (1X Click-iT reaction buffer prepared): 860uL 
ii. Component E (CuSo4): 40uL 
iii. Component B (Alexa Fluor Azide): 2.4uL 
iv. Reaction buffer additive (prepared in step 12). 
v. Note: This must be used within 15 minutes of preparation. 
14. Remove methanol and rinse 3x with PBS +/+. 
15. Add 125uL of reaction cocktail to each well.  Rock plate and incubate for 30 
minutes, protected from light at room temperature. 
16. Remove the reaction cocktail and wash each well 3x with PBS. 
DNA Staining (in dark) 
17. Dilute component G 1:2000 to obtain 1X Hoeshst 33342 solution a 1X Hoechst 
33342 solution (concentration of 5 ug/mL). 
i. 2uL component G 
ii. 3998uL PBS +/+ 
18. Add 0.5 mL/well of diluted Hoechst 33342 solution.  Incubate for 30 minutes 
at room temperature, covered from light. 
19. Wash each well 3x with 1 mL/well of PBS.  Remove the wash. 
 
Mounting Slides (in dark) 
20. Remove well from Transwell Plate and place on filter paper on top of Petri 
dish to dry the excess liquid. 
21. Aspirate PBS wash from Transwell insert. 
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22. Cut out membrane with scalpel (do on top of petri dish).  I find that is best to 
rotate the insert and leave the scalpel in place. 
23. Transfer the membrane to a glass slide with forceps. 
24. Add a drop of vectashield to the membrane. 
25. Cover with a 22x22mm glass coverslip and repeat for other wells. 
 
Imaging and Analysis 
26. Use excitation/emission of 495/519nm for Alexa Fluor 488 and 350/461 for 
Hoechst.  For the Reichert scope this is the FITC and DAPIn filters. 
27. % proliferation = #EdU-stained cells/#Hoechst-stained cells * 100% 
 
Cleaning Slides 
28. To clean slides, remove coverslip and membrane with kim wipe.  Discard 
membrane. 
29. Spray ethanol on kim wipe and wipe coverslips and slides.  Dry coverslips 
and slides with kim wipes and then store for later use. 
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Appendix F: Senescence β–Galactosidase Staining for 6 
wells of a 24 well plate 
Materials 
1 β-Galactosidase Staining Kit (Cell Signaling) 
DMF 
PBS+/+ 
3 eppendorf (labeled “X-gal/DMF”, “Fixative Soln”, and “Staining Soln”) 
15mL conical (labeled “Staining Mix”) 
Micropipettes (1mL, 200µL, 20µL) 
24 well plate with cells 
Deionized water 
 
Preplating Steps (lasts over three plates) 
1. Dissolve 20mg X-gal in 1mL DMF to prepare 20X stock solution in eppendorf.  
Mix very well. Store excess solution in a light resistant container at -20°C up to 
one month. 
 
Setup 
2. Prepare 1X dilution of 10X Staining Solution with distilled water. 
a. 300µL 10X Staining solution, 2700µL distilled water 
3. Prepare 1X dilution of 10X Fixative Solution with distilled water. 
a. 150µL 10X Fixative solution, 1350µL distilled water 
 
Procedure 
1. Remove media from wells (top and bottom) and wash plate once with PBS. 
2. Fix cells with 250µL/well 1X Fixative solution for 10-15 minutes at room 
temperature. 
3. While plate is in Fixative Solution, prepare the Staining Solution in 15mL conical: 
a. 2790µL 1X Staining Solution 
b. 30µL Staining Supplement A 
c. 30µL Staining Supplement B 
d. 150µL 20mg/ml X-gal in DMF 
4. pH solution to 6.0. 
5. Wash the wells twice with PBS. 
6. Add 500µL of Staining Solution mix to each well in the plate 
7. Incubate plate overnight in dry incubator at 37°C. 
8. Image with color camera using “Auto White” and medium contrast. 
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Appendix G: qRT-PCR Protocol 
Making fresh 5µM primer stock solutions (NOTE: There are stock 100µM solutions of the 
primers in the -20°C that are stable for around 24 months or so. These stocks should be unthawed 
rarely. There are also 5µM solutions of the primers in the 4°C that are stable for around 1-2 
months. 
1) Place the 100µM stock solution in an ice bucket to unthaw. 
2) Add 475µL of nuclear-free water to a 2.0mL colored tube. 
3) Add 25 µL of the 100µM stock solution to the 2.0mL colored tube. 
4) Place the 100µM stock primer solution in the -20°C immediately. 
5) Place the 5µM solution in the 4°C. 
 
Measuring RNA Concentration using the Nanodrop (NOTE: Avoid free-rethaw cycles as RNA 
degrades really quickly. Also the RNA should ALWAYS be kept on ice.) 
1) Wipe down the bench, pipettes, and your gloves thoroughly with RNAse Zap.  
2) Place the RNA samples, nuclease-free water, P2 pipette, small tips, and RNAse 
Zap in a bucket of ice. 
3) Go upstairs to the nanodrop (username: microarray, password: extraction). 
4) Select the correct program. 
5) Wipe the stage down with RNase zap using the small spray bottle (only use 
enough to barely moisten a Kimwipe). 
6) Next wash the stage with nuclease-free water. 
7) Add 1.5uL of nuclear-free water to the stage. 
8) Select “Blank” 
9) Remove the water using only a Kimwipe. 
10) Change DNA-### to RNA-### using the pull-down menu in the upper-right 
corner. 
11) Add 1.5uL of nuclear-free water to the stage. 
12) Select blank again. 
13) Remove the water using only a Kimwipe. 
14) Add 1.5uL of the first RNA sample to the stage. 
15) Select measure. 
16) Remove the sample using a Kimwipe, wipe the stage with a Kimwipe that is 
barely moistened by RNAse Zap, wipe the stage with a Kimwipe that is wet with 
nuclease-free water, and dry the stage with a dry Kimwipe. 
17) Repeat steps 14) through 16) for each RNA sample 
18) Select the “Print Report” button on the top right of the screen. 
19) Turn 90°C to the left (facing the computer screen) and walk to the end of the hall 
and pick up the report from the printer. 
20) Log-out when you are finished. 
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Making cDNA (NOTE: You need to do this step on the same day) 
1) Add 5x iScript Reaction Mix (blue tube) and iScript Reverse Transcriptase 
(yellow tube) to the ice bucket. 
2) Calculate the number of µL of RNA required to add 250 ng of RNA by dividing 
250ng by “ng/ µL.” 
3) Calculate the number of µL of nuclear-free water required such that the total 
amount of nuclear-free water + RNA is 18 µL. 
4) Add the nuclease-free water to the small microcentrifuge tubes (one for each 
RNA sample) first. 
5) Add the calculated µLs of RNA next. 
6) Add 5µL of the 5x iScript Reaction Mix (blue tube) to each microcentrifuge tube. 
7) Add 1.25µL of the iScript Reverse Transcriptase (yellow tube) to each tube 
(NOTE: This is the polymerase that initiates the reaction, so you should add this 
last). 
8) Pipette gently up and down (NOTE: Do not vortex as RNA is unstable). 
9) Add the microcentrifuge tubes to the Thermocycler. Select “Run” as the 
thermocycler is already preset for use with the BioRad iScript cDNA Synthesis 
Kit. The cycle takes exactly 40 minutes. (NOTE: After 40 minutes, the 
thermocycler will attempt to “hold” the cDNA at 4°C. You should ideally 
remove the samples after the 40 minute period and continue with the next step or 
else store them in the -20°C). 
 
NOTE: You can take a break here if you need to, but it is best to just get everything over 
with. If you decide to take a break, store the cDNA in -20°C. 
 
RT-PCR protocol (NOTE: Keep everything on ice during this process). 
1) Wipe down the bench, pipettes, and your gloves thoroughly with RNAse Zap.  
2) Take a freezer box from the -20°C and place a 96-well plate in the freezer box. 
(NOTE: Make sure that you do not touch the bottom of the 96-well plate, set it on 
the counter, etc.). 
3) Place the iQ SYBR Green Supermix (orange tube) and primers (both 5’ and 3’ 
primers) in an ice bucket. 
4) Let X be the number of genes of interest (2 in the case of smMHC and β2). Label a 
600mL colored microcentrifuge tube with the name of the gene for each gene of 
interest. 
5) Let Y be the number of conditions (6 in the case of SMC(mono), SMC(HAEC), 
SMC(EPC), MSC(mono), MSC(HAEC), and MSC(EPC)). Then combine the 
following reagents in each 600mL microcentrifuge tube 
6.6*(3.5*Y+3) µL nuclease-free water 
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1.2*(3.5*Y+3) µL 3’ primer (5µM) 
1.2*(3.5*Y+3) µL 5’ primer (5µM) 
10*(3.5*Y+3) µL IQ SYBR Green Supermix 
6) Mix the solutions by pipetting up and down. 
7) Next label X 600mL microcentrifuge tubes with the gene of interest. (NOTE: All 
of the microcentrifuge tubes should be the same color). 
8) Repeat step 6) for each of the Y treatments and using a different color for each 
treatment. (NOTE: You should have X*Y tubes total clearly labeled with the gene 
name). (i.e. If you were running SMC(mono) and MSC(mono) for smMHC and 
β2 only, you would have 1 red and 1 blue tube labeled “smMHC” and 1 red tube 
and 1 blue tube labeled “β2” where the red tubes correspond to SMC(mono) and 
the blue tubes correspond to MSC(mono). 
9) Add 66.5µL of the solutions prepared in step 5) to each of the corresponding, 
labeled 600mL microcentrifuge tubes. (NOTE: At this point, you should have X*Y 
labeled microcentrifuge tubes containing 66.5µL of the corresponding primer 
solution). 
10)  Resuspend the cDNA samples using 20µL of nuclear-free water. 
11)  Add 3.5µL of the cDNA sample to each 600mL microcentrifuge tube of a single 
color. 
12)  Mix the cDNA solution by pipetting up and down or gentle vortexing. 
13)  Add 20µL of the mixed solution to each of 3 wells of the 96-well plate. (NOTE: 
Add the mixed solution to the side of the well and let it drip down. Make sure to 
avoid making air bubbles even though this a lot with the new tips). Repeat for 
the other microcentrifuge tubes. 
14)  Repeat steps 11-13) for each treatment. 
15)  Cut a piece of optical tape to fit precisely over all 96 wells of the plate. 
16)  Move the air bubbles to the top by centrifuging 3 times for 30 seconds each. 
Hold the forward arrow down for 30 seconds rather than specifying a specific 
speed or duration. (NOTE: Again, try to not touch the bottom of the 96-well 
plate) 
17)  Place the 96-well plate in the RT-PCR machine. 
18) Open the MyiQ Software and select the protocol “2stepmelt4ebd.tmo.” 
19) Select “View Plate Setup” and then select “Edit This Plate Setup.” 
20) Label each triplicate set with a unique number (NOTE: Do not label the blank 
wells as “Blank,” just leave them unlabeled.) 
21) Save the plate setup and select “Run with Selected Protocol.” 
22) Change the sample size to “20µL” and select “Begin Run.” 
(NOTE: If you receive an error message, then the baseline iQ SYBR fluorescence 
was not detected in at least one of the wells. You may have mislabeled the wells 
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using the MyiQ software, or you may have forgotten to load the iQ SYBR reagent 
into one of the wells.) 
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Appendix H: RNA Isolation 
for use with Aurum Total RNA Mini Kit from Bio-Rad 
created by C.Cheng 05.25.2011 
modified by C.Cheng 06.15.2011 
 
1. RNase Zap bench surface and wipe down all micropipettors and the aspirator 
tip. RNase Zap your hands and get 3 capped 1.5-ml tubes, 1 capless tube + filter 
for each sample. Place 90ul of elution per sample into one capped 1.5- or 2-ml tube 
and place into heat block set to 70oC. 
2. Bring sample over to RNA station and place on ice. Aspirate all media.  
3. Gently add 1ml of DPBS to each sample, making sure not to add directly on top 
of the cells. Aspirate DPBS. 
4. Add 250ul of DPBS directly to the cells. Use a cell scraper and carefully scrape off 
cells.  
5. Use a micropipetter to transfer DPBS + cell mixture from all wells into one 1.5-ml 
capped microcentrifuge tube. Place tube (with a balance) into microcentrifuge 
and spin down for 5 min at speed 10. While the cells are spinning down, place 
used plate and cell scrapers in biohazard trash and scraper wrappers in the 
normal trash. 
6. After spinning down, carefully aspirate all supernatant and add 350ul of lysis 
solution to the cell pellet. Vortex tube for 1min to lyse cells. 
7. Add 350ul of 70% Ethanol to tube and vortex 1min. 
8. Transfer solution into filter (aka “RNA binding column”). Centrifuge for 30sec at 
speed 10. After centrifugation, hold filter while aspirating filtered liquid. Place 
filter back into tube 
9. Add 700ul of low stringency wash solution to filter. Centrifuge 30sec at speed 10; 
aspirate filtered liquid 
10. For each sample, mix 5ul of reconstituted DNase I (in -20 freezer) with 75ul 
DNase dilution solution in a 1.5-ml capped tube. Add 80ul of mixture directly to 
the membrane of each filter. Incubate at room temperature for 15min.  
11. After 15min incubation, centrifuge for 30sec at speed 10. Aspirate liquid 
12. Add 700ul of high stringency wash solution to filter; centrifuge for 30sec at speed 
10; aspirate 
13. Add 700ul of low stringency wash solution to filter; centrifuge for 1min at speed 
10; aspirate 
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14. Centrifuge for 2min to remove residual wash solution. Check that heat block for 
elution solution has reached 70oC. 
15. Transfer filter to a new 1.5-ml capped centrifuge tube and pipet 90ul of warmed 
elution solution onto membrane in the filter. Let sit for 1min to allow solution to 
saturate membrane. Centrifuge uncapped for 2min at speed 10 to elute the RNA 
from the filter. 
16. Store in -80. 
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Appendix I: Western Blot Protocol 
Modified from CR and SW Protocols 
Materials 
• Lysis Buffer: CellLytic-M (Sigma C2978)+Protease inhibitor cocktail (Sigma 
P8340) 
• Mini Ready Gel 
• Laemmli’s Sample Buffer (Biorad #161-0737) 
• Beta-Mercaptoethanol (Biorad 161-0710) 
• TBST: Dilute 10x Tris-Buffered Saline (Biorad #170-6435) to 1X with DI water and 
add 0.1 % Tween 20 (Biorad 170-6531) (i.e. 50mL TBS, 450mL DI water, 0.5mL 
Tween 20) 
• Transfer Buffer: 100 mL 10x Tris Glycine Buffer (Biorad #161-0771), 700mL 
distilled water, 200mL methanol (if using PVDF membrane, otherwise 900mL 
distilled water) 
• Running Buffer: 100mL 10x Tris/Glycine/SDS Buffer (Biorad #161-0772), 900mL 
distilled water 
• PVDF membrane 
• Fiber pads 
• Filter paper 
• Kaleidoscope Ladder (Biorad 161-0375) 
• SuperSignal West Pico Stable Peroxide Solution 
• SuperSignal West Pico Luminal/Enhancer Solution 
• RESTORE Stripping Solution (21059) 
• Pierce BCA Assay Kit (Pierce 23227) 
• Film 
• Non-Fat Dry Milk Powder 
• Primary and Secondary Antibodies 
• Methanol 
• PBS -/- 
• Eppendorf tubes 
• Micropipettes 
• Pipettes 
• 96-well plate for BSA 
• 50mL and 15mL conical tubes 
 
DAY 1 
Buffer Preparation 
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1. Mix ingredients together for Transfer and Running Buffers and put into labeled 
1L jars.  These can be stored in the fridge overnight. 
2. Mix ingredients together for TBST.  Tween 20 is very viscous.  Store in fridge 
overnight. 
 
DAY 2 
Protein Harvest (Can be done as cells are ready and stored in -20C) 
1. Prepare Lysis Buffer (KEEP ON ICE) 
• Cell-lytic M (Add 0.5mL protease/phosphatase inhibitor cocktail to every 
5mL Cell-lytic M used) 
2. Carefully aspirate media from cells.  The whole process should be done on ice. 
3. Wash once with cold DPBS -/- 
4. Add DPBS to each flask or well (~400uL/well). 
5. Scrape cells with cell scraper.  Keep plate tilted at all times in order to keep all 
the cellular debris in the PBS.  Pipette out all liquid and cells.  Add suspension to 
2.0mL eppendorf tube. 
6. Spin down tubes with microcentrifuge at speed 3 for 5 minutse. 
7. Remove supernant and resuspend cells in ~70uL of of lysis buffer. 
8. Shake for 30 minutes at 4C with lab quake. 
9. Spin down tubes at max speed for 15 minutes at 4C (place microcentrifuge in 
fridge). 
10. Remove supernatant (this is the protein soluble fraction) and place each into 
sterile vials.  Store in -20C. 
 
BSA Protein Concentration Determination Protocol 
1. Prepare BSA Standards as described in the manual that comes with the BSA kit, 
EXCEPT dilute in lysis buffer rather than PBS.  (Note: The standards can be 
prepared ahead of the time and aliquoted and stored at -20C.) 
2. Prepare BCA indicator solution (# samples + # of samples) * (number of 
replicates) * (volume of indicator solution per sample) = total volume of indicator 
solution needed.  Make the solution with 50 parts Reagent A with 1 part Reagent 
B (example: 2500uL Reagent A, 50uL Reagent B). 
3. Add 100uL of BCA solution to each well of a 96-well plate. 
4. Add 2uL of each BSA standard to the wells (do in duplicate in rows A and B of 
plate). 
5. Add 2uL of each unknown sample to wells (do in duplicate, rows C and D). 
6. Shake for 30s on plate shaker. 
7. Incubate at 37C for 35 minutes. 
8. Read using plate reader in Yuan lab (ABS 590) or Bursac Lab (Mina_BSA). 
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Prepare Proteins 
1. Use Excel spreadsheet and BSA results to calculate volume of lysate needed to 
get desired amount of protein (usually, 10ug-30ug). 
2. In 1.5mL eppendorf tubes, add amount of DI water calculated on spreadsheet, 
then add protein lysate (amount specified on spreadsheet). 
3. Make Loading Buffer in a separate 1.5mL tube; solution should be 19 parts 
Laemmli’s Sample Buffer, 1 part BME (calculation on spreadsheet).  This should 
be added 1:1 with the rest of your protein solution (protein+water made in step 
2), see spreadsheet for calculation.  ADD AND STORE BME in fume hood. 
4. Put samples on heat block set at 100C for 5 minutes.  Squirt DI H2O on set to 
help seal space between tube and set.  Make sure tubes are sealed and use 
forceps to poke holes in top of tube so that the pressure does not build up.  DO 
NOT BOIL STANDARD. 
 
Run Gel 
1. During 5 minutes-Add gel to box 
a. Cut bottom film from ready gel (leave no black from cut line). 
b. Add gel to box with comb facing inward (push all the way down and 
lock).  The shorter plate faces the inside. 
c. Carefully remove comb. 
d. Add running buffer and then add to box (fill to top in inner and near top 
to outer). 
2. Add protein samples and ladder (15uL for ladder, usually 30uL for protein 
samples depending on gel lane size). 
3. Run the gel at 150 volts, max current and power for ~30-45 min (until visible 
bands reach bottom of gel, near wire). 
 
Transfer 
1. While the gel is running, soak the PVDF membrane in 100% methanol. 
2. Soak PVDF membrane, 2 fiber pads, 2 pieces of thin transfer/filter paper in 
transfer buffer right before the gel is done. 
3. Take the gel out of the cassette and gently break it open in transfer buffer.  Pour 
out Running Buffer, but DO NOT wash gel box (need a small amount of SDS in 
transfer buffer). 
4. Cut off top and bottom parts of gel with green blade. 
5. Open up the cassette (black and clear parts) and lay the black part down. 
6. Put items in following order on the black part: fiber pad, filter paper, gel, PVDF 
membrane, filter paper, fiber pad.  Roll out air bubbles with pipette after you add 
membrane, paper, and pad. 
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7. Cut one corner of the membrane so that you remember which side of the 
membrane is in contact with the gel. 
8. Close and clamp cassette. 
9. Place the holder into the trans-blot, BLACK FACING BLACK. 
10. Put box in bin (like the small autoclave bin) on stir plate with magnetic stirrer set 
at a 9, add transblot, and BioIce (in freezer). 
11. Fill box to the top with transfer buffer. 
12.  Add ice to the bin to surround the box.  This is to keep the transfer cold. 
13. Set transfer for 200V, 500mA, 40W current for 3 hours for proteins above 175kDa, 
2.5 hours for proteins 100-175kDa, 1.5 hours for 45-100kDa, and 1 hour for less 
than 45kDa (RT) and stir at Fast setting. 
 
Probe with Antibodies 
14. While transferring, make 5% milk (1g non-fat milk with 20ml TBST) in 50mL 
conical tube and 1% milk (1g non-fat milk with 100mL TBST) in flask.  Add stir 
bar to flask and stir to mix. 
15.  Take apart trans-blot and remove the membrane and put into a tray with 5% 
milk, rock at RT for 1 hour (this can be extended if there is a lot of background). 
16. Rinse membrane quickly with 1% milk in TBST. 
17. Place the membrane in 1% milk and add the primary antibody (usually about 
5mL milk needed) at the proper dilution. 
18. Incubate overnight in the cold room using gentle tilting. 
 
DAY 3 
19. Rinse once quickly, then 3X for 10 minutes each in TBST using gentle tilting. 
20. Add secondary antibody to the membrane in 1% nonfat dry milk (usually about 
1:5000 dilution). 
21. Incubate for 45 minutes at RT using gentle tilting. 
22. Rinse 3X, 10 minutes each in TBST using gentle tilting. 
 
Expose Membrane to Film 
1. In foil-wrapped 15mL conical tube, mix together 2.5mL of SuperSignal West Pico 
Stable Peroxide Solution and 2.5mL of SuperSignal West Pico Luminal/Enhancer 
Solution (1:1 ratio) (ECL Solution). 
2. Lay the membrane on Plastic Wrap and put ECL solution on the membrane 
(~5mL/membrane). 
3. Turn off the lights and let the solution sit on the membrane for 5 minutes. 
4. Transfer membrane with forceps over to new Plastic Wrap which is laid on top of 
a book or the film box. 
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5. Add a new piece of Plastic Wrap over the top of the membrane and seal.  Roll out 
any air bubbles with pipette. 
6. Cut Plastic Wrap around membrane. 
7. Place and tape membrane into the cassette. 
8. Take cassette, film, scissors, pen, and timer to the dark room (2nd floor C wing of 
LSRC). 
9. Remove film and cut corner to match the cut corner on the membrane.  Place film 
on membrane, and close cassette.  The film can be cut in half if only one 
membrane is being used. 
10.  Set timer for exposure time (3 minutes is a good place to start). 
11.  Remove film from cassette at end of exposure time, flip over, and add to 
developing machine. 
12. Repeat film exposure with other pieces of film and adjust exposure time as 
necessary. 
13. Analyze films using densitometry (see protocol below). 
 
Strip Membrane (Only necessary if reprobing) 
1. Submerge membrane in RESTORE Stripping Solution (Pierce) and incubate at RT 
for 15 minutes with occasional agitation. 
2. Wash with TBST 3X for 5 minutes each.  Repeat steps 1 and 2 of this section. 
3. Re-block in 5% milk for 1 hour at RT, then can probe for a different primary 
antibody. 
 
Data Analysis – Densitometry Protocol (Using ImageJ Software) 
1. Scan films with scanner. 
2. Open ImageJ Software.  Go to File>Open and open the scanned image of your 
membrane. 
3. Select the rectangle tool and draw a box around your first lane.  Make sure that 
you do not overlap an y other lanes. 
4. Once first lane is selected, go to Analyze>Gels>Select First Lane, or type ctrl+1. 
5. Drag box onto the next land and go to Analyze>Gels>Select Next Lane, or type 
ctrl+2.  The box for each lane must be the same size.  Make sure that each box 
encloses only the desired lane and does not overlap with other bands … this will 
create error in your data. 
6. Repeat this until all lanes on your gel have been selected. 
7. Go to Analyze>Gels>Plot Lanes, or type ctrl+3. 
8. Select the line drawing tool and draw a horizontal line even with the baseline (no 
signal) part of the graph for each line.  Make sure that the curve corresponding to 
your band is completely closed in by this line (draw vertical lines if necessary to 
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create a closed shape.  NOTE: Your procedure for this part isn’t as important as 
making sure you are consistent with what you do for all bands. 
9. Select the wand tool (to the left of the text tool).  Click inside each closed curve.  
Another box will appear, containing the area of the enclosed area (arbitrary 
units). 
10. If you are using a loading control or standard (such as B-actin), divide the 
numbers you get by the corresponding number for that control for the same lane. 
11. Plot your results using excel. 
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Appendix J: JMP Statistical Package for ANOVA and 
post-hoc Tukey Test 
2-factor ANOVA 
1. Copy and paste data into JMP. 
2. Name the columns by double clicking on the column header. 
3. If necessary, stack columns.  Go to Tables->Stack Columns.  Stack your 
numerical data.  The data type is shown by an icon next to the column name at 
the left hand side of the window. 
4. Rename the “label” column to reflect the condition. 
5. Go to Analyze -> Fit Model 
6. Under Y, add the “data” column. 
7. Under Construct Model Effects add your factors (i.e. “days post plating”, “cell 
type”).  You should have two factors for a 2-factor ANOVA.  If you only have 
one factor, you are doing a one-way ANOVA.  This is also known as a t-test. 
8. After you have added your factors, hit Run. 
9. In the results window, look under effect tests for the p-values. 
 
Tukey Test 
1. Copy and paste data into JMP. 
2. Name the columns by double clicking on the column header. 
3. If necessary, stack columns.  Go to Tables->Stack Columns.  Stack your 
numerical data.  The data type is shown by an icon next to the column name at 
the left hand side of the window. 
4. Rename the “label” column to reflect the condition. 
5. Go to Analyze -> Fit Y by X. 
6. Add the “data” column, to “Y, response” by clicking on the “Y, response” 
button. 
7. Add any factors to “X, factor” by clicking on the “X, factor” button. 
8. Click ok. 
9. In the results window, click the little red arrow next to the graph. 
10. Select Compare Means -> All Pairs, Tukey HSD. 
11. If necessary, click the little red arrow next to the newly generated graph. 
12. Select Connecting Letters Report. 
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